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ABSTRACT 
4,4-Difluoro-4-bora-3a,4a-diaza-5-indacene (BODIPY) have drawn a large number of research 
attention, for its numerous useful application in the fields of material and biology. Small 
modification of this well-known fluophore has been shown to optimize its photophysical and 
chemical properties. This work mainly focuses on functionalization of BODIPY cores with 
halogenated atoms, particularly iodine, and their subsequent post-functionalization reactions, 
mainly cross-coupling reaction and substitutions, for various further applications. 
Chapter 1 of this dissertation gives a general overview of BODIPYs including their synthetic 
strategies, post-functionalization, and how BODIPYs are utilized in many biological applications. 
Chapter 2 mainly focuses on the synthesis and characterization of 3,5-diiodo-BODIPYs’ and 
2,3,5,6-tetraiodo-BODIPY’s cross coupling products, together with the best coupling reaction 
methodology developments. 
Chapter 3 presents various aromatic substitution reactions of 3,5-diiodo-BODIPYs and 2,3,5,6-
tetraiodo-BODIPY. The methods are developed with the best solvents, temperature and 
equivalents of nucleophiles. Due to the high reactivity of the 3,5-iodines, 
123
I radio labeling 
reactions were also attempted to produce 
123
I exchanged BODIPYs within one hour.   
Chapter 4 investigates the aromatization reactions on β,β’-bicyclo-BODIPYs, and a full scan of 
all 3,5-substited groups shows that only electron withdrawing groups are stable during the 
aromatization reactions. Based on this conclusion, a bis(isothiocyanate)-BODIPY that emits in 
the near-IR region was prepared and conjugated to an EGFR-L1 peptide. 
Chapter 5 reports the synthesis of nitrophenyl BODIPYs, and their electrochemical properties 
were studied, in collaboration with Dr. Karl Kadish group from University of Houston. In the 
x 
 
reductive area, reversible peaks are found, which are corresponded to the reductive reactions on 
the nitrophenyl units. 
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CHAPTER I: INTRODUCTION 
1.1 BODIPY
®
 Structure 
Fluorescent dyes attract the attention of scientists from numerous fields, such as material 
science, molecular biology, drug discovery, tissue diagnostics, analytical chemistry and 
environmental chemistry.
1-3
 An increasing number of applications are now requiring design and 
synthesis of fluorescent chromophores to emit in the red or near infrared (NIR) region. The 
development on fluorescent chromophores’ physical and biological properties, including high 
stability and solubility and low toxicity, are being investigated by numerous research groups. 
Though a variety of fluorescent organic dyes, including fluorescein, rhodamines, cyanine and 
phthalocyanines, are commercially available, BODIPY, which is the abbreviation for boron 
dipyrromethene (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene), has been discovered and studied 
over the past two decades as a highly popular fluorophore in many applications. 
 
Figure 1.1: Structure of common fluorophores 
2 
 
BODIPY is usually prepared from the complexation of a dipyrromethene molecule with a 
disubstituted boron unit, and this is often completed by using boron trifluoride diethyl etherate. 
The dipyrromethene’s structure if formed by linking the α-positions of two pyrroles via an sp2 
carbon. The complexation of the dipyrromethene with the BF2 unit forms a rigid system and 
prevents the cis/trans isomerization of the dipyrromethene molecule. This stable rigidification 
allows the conjugation of π-electron system along the carbon-nitrogen backbone, and it leads to 
unusually intense fluorescence quantum yields.
4
 
Several numbering systems have been reported for the BODIPY core. The first system 
utilizes the similarity between BODIPY and s-indacene, which is an all-carbon tricyclic analog 
(Figure 1.2). In this numbering system, the 3- and 5- carbons are referred to as alpha and the 1, 2, 
6 and 7 are denoted as beta, which is similar to pyrroles. The C-8 position is referred to as the 
meso- position, following porphyrinic systems, and positions 4 and 4’ are for the two fluoride 
atoms on the boron atom.
2
 
 
Figure 1.2: Numbering system of BODIPY structure 
BODIPYs have a variety of applications because of their valuable characteristics, such as 
sharp bands in the absorption and emission spectra giving high sensitivity, large molar 
absorption coefficients (40000-110000 M
-1
 cm
-1
), relatively high fluorescence quantum yields, 
long excited singlet- state lifetimes (1-10 ns), high chemical and photo- chemical stability in both 
solution and solid states, versatile charge- transfer properties, good solubility in most common 
solvents and resistance toward aggregation in solution.
2-3
 
3 
 
The absorption band of a typical BODIPY is a narrow and intense band due to the S0- S1 
(π- π*) transition, around 500- 525 nm, a shoulder at high energy around 480± 5 nm due to the 0-
1 vibrational transition, and a weak and broad band around 375± 5 nm attributed to the S0- S2 (π-
π*) transition.5-6 BODIPY has a narrow and Stokes- shifted emission band, of mirror image 
shape to the absorption band, with λmax located between 530- 560 nm, which comes from the S1 
state. Low phosphorescence is observed from BODIPY dyes mainly due to negligible triple state 
formation and a fairly slow rate of intersystem crossing (except for heavy- atom effect of 2,6-
diiodo-BODIPYs).
7
 
 
Figure 1.3: Jablonski diagram
8
 
The replacement of C-8 in the BODIPY with a nitrogen atom gives a so-called aza- 
BODIPY structure. In addition to the advantages of normal BODIPY molecules, aza-BODIPYs 
have a ca. 90 nm red shift
9 
of the absorption and emission bands. Besides being a promising 
agent for photodynamic therapy,
10
 aza-BODIPYs can also be utilized as luminescent 
chemosensors.
11
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Near-infrared fluorophores (700- 900 nm) have optimal optical sensitivity for biological 
studies, including minimal interference from endogenous chromophores, optimal photon 
penetration through tissue, reduced light scattering, and lower damage to the cells and tissues 
under observation.
12-15
 The absorption and emission bands of BODIPY dyes have been tuned to 
the red or NIR region by a number of chemical reactions aimed at extending their π-systems, and 
other photophysical characteristics of BODIPYs can also be optimized. Consequently, many 
research groups have studied many synthetic methodologies to these systems. 
 
Scheme 1.1: Methods for syntheses of unsubstituted BODIPY. 
1.2 BODIPY Synthetic Methodologies 
1.2.1 Synthesis of unsubstituted BODIPYs 
Though numerous reports of synthesis of BODIPY are seen in the literature, the fully 
unsubstituted BODIPY 1 remained to be a challenge due to the very low stability of this 
compound and its intermediates. There are so far three methods reported on syntheses of 
unsubstituted BODIPY 1. The first method started from dipyrromethane 2, which is oxidized to 
the corresponding dipyrromethene using DDQ. To avoid other reactions such as decomposition 
or polymerization, the oxidation step is carried out at low temperature (-78 °C). The 
complexation step with BF3·OEt2 is performed in situ in the presence of an organic base to give 
5 
 
the desired compound in relatively low yield.
16
 Second, a reactive electrophilic pyrrole 
carbaldehyde 5 and nucleophilic α-free-pyrrole 4 afford the corresponding dipyrromethene, 
which is deprotonated using a secondary or tertiary amine, followed by complexation with boron 
trifluoride etherate (BF3·OEt2) to give the BODIPY. Interestingly, the unsubstituted BODIPY 
was synthesized in 98% yield from an efficient method, which was developed by Pena-Cabrera 
and coworkers.
17
 A meso-thiomethyl BODIPY 3 was treated with trimethylsilane under mild 
conditions, using copper(I) thienyl-2-carboxylate (CuTc) and palladium(0) in refluxing THF. 
According to the literature, no reaction was observed in the absence of CuTc or palladium(0). 
This method afforded BODIPY 1 in high yield (93%), as shown in Scheme 1.1.
18
 
1.2.2 Synthesis of substituted BODIPYs 
 
Scheme 1.2: Synthetic route to BODIPY using an arylaldehyde and an α-free pyrrole 
The most common reported and used methodology for the preparation of 8-substituted BODIPYs 
is by a condensation  reaction among two α-free pyrroles and an aldehyde under acidic 
conditions, as shown in Scheme 1.2. An oxidation step is also required for the formation of the 
dipyrromethene (common used oxidants are DDQ or p-chloranil), with a subsequent 
complexation step with BF3∙ OEt2.  
Another synthesis of 8-substituted BODIPYs is via the condensation of acyl chlorides or 
anhydrides with α-free pyrroles, as shown in Scheme 1.3. This reaction directly produces a 
dipyrromethene without the need for an additional oxidation step. The only problem with this 
route is the high reactivity of acyl chlorides that often lead to side-products. 
6 
 
 
Scheme 1.3: Synthetic routes to BODIPY using an acyl chloride and an α-free pyrrole 
Asymmetrically substituted BODIPYs can be obtained via preparation of ketopyrrole or 
formylpyrrole intermediates, with another α- free pyrrole, as shown in Scheme 1.4. 
 
Scheme 1.4: Synthesis of asymmetric BODIPY from ketopyrroles 
Anhydrides are also employed to react with an α-free pyrrole to give the corresponding 
dipyrromethene, followed by a complexation step to give BODIPYs with linkers and carboxylic 
acids at the chain ends, as shown in Scheme 1.5. This method allows the preparation of 
BODIPY-acids for subsequent conjugating reactions. 
Although the introduction of aromatic groups to the BODIPY’s meso-positions is not able to 
extend the π-conjugation significantly due to the nearly perpendicular geometry of the aryl 
groups, it increases the BODIPY stability, because the meso-positions are relatively reactive 
under many reaction conditions.
2-3, 19-20
 
1.2.3 Synthesis of aza-BODIPYs 
 
Scheme 1.5: Synthesis of aza-BODIPY through nitroso-pyrroles
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The aza-BODIPY’s precursor, the azadipyrromethene chromophore, was first described in the 
1940s, but aza-BODIPY’s research was only developed in last two decades, mainly by O’Shea’s 
group. The classical way to synthesize aza-BODIPYs is via a nitrosation of a 2,4- diaryl pyrrole, 
followed by a reaction with an α-free pyrrole and generation of azadipyrromethenes, as shown in 
Scheme 1.6.
21
 Phthalonitrile was treated with aryl Grignard reagents, and water distillation was 
able to give aza-dipyrromethenes after 24 hours. The aza-dipyrromethenes were then complexed 
to give dibenzo-fused aza-BODIPYs, as shown in Scheme 1.7.
9
 In 2010, Li et al reacted 2-
chloroindole with 1,3-diiminoisoindoline, and after complexation, an indole- based aza- 
BODIPY was prepared, as shown in Scheme 1.8.
22
 
 
Scheme 1.6: Synthesis of benzo-fused aza-BODIPYs 
1.3 Derivatization of the BODIPY Platform 
 
Scheme 1.7: An aza-BODIPY synthesis from 1,3-diiminoisoindoline 
Several BODIPYs are commercially available, and most of them are synthesized in just a few 
steps, following earlier literature. Their prices are relatively inexpensive, particularly as 
fluorescent molecules with activated acids, as shown in Table 1.1. However, looking at their λmax 
(abs) and λmax (emi) wavelengths, most of these molecules’ wavelengths are still within the 500-
8 
 
600 nm region, and their Stokes’ shifts are relatively small. In addition, due to the absence of 
meso-aryl groups in most of these structures, their stability is not compatible for some of their 
desirable applications. 
Table 1.1: Commercially available BODIPYs ready for amino-conjugation (the numbers below 
the structures show their λmax (abs.) and λmax (emi.) wavelengths) 
 
500/510 
 
527/546 
 
558/568 
Price: 5mg/ ~$300 
 
500/510 
 
541/569  
530/550 
 
576/589 
 
500/510  
493/503 
 
590/620 
 
500/510 
 
500/510  
630/650 
 
650/665 
 
581/591 
 
 
Figure 1.4: An overview of possible functionalizations on BODIPY molecules
23
 
1.3.1: Functionalization at the meso-position 
9 
 
Functionalization at the meso-position is relatively easy, compared to the substitution at 
the other pyrrolic positions, since it can be achieved by condensation of pyrroles with suitable 
aryl aldehydes or acyl chlorides. This method is still the most common method used for direct 
introduction of various aryl units on the BODIPY core, such as ligands,
1, 3, 24
 chiral auxiliaries, 
donor-acceptor groups
25-27
 and water-solubilizing groups
15, 28
 for various applications, as shown 
in Figure 1.5. The introduction of ortho-substituents on the meso-phenyl ring, the replacement of 
phenyl with bulkier groups and/or the introduction of 1,7-substituents on the BODIPY skeleton, 
are able to improve the fluorescence emission quantum yields significantly, due to restricted 
intramolecular rotation and steric hindrance between the substituents. 
 
Figure 1.5: Several meso- functionalized BODIPYs
2-3, 29-31
 
In 2012 and 2014, the synthesis of meso-chloro-BODIPYs was reported from 
dipyrroketone,
32-33
 and the reactive BODIPYs opened a door to more meso-functionalizations.
34-
39
 A dipyrrylketone was chlorinated to give 5-chloro-dipyrromethene, which was then complexed 
to give meso-chloro-BODIPY, as shown in Scheme 1.9. Further reactions indicated this chlorine 
was a good leaving group for subsequent cross-coupling reactions and substitution reactions. 
1.3.2: Functionalization at the 1,3,5,7-positions 
10 
 
 
Scheme 1.8: Synthesis of meso-chloro-BODIPYs from dipyrrylketone 
The photophysical properties of the BODIPY core can be easily tuned by switching the 
substituents on the carbon framework, particularly at the 1,3,5,7-positions. The 3,5-methyl 
groups are relatively acidic, due to being in close proximity to the pyrrolic nitrogen atom. In 
order to extend the π-conjugation system, the methyl groups can be deprotonated and further 
condensed with aromatic aldehydes through Knoevenagel reactions, generating trans-stryryl 
groups.
40-41
 Although the Knoevenagel condensation reactions require large excess of aldehydes 
and prolonged refluxing time, extension of π-conjugation is still mainly accomplished through 
this method. Addition of conjugation at the 3,5-positions generally produces a greater 
bathochromic shift (ca. 50 - 100 nm) than adding conjugation through the 2,6-positions, 
producing the greatest shift when all four methyls are converted to styryl groups.
2
 Addition of 
halogens, particularly iodine atoms, at the 3,5-positions allows BODIPY to become highly 
reactive toward nucleophilic aromatic substitutions (SNAr) and palladium-catalyzed cross-
coupling, which will be discussed in detail in the following chapters. 
 
Figure 1.6: Several cases with functionalizations at 1,3,5,7-positions
42-44
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1.3.3 Functionalization at the 2,6-Positions 
The reactivity of the BODIPY core can be predicted based on the resonance structure, as 
shown in Figure 1.7, where the 2- and 6-positions contain the least positive charge. For this 
reason, they are susceptible to undergo electrophilic aromatic substitution. Different functional 
groups have been introduced at the 2- and 6-positions via reactions including halogenation,
45-46
 
nitration,
47-48
 sulfonation,
49-50
 and formylation.
51
 For example, the introduction of sulfonate 
groups is able to largely increase the BODIPY’s water solubility for potential biological 
applications. Though sulfonate groups do not make significance changes in the absorption and 
emission spectra, BODIPYs containing sulfonates are still highly fluorescent in polar solvents, 
and more stable than their precursors. It was also reported that the addition of nitro groups at the 
2,6-positions reduces the BODIPY fluorescence quantum yields.
52
 
 
Figure 1.7: Resonance structures of BODIPY core 
The addition of halogen groups (bromide or iodide) at the 2- and 6-positions is able to 
produce red shifts in the absorption and fluorescence emission maxima, but this transformation 
largely quenches the quantum yield, due to the heavy atom effect.
46, 53
 Furthermore, post-
modification on these 2,6-halogenated BODIPYs typically involves palladium-catalyzed cross-
coupling reactions, such as Suzuki,
37, 54
 Sonagashira,
55
 and Heck reactions.
56 
 
Scheme 1.9: Protection and deprotection strategy for the BF2-BODIPY  
12 
 
1.3.4 Functionalization at the Boron-Positions 
Boron-substituted BODIPYs have been investigated in the past ten years, mainly to 
increase the stability, and in the preparation of energy cassettes. Most reports employ oxygen and 
carbon nucleophiles (sp
3
 and sp carbons) to replace the fluorines. The first 4,4-dialkyl-BODIPYs 
were synthesized via the reaction of dipyrromethenes with boron-alkyl chemicals. Alternatively, 
Ziessel et al investigated the synthesis of 4,4-dialkyl-, 4,4-diaryl-, and 4,4-diethynyl-BODIPYs 
by treating BODIPY with Grignard and organolithium reagents.
49, 57-64
 These boron-aryl 
BODIPYs have relatively larger Stokes shifts compared to their corresponding BF2 molecules. 
Cyano groups were also reported to replace the fluoride atoms, using trimethylsilyl cyanide, and 
the reactions were performed in high yields, in the presence of a Lewis acid.
49
 Recently, Ankush 
et al reported a new method to introduce ethyl groups onto the boron center in high yields via 
treating BODIPY with Et2AlCl, and the boron atom can be deprotected by boron trifluoride 
etherate, to give the BF2 BODIPY, as shown in Scheme 1.9.
65
  
 
Figure 1.8: Several 2,6-functionalized BODIPY via electrophilic substitution reactions 
Oxygen groups on the boron atom are expected to increase the solubility of BODIPY in 
aqueous solution. In 1999, the Burgess group reported the first oxygen substitution on the boron 
center by intramolecular cyclization.
66
 Since then, a series of 4,4-dialkoxy- and diaryloxy-
BODIPYs were synthesized and reported, either by treating with sodium alkoxide in refluxing 
alcohol, or with alcohols in the presence of a Lewis acid.
67
 On the other hand, Courtis et al 
conducted a synthesis of mono-alkoxy BODIPYs for further bioimaging applications.
68
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Figure 1.9: Several boron-functionalized BODIPYs 
1.4 BODIPY’s Applications 
 
Figure 1.10: Common fluorescent dyes with different emissive wavelengths and brightness.
69
 
Reprint with permission from Copyright (2008) American Chemical Society. 
1.4.1 Biological Labels 
14 
 
BODIPYs linked to a biomolecule, can facilitate visualization of interactions between 
proteins, enzymes and other targets in living cells via fluorescence detection, especially for 
systems that lack detectable signals by other means. 
BODIPYs usually have low dark toxicities, high fluorescent intensity and do not 
significantly influence the biological functions because of their small sizes. BODIPY-based 
probes can be functionalized with reactive ligands for bio-conjugations. BODIPYs with ligands 
have been studied for the detection and visualization of various proteins. Additionally, many 
BODIPY probes are being employed to label biomolecules. 
 
Figure 1.11: Biological applications of molecular fluorescent probes.
69
 Reprint with permission 
from Copyright (2008) American Chemical Society 
1.4.2 Environmental Indicators 
15 
 
 
Figure 1.12: Mouse’s vital organs and BODIPY fluids autofluorescence with different 
excitation/emission filters. a) no filter; b) blue/green (460-500nm/505-560nm) filter; c) green/red 
(525-555nm/590-650 nm) filter; d) NIR (725-775nm/790-830nm) filter. GB = gall bladder, SI = 
small intestine, BL = bladder. Reprinted with permission from Copyright (2002) Elsevier.
70
 
BODIPY dyes can be selective and sensitive fluorescent chemosensors for intracellular 
pH and a variety of metal ions. Fluorescent sensors are either constructed as fluorophore- spacer- 
receptor or as intrinsic fluorescent probes.  
Fluorophore-spacer-receptor systems operate on the basis of photoinduced electron 
transfer (PET) and internal charge transfer (ICT) processes. After binding the analyte to the 
sensor, alteration in either the fluorescence intensity or wavelength is detected. In PET sensors, 
binding of the analyte inhibits the PET while increasing the fluorescence intensity without much 
change in the spectral shift. In contrast, ICT sensors show a moderate increase in their emission 
intensity followed by significant shifts in their λmax. A series of BODIPY based sensors have 
been reported for detection of H
+
, K
+
, Ni
2+
, Cu
2+
, Zn
2+
, Hg
2+
, etc metal ions in living cells, 
examples are shown in Figure 1.13.
44, 71-76
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Figure 1.13: Some BODIPY chemosensors 
1.4.3 Cellular Stains 
Many biological samples and cells are transparent under the microscope. The internal 
parts of the cells, such as the organelles are transparent and therefore hard to be seen. As 
organelle stains, small BODIPY dyes can pass through viable cell membranes more efficiently 
than large molecules and remain inside the cell. For example, BODIPY ceramide is 
commercially available and used to specifically label ER/ Golgi, as shown in Figure 1.14. 
 
Figure 1.14: Chemical structure of BODIPY TR ceramide
77
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1.4.4 Photodynamic Therapy 
Photodynamic therapy (PDT) is a new form of treatment that utilizes a photosensitizer 
(PS), a specific wavelength of light that can excite the PS and tissue oxygen to kill cancer cells in 
a selected region of the patient’s body. When in the dark cell environment, both the PS and 
oxygen (
3
O2) present in the cell is not toxic. The conversion from triplet oxygen to singlet 
oxygen can only take place upon light activation of the PS.
78
 Once the PS absorbs photon energy 
and is excited to higher energy levels, it can relax through non-radiative decay, fluorescence or 
phosphoresce. Molecules that go through ISC take a longer time in the excited triplet state and 
therefore have a higher probability of reacting. The energy lost is taken up by molecular oxygen 
to generate a highly reactive cytocidal 
1
O2.
78-80
 
A number of BODIPYs have been observed to show low dark toxicities but high photo 
toxicities. Most phototoxic BODIPYs have two halogen atoms (Br or I) on the 2,6- positions,
81
 
but not all BODIPYs with two halogen atoms on the 2,6-positions are phototoxic. Electron-
donating 8-substituents are also necessary for phototoxicity.
46, 82
 Computational studies show 
that 2,6- substituted BODIPYs favor ISC and singlet oxygen generation.
53 
1.5 Research Outlook 
Though a number of reports are published with various methods to functionalize 
BODIPYs, we are still investigating efficient platforms and methodologies to prepare BODIPY 
with near-IR absorptions and emissions, high fluorescence quantum yields, high stability, 
solubility, and cell permeability. In this dissertation, the design, synthesis, characterization, and 
evaluation of near-IR BODIPYs for various applications is discussed in the next Chapters.  
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CHAPTER II: SYNTHESIS OF IODINATED BODIPYS AND 
INVESTIGATIONS OF THEIR PD-CATALYZED CROSS COUPLING 
REACTIONS 
2.1 Introduction 
2.1.1 Cross-Coupling Reactions 
Organometallic catalyst cross-coupling reactions were largely developed in last two decades, 
mainly providing a method to generate carbon-carbon and aromatic carbon-nitrogen bonds, 
which brought opportunities of building more organic synthesis than those of traditional 
chemistry, as shown in Scheme 2.1.
1-4
 During a general catalytic cycle for the cross-coupling 
reactions, three major processes are involved: oxidative addition, transmetalation and reductive 
elimination. The oxidative addition is considered as the rate-determining step, and the relative 
reactivity increases in the order of Cl<<Br<OTf<I.
5
 
 
Scheme 2.1: Cross coupling reactions 
There are various methods reported to functionalize the 3,5-positions of BODIPYs, including 
cross-coupling reactions, aromatic substitutions, Knoevenagel condensations, radical arylations 
and C-H arylations.
6
 For the functionalizations of the 2,6-positions, cross-coupling reactions with 
2,6-dihalogenated BODIPYs were also reported. 
7
Among these, the Pd(0)-catalyzed cross-
coupling, including mainly Suzuki, Stille, Sonogashira and Heck coupling reactions, are 
particularly convenient due to the variety of commercially available boronic acids, tin reagents, 
alkene and alkynes. 
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2.1.2 Halogenated BODIPYs 
 
Scheme 2.2: Syntheses of 3,5-dichloro-BODIPYs and their post-functionalizations
8-9
 
Scheme 2.3: Syntheses of halogenated pyrroles and unsymmetric BODIPYs
10
 
The preparation of a variety of halogenated BODIPYs has been reported in the last ten years. 
Dehaen et al contributed several methods to produce chlorinated BODIPYs. They first reported 
the synthesis of 3,5-dichloro-BODIPYs, by NCS chlorination at  -78
o
C on unsubstituted 
dipyrromethanes, followed by DDQ or p-chloranil oxidation and typical complexation conditions 
with a tertiary amine (mainly triethylamine) and boron trifluoride etherate, as shown in Scheme 
2.2.
8-9, 11-12
 Another main contribution to the synthesis of halogenated BODIPYs by Dehean et al 
was to start the routes from halogenated pyrroles with 2-acyl groups. The acylated pyrroles were 
then condensed with another α-free pyrrole in the presence of POCl3 and finally complexed to 
give unsymmetrical halogenated BODIPYs, as shown in Scheme 2.3.
10, 13
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Scheme 2.4: A stepwise bromination on an unsubstituted BODIPY
14
 
In 2010, Hao & Jiao and co-workers published an elegant stepwise bromination study, 
with results showing that mono-, di-, tetra- and pentabromo-BODIPYs can be prepared by 
reacting a meso-aryl-BODIPY with 1.6, 3.0, 6.0 and 40 equivalents of bromine.
14
 As shown in 
Scheme 2.4, the bromination was regioselective, first at the 2,6-positions, followed by the 3,5-
positions and finally the 1,7-positions, which was also demonstrated by X-ray analysis results.  
Ortiz group investigated BODIPY’s halogenation with two different conditions, including ICl 
and HIO3/I2. Especially with different equivalents of iodic acid and iodine, the degree of 
iodination on the BODIPY core was controlled, which enabled the synthesis of mono-, di- and 
polyiodinated BODIPYs.
15
 
Our group also contributed to this topic with several publications on globally 
halogenation and 3,5-diiodinations of BODIPYs. Starting from an unsubstituted meso-chloro-
BODIPY,
16
 our group found that the chlorination was controlled to stepwisely occur at the 2-, 6-, 
3- and 5-positions with 1.3, 2.3, 5.0 and 10 equivalents of trichloroisocyanuric acid in acetic 
acid,
17
 and Br2 was able to further substitute the 1,7-positions in DCM, to give perhalogenated 
BODIPYs, as shown in Scheme 2.5.
18
 We also reported the synthesis and further reactions of 
3,5-diiodo-BODIPYs. The route began with a dipyrromethane bearing two α-carboxybenzyl 
which were hydrolyzed, iodinated, followed by oxidation to dippyromethene and boron 
compelcation to give a 3,5-diiodo-BODIPY, as shown in Scheme 2.6.
19-20
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Scheme 2.5: Syntheses of pentachloro-BODIPY and its further bromination reactions 
My research involved the synthesis of two kinds of iodinated BODIPYs, based on their 
stability, further functionalizing diversity, and the commercial availability of starting materials. 
All BODIPYs were designed to contain meso-aryl groups to enhance their stabilities. In the 3,5-
diiodo-BODIPY cases, the β, β’-bicyclic structure not only provides further aromatization 
reaction possibilities, but also facilitate the starting pyrrole’s preparation.  
 
Scheme 2.6: Syntheses of 3,5-diiodo-BODIPY and its further functionalizations 
2.2 Results and Discussion 
2.2.1 Syntheses  
2.2.1.1 Syntheses of 3,5-DiiodoBODIPYs and 2,3,5,6-TetraiodoBODIPYs 
3,5-Diiodo-BODIPY 6a and 6b, with two bicyclo-rings that could potentially be 
aromatized, was prepared as shown in Scheme 2.7.
21
 Tetrahydroisoindole 2 was prepared as 
previous literature described
22
 from 1-nitro-1-cyclohexene and ethyl isocyanoacetate, and it was 
treated with arylaldehyde under acidic condition in the presence of nBu4NI, to give 
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dipyrromethanes 3a and 3b in 85% yield. The ethyl esters were hydrolyzed under classical basic 
conditions, followed by acidic work-up, and the acid 4 precipitated out. This acid was then 
iodinated and oxidized in one step by I2/MeOH/H2O conditions to afford 3, 5-diiodo-
dipyrromethene 5a and 5b. The oxidation from dipyrromethane to dipyrromethene was not 
performed by I2 in previous BODIPY iodination conditions, thus the meso-phenyl group is key 
role to help fulfill this step. Dipyrromethenes 5a and 5b were complexed with BF3·Et2O in situ 
under basic conditions to afford BODIPY 6a and 6b, in 40% overall yields for 4 steps. BODIPY 
6b bearing methoxy groups on the meso-phenyl could potentially show enhanced water 
solubility. The structure of BODIPY 6a was confirmed by its X-ray structure, as shown in Figure 
2.1.  
 
Scheme 2.7: Preparation of 3,5-diiodo-BODIPYs 6a,b from 1-nitro-1-cyclohexene 
The average length of C-I bonds is 2.06 Å, indicating these long bonds favor palladium (0) 
insertion. The plane of the meso-phenyl ring is nearly perpendicular to the central plane, forming 
a dihedral angle of 86.9°. 
2,3,5,6-Tetraiodo-BODIPY was prepared from a multi-iodination reaction of meso-aryl 
BODIPYs, as shown in Scheme 2.8. Three equivalents of pyrrole were treated with one 
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equivalent of arylaldehyde in HCl solution, and the dipyrromethane was precipitated. The 
dipyrromethane was oxidized with p-chloranil and further complexed with boron trifluoride 
etherate, producing BODIPYs 8a,b in 31-36% overall yields from pyrrole. The 3,5-
dimethoxyphenyl group was installed at the meso-position due to its reported enhancement of the 
phototoxicity and solubility.
23
 However, the attempts to iodinate unsubstituted BODIPY 8b 
failed due to the reactivity of the meso-phenyl group under those conditions, which produced a 
mixture of iodinated BODIPYs that were difficult to isolate in good yields. Meso-tolyl BODIPY 
8a was iodinated at the 2,3,5,6-positions by reacting 8a with 4.5 equivalents of iodic acid and 4 
equivalents of iodine, in refluxing anhydrous ethanol, 
15
 and the tetraiodo-BODIPY 9a was 
obtained in 76% yield. 
 
Figure 2.1: X-ray crystal structure of β,β’-bicyclo-3,5-diiodo-BODIPY 6a 
 
Scheme 2.8: Preparation of meso-aryl BODIPYs 8a,b and their tetra-iodination 
2.2.1.2 Pd-Catalyzed Stille Coupling on Iodinated BODIPYs 6a,b and 9a 
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Pd-Catalyzed Stille cross coupling reactions were investigated first, due to previous 
reports on meso-chloro-BODIPY’s showing that this reaction might proceed without a base,16, 24-
25
 although Dehean et al used base in their investigations of 3,5-dichloro-BODIPYs.
9
 We 
assumed that the meso-chloro-BODIPY’s C-Cl bonds are less steric hindered, and PdLn units are 
easier to insert into the longer C-I bonds. As C-I bonds are longer than the C-Cl bonds, no base 
was present in the attempts of the Stille coupling reactions on 3,5-diiodo-BODIPYs. BODIPY 6a 
was treated with ten equivalents of 2-(tributylstannyl)-thiophene, and the reaction was heated in 
toluene at 110
o
C in the presence of a catalytic amount (5 mol%) of tetrakis(triphenylphosphine)-
palladium(0). The reaction was monitored by TLC, which indicated that the reaction was 
complete after 2 hours, producing 3,5-dithienyl-BODIPY 10a in 88% yield, as shown in Scheme 
2.9. We then decreased the temperature to 100
o
C, 90
o
C and 80
o
C, and at 100
o
C and 90
o
C 
BODIPY 10a was obtained in similar yields of 88% and 89%, but at 80 
o
C no product was even 
obtained after 24 hours, as monitored by TLC and UV-Vis spectroscopy.  
 
Scheme 2.9: Symmetric Stille cross-coupling reactions 
Bis(triphenylphosphine) palladium(II) dichloride, which generates Pd(0) in situ, is 
cheaper than tetrakis(triphenylphosphine)palladium(0), and can be stored longer on bench-top at 
room temperature, rather than a 0 
o
C for Pd(PPh3)4. The Stille coupling reaction of 6a was then 
performed with 5 mol% of Pd(PPh3)2Cl2, and the yield obtained for 10a is the same. The 
optimized conditions (5 mol% Pd(PPh3)2Cl2, toluene, 90 
o
C for 2 hours) was applied to two other 
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commercially available tin reagents, 2-(tributylstannyl)-furan and tributylphenylstannane, and 
BODIPYs 10b and 10c were obtained 80% and 69% yield, as shown in Scheme 2.9. 
Unsymmetrical Stille coupling reactions were studied using the same catalyst, and initially 
mono-coupling product was attempted to be prepared by controlling the equivalents of tin 
reagents. A one-pot reaction condition was attempted by reacting one equivalent of 3,5-diiodo-
BODIPY 6a with one equivalent of 2-(tributylstannyl)-thiophene, and when the mono-coupling 
product was observed on TLC, another two equivalents of 2-(tributylstannyl)-furan were added 
without any work-up or purification of the first step, and BODIPY 11 was obtained in only trace 
amount, as shown in Scheme 2.10. This low yield is not only due to the difficulty of purification, 
but also mainly because the reaction between BODIPY 11 and only one equivalent of the tin 
reagent was slow, while prolonged heat would lead to decomposition and side reactions, such as 
reduction generating 3,5-unsubstituted BODIPYs. 
 
Scheme 2.10: “One-pot” Stille coupling reaction without isolation of the mono-iodo intermediate 
Since the “one-pot” conditions did not give the unsymmetric BODIPY in good yield, the 
route was designed as a stepwise way. BODIPY 6a was treated with 2,3,4 and 5 equivalents of 2-
(tributylstannyl)-furan in 100
o
C toluene, and the reactions were monitored by TLC. This 
comparative study showed that three equivalents of tin reagent gave the mono-coupling product 
as a major product, after 25 minutes reaction time. Another Suzuki cross-coupling reaction was 
then performed at the other iodinated position, by treating BODIPY 12 with 2 equivalents of 5-
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methyl-2-thienylboronic acid in refluxing toluene, and BODIPY 13 was obtained in 38% overall 
yield, with a catalytic amount of Pd(PPh3)2Cl2, as shown in Scheme 2.11. 
 
Scheme 2.11: Mono- Stille coupling followed with a Suzuki cross-coupling on BODIPY 6a 
The Stille cross-coupling conditions were also utilized in tetraiodo-BODIPY’s 
functionalization. Using toluene as the solvent, BODIPY 9a reacted with ten equivalents of 
phenylstannane, in the presence of 10 mol% Pd(PPh3)2Cl2, and BODIPY 14 was isolated in 53% 
yield, as shown in Scheme 2.12. 
 
Scheme 2.12: Stille cross-coupling reactions on tetraiodo-BODIPY 9a 
2.2.1.3 Pd-Catalyzed Suzuki Coupling on Iodinated BODIPYs 
Halogenated BODIPY’s Suzuki cross-coupling have been studied often, due to a variety 
of commercially available boronic acids, relatively low toxicity and the ease of removal after the 
reaction. Three palladium catalysts, Pd(PPh3)4, Pd(OAc)2/PPh3 and Pd(PPh3)2Cl2 were employed 
in the attempted coupling reaction between BODIPY 6a and the phenyl boronic acid, using 
toluene as the solvent and K2CO3 as the base. After refluxing in toluene for 8 hours, the 3,5-
diphenyl-BODIPY 10c was obtained in 45%, 35% and 52% yields, respectively. These moderate 
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yields and prolonged reaction time led us to investigate a bidentate ligand complexed catalyst,  
[1,1′-bis(diphenylphosphino)ferrocene] dichloropalladium(II) (Pd(dppf)Cl2), since this complex 
is reported to be relatively more reactive in the oxidative addition step, with a fairly cheap price. 
BODIPY 10c was produced from 6a in 73% yield, using Pd(dppf)Cl2 as the catalyst. The 
reaction took 2 hours only, in refluxing toluene and in the presence of K2CO3. The reaction 
conditions were further optimized by employing a co-solvent system, toluene and THF in 1:1 
ratio,
26
 and after the optimization BODIPY 10c was obtained in 85% yield. The developed 
conditions were then used for the coupling reactions of all other boronic acids, such as 2-
thienylboronic acid, 2-furanylboronic acid, 4-nitrophenylboronic acid and the products from 
these reactions, BODIPYs 10a, 10b and 15 were isolated in high yields, as shown in Scheme 
2.13.  
 
Scheme 2.13: Symmetric Suzuki cross-coupling reactions on 3,5-diiodo-BODIPY 6a 
 
                   10a                                 10b                                10c                               15 
Figure 2.2: Suitable crystal structure of BODIPY 10a, 10b, 10c and 15. 
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Suitable crystals for X-ray analysis were obtained for BODIPYs 10a, 10b, 10c and 15, 
and they are shown in Figure 2.2. BODIPY 10a’s central ring and the meso-phenyl gave a 77.3o 
dihedral angle, and a 40.3
o
 dihedral angel between the thienyl group and the central ring. The 
dihedral angle between BODIPY 10b’s furanyl ring and central C3N2B is surprisingly low as 
1.2
o
, and the meso-phenyl is almost perpendicular to the central ring, with an 86.1
o
 dihedral 
angle. In BODIPY 10c, the central C3N2B ring is nearly planar, with mean deviation 0.014 Å. Its 
meso-phenyl ring forms a dihedral angle of 79.8° with the central ring, and its 3,5-phenyl rings 
form a dihedral angle of 56.2° with the central ring. BODIPY 15’s central ring is slightly twisted, 
with the carbon atoms lying 0.076 Å off the plane, and the N atoms 0.072 Å. The meso-phenyl 
group forms a dihedral angle of 60.4° with the central C3N2B plane, and the 3,5-diphenyl groups 
47.2°. 
 
Scheme 2.14: Unsymmetric Suzuki cross-coupling reactions on BODIPYs 6a and 6b 
BODIPY 6a was also subjected to unsymmetric functionalization reactions, using two 
different boronic acids, as shown in Scheme 2.14. Following the experience from Stille 
unsymmetric coupling, BODIPY 6a was treated with 2,3,4 and 5 equivalents of (4-
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(benzyloxycarbonyl)phenyl) boronic acid, and 3 equivalents of boronic acid produced mono-
coupling BODIPY 16a after 30 minutes reaction time. After a quick work up and purification 
with a flash column, BODIPY 16a was immediately subjected to a second Suzuki cross-coupling 
reaction in the presence of five equivalents of 4-(trifluoromethyl)phenylboronic acid for 15 
minutes, affording BODIPY 17a in 95% yield. 
Due to the availability of a variety of boronic acids, BODIPY 9a was also functionalized 
with phenyl boronic acid, 3,5-dimethoxyphenyl boronic acid and 3,4,5-trimethoxyphenyl boronic 
acid, in the presence of 10 mol% Pd(dppf)Cl2, and 2,3,5,6-tetraaryl-BODIPYs 14, 18 and 19 
were produced in 45%, 48% and 48% yields, as shown in Scheme 2.15. 
 
Scheme 2.15: Suzuki cross-coupling reactions on tetraiodo-BODIPY 9a 
2.2.1.4 Pd-Catalyzed Heck Coupling reactions on Iodinated BODIPYs 
Reported typical Heck cross-coupling reactions require relatively high temperature and 
long reaction time, and some BODIPYs decompose or polymerize under such conditions, thus 
Heck cross-coupling reactions on BODIPYs are not investigated as often as Stille and Suzuki 
cross-coupling reactions. However, the extension of π-systems of BODIPYs is important, due to 
arylstyryl substitution at 3,5-positions red-shift BODIPY’s absorption and emission spectra by 
up to 250 nm,
27-28
 and they can also increase fluorescence quantum yields when they are at the 
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2,6-positions.
29
 Knoevenagel condensation reactions are widely reported to functionalize the 
3,5
27-28
 and meso
30
 positions with arylstyryl units due to the ease of preparation of methylated 
BODIPYs and the readily availability of aryl aldehydes. One example is shown in Scheme 2.16. 
However the low yields and prolonged reaction times limit the synthesis of BODIPYs with 
arylstryl groups. Another drawback of the condensation reaction is that Knoevenagel reactions 
are not accessible for 2,6-methyl groups, probably due to their relatively low acidity. The Heck 
reaction is considered a candidate to replace classical condensation reactions, and we are 
expecting to develop Heck cross-coupling conditions that require lower temperature, shorter 
reaction time and fewer reagents to avoid further reactions on styrylated BODIPYs. 
 
Scheme 2.16: A typical Knoevenagel reaction condition
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Other than halide compounds and olefins, a typical Heck reaction condition also requires 
reagents including a base, a Pd catalyst and high boiling point solvents. We chose anhydrous 
DMF as the first solvent to try since it was mostly reported in previous literature
9
 (boiling point: 
153 
o
C), and triethylamine was employed as the base due to its high solubility. Pd(dppf)Cl2 was 
attempted as the first catalyst due to its efficient catalytic performance in Suzuki and Stille cross-
coupling reactions. BODIPY 6a was treated with 10 equivalents of 4-vinyl-anisole, and 3 hours 
later TLC indicated a consumption of the starting material and a new green fluorescent was seen. 
However, after a quick work up and column chromatography, no desired product was obatined. 
38 
 
This failure was mainly because the target BODIPY’s solubility is very low in most organic 
solvents. BODIPY 6 was then employed, since the methoxyl groups on the meso-phenyl unit 
enhance solubility largely, and BODIPY 20 was obtained in 55% yield, using the same 
conditions. We then perform the same reaction condition in refluxing toluene (110
o
C) for three 
hours to lower down the reaction temperature, and BODIPY 20 was isolated in a higher yield, 
64%, as shown in Scheme 2.17. Other attempted optimizations, such as lowering the temperature 
to 90
o
C or replace triethylamine with potassium carbonate, did not produce BODIPY 20 at all. 
BODIPY 6 was also treated with 10 equivalents of 4-vinyl-anisole, and BODIPY 21 was 
obtained after 3 hours, in 60% yield. The Heck reaction’s yields from 6b clearly indicated the 
meso-(3,5-dimethoxy)-phenyl groups increased solubility of the 3,5-styrylated BODIPYs. 
 
Scheme 2.17: Symmetric Heck cross-coupling reactions on BODIPY 6b 
The relatively longer Heck reaction time shows it might be easier to perform mono-Heck 
cross-coupling reactions with lower equivalents of olefins. BODIPY 6 was subjected to 
unsymmetric functionalization, first a Heck cross-coupling reaction, followed by a Suzuki 
coupling reaction, as shown in Scheme 2.18. Following the experience from Stille unsymmetric 
coupling, BODIPY 6 was treated with 4, 5 and 6 equivalents of 4-vinyl-anisole, and 6 
equivalents of the olefin produced mono-coupling BODIPY 22 after 2 hour reaction time. After 
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quick work up and purification with a flash column, BODIPY 22 was subjected to a Suzuki 
cross-coupling reaction in the presence of five equivalents of 2-furanyl boronic acid for 15 
minutes, affording BODIPY 23 in 24% overall yield from 6a. 
 
Scheme 2.18: Mono- Heck coupling on BODIPY 6a followed by a Suzuki coupling reaction 
2.2.2 Structural Characterization 
All BODIPYs were characterized by 
1
H-, 
13
C- and 
11
B-NMR, HRMS, UV-Vis and 
fluorescence. All 
11
B-NMR show triplets for the BF2 units, demonstrating no cross-coupling 
reactions affected the BF2 units. 
In proton NMR of 3,5-diiodo-BODIPYs 6a and 6b and their derivatives, in addition to 
signals from aromatic protons and methoxy groups, the bicyclic units show CH2 peaks between 
2.8 to 1.3 ppm. Symmetric BODIPYs generally show four signals of four protons each due to the 
symmetry of the BODIPY, while unsymmetric BODIPYs produced two triplet signals in the 2.8 
ppm to 2.4 ppm region, indicating those two CH2 units are in different environment, as shown in 
Figure 2.3 and 2.4. The carbon NMRs also agree with this observation, because the sp
3
-C region 
shows four signals when the BODIPY is symmetric and eight signals when the BODIPY is 
unsymmetric with two different units at the 3,5-positions, as shown in Figures 2.5 and 2.6. 
The NMR spectra of tetraiodo-BODIPY 9a and its derivatives show relatively high 
symmetry. Through iodination reactions, the 1,7-protons remained around 7.0 ppm, and the 
protons at the 2,3,5,6-positions disappeared. After the installation of four aryl groups, a number 
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of aromatic signals overlap with each other, and the signals from the methoxy groups were 
clearly isolated, as shown in Figure 2.7 shows. 
 
Figure 2.3: The 2.7-1.3 ppm region from the 
1
H-NMR of BODIPY 10a 
 
Figure 2.4: The 2.9-1.3 ppm region from the 
1
H-NMR of BODIPY 23 
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Figure 2.5: The 25-22 ppm region from the 
13
C-NMR of BODIPY 10a 
 
Figure 2.6: The 25-22 ppm region from the 
13
C-NMR of BODIPY 13 
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Figure 2.7: The 3.9-3.5 ppm region from the 
1
H-NMR of BODIPY 19 with OCH3 signals  
2.2.3 Spectroscopic Study 
 
Figure 2.8: Normalized absorption spectra of BODIPYs 10a (black), 10b (red), 20 (blue), 21 
(cyan), 13 (magenta) and 23 (yellow) in THF at RT. 
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Figure 2.9: Normalized emission spectra of BODIPYs 10a (black), 10b (red), 20 (blue), 21 
(cyan), 13 (magenta) and 23 (yellow) in THF at RT 
 
Figure 2.10: Normalized absorption spectra of BODIPYs 14 (black) and 19 (red) in THF at RT 
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Figure 2.11: Normalized emission spectra of BODIPYs 14 (black) and 19 (red) in THF at RT 
The spectroscopic properties of BODIPYs were investigated in THF. BODIPY 6a, 6b 
and their derivatives showed absorption bands between 550 and 657 nm and emission bands 
between 559 and 671 nm in THF with strong absorption bands (log ε= 4.7-5.0), as Table 2.1 
shows. The thienyl group was able to red-shift 39 nm for the absorption, and its Stokes shift is 
also the highest, showing that the free rotation of thienyl groups is relatively fast. The furanyl 
group largely shifts BODIPY’s absorption by 69 nm, but its Stokes’ shift is reduced to 15 nm. 
BODIPY 6a and 6b’s low quantum yields are probably due to the heavy-atom effect caused by 
the iodine atoms. The introduction of styryl groups induced greatly red-shifts of 79–90 nm and 
92–112 nm for the absorption and emission, respectively, due to further extension of the π-
conjugation. In addition, the methoxy- group on styryl groups red-shifts BODIPY’s absorption 
and emission spectra with a further 17 nm and 20 nm, respectively, and this can be explained by 
a push-pull effect.
31
 Both 3,5-distyrylated BODIPYs show a shoulder at lower wavelength that is 
attributed to the vibrational transitions. The broader and weaker absorption bands seen in the 
absorption spectra of the styryl-BODIPYs centered at 560 nm are likely due to the S0–S2 
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transition.
32
 Most BODIPYs produced by cross-coupling reactions show higher fluorescence 
quantum yields than the 3,5-diiodo-BODIPYs 6a and 6b, and their quantum yields are in 
agreement with similar BODIPY’s reports.31 
Table 2.1: Spectroscopic properties of BODIPYs 6a, 6b, 10a, 10b, 10c, 13, 20, 21 and 23 in 
THF at RT 
BODIPYs Abs. λ
max
 (nm) log ε (M
-1
cm
-1
) Emission λmax
 (nm) Φf Stokes shift (nm) 
6a 550 5.00 560 0.14 10 
6b 550 5.00 559 0.14 9 
10a 589 4.69 634 0.74 45 
10b 629 4.76 644 0.63 15 
10c 548 4.74 574 0.42 26 
20 640 4.78 651 0.53 11 
21 657 4.81 671 0.28 14 
13 637 4.74 656 0.65 19 
23 640 4.79 655 0.49 15 
 
 BODIPY 14, 18 and 19 showed absorption bands between 577 and 617 nm and emission 
bands between 597 and 668 nm in THF with high extinction coefficients (log ε= 4.9-5.0), as 
Table 2.2 shows. Comparing with BODIPY 6a, BODIPY 9a’s red-shifts from absorption and 
emission spectra are mainly due to the 2,6-iodine groups. BODIPY 14 and 18 show similar λmax 
in the absorption and emission spectra, but BODIPY 14’s quantum yield is higher, because of the 
relatively fast rotation of the aryl groups on BODIPY 18’s 2,3,5,6-positions. BODIPY 19’s large 
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red-shifts of the absorption and emission spectra are due to a push-pull effect, and the fastest free 
rotation rate induces the lowest quantum yield. 
Table 2.2: Spectroscopic properties of BODIPYs 9a, 14, 18 and 19 in THF at RT 
BODIPYs Abs. λ
max
 (nm) log ε (M
-1
cm
-1
) Emission λmax
 (nm) Φf Stokes shift (nm) 
9a 577 5.02 597 0.09 20 
14 583 4.87 619 0.36 36 
18 585 4.99 623 0.10 38 
19 617 5.06 668 <0.01 51 
 
2.3 Conclusions 
In summary, two types of iodinated BODIPYs were successfully prepared and their 
reactivity under Pd-catalyzed cross-coupling reactions were investigated. We were able to 
synthesize a series of symmetric and unsymmetric BODIPYs with aryl and/or styryl groups. 
Stille cross-coupling reactions are accessible with most Pd(0) catalysts, but Suzuki and Heck 
coupling reactions favor Pd(dppf)Cl2 as the most efficient catalyst. Methodology development 
provided methods to functionalize BODIPY’s 2,3,5,6-positions with aryl and styryl groups in 
higher yields and shorter time, compared with the yields from chlorinated and brominated 
BODIPYs. The Heck cross-coupling reaction on iodinated BODIPYs also provided a better 
method to replace the Knoevenagel reaction. Most cross-coupling products show red-shifted 
absorption and emission spectra, thus iodinated BODIPYs could potentially be functionalized 
with cross-coupling reactions to produce near-IR platforms for bio-imaging and other 
applications. 
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2.4 Experimental 
2.4.1 General Information 
 All the reagents and solvents were purchased from Sigma-Aldrich and were used without further 
purification. All reactions were carried out with oven-dried glassware under a dry argon 
atmosphere. All the reactions were monitored using Sorbent Technologies 0.2 mm silica gel TLC 
plates with UV-254 nm indicator. Flash column chromatography was performed using Sorbent 
Technologies 60 Å silica gel (230-400 mesh). Prep-TLC 60 Å silica gel 20 x 20 cm (210-270 
μm) was used. All 1H-, 13C-, and 11B-NMR spectra were collected on a Bruker AV-400 and AV-
500 spectrometer in deuterated chloroform or dichloromethane. The CDCl3 chemical shifts (δ) 
are reported in ppm using as reference 7.26 for proton and 77.00 for carbon and BF3•OEt2 was 
used as reference (0.00 δ) for boron NMR. The CD2Cl2 chemical shifts (δ) are reported in ppm 
using as reference 5.32 for proton and 53.50 for carbon. 
Coupling constants are reported in Hertz (Hz). All the mass spectra were collected using an 
Agilent 6210 ESI-TOF mass spectrometer. All melting points were recorded using a MEL-
TEMP electrothermal instrument. 
2.4.2 Synthesis 
Synthesis of 3,5-diiodo-8-aryl-BODIPYs 6a,b. To a solution of tetrahydroisoindole 2 (772 mg, 
4.00 mmol) p-TsOH monohydrate (40.0mg, 0.210 mmol) and nBu4NI (20.0 mg, 0.0541 mmol) 
in dicloromethane (50 mL) was added 0.6 equiv. of arylaldehyde. The reaction was stirred for 12 
h at room temperature under inert atmosphere. The mixture was washed with sat. NaHCO3 (1 x 
50 mL) and with sat. NaCl (1 x 50 mL) before being dried over anhydrous Na2SO4. The solvent 
was removed under vacuum and the residue was purified by silica gel column chromatography 
(elution: hexanes/ethyl acetate 5:1). Dipyrromethanes 3a (from benzaldehyde) and 3b (from 3,5-
dimethoxybenzaldehyde) were obtained in 95% and 86% yield, respectively, and 3a’s NMR and 
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MS are in agreement with those reported.
33
 For 3b: Orange solid, mp(°C) 89; 
1
H NMR (CDCl3, 
400 MHz) δ 9.39 (s, 2H), 6.33 (t, J = 2.3 Hz, 1H), 6.24 (d, J = 2.3 Hz, 2H), 5.40 (s, 1H), 4.19 – 
4.09 (m, 4H), 3.67 (s, 6H), 2.76 (d, J = 6.3 Hz, 4H), 2.27 (d, J = 5.5 Hz, 4H), 1.73 – 1.64 (m, 
8H), 1.24 (t, J = 7.1 Hz, 6H); 
13
C NMR (CDCl3, 100 MHz) δ 161.9, 161.0, 141.7, 130.8, 129.0, 
119.7, 116.7, 106.5, 98.3, 59.7, 55.1, 40.3, 23.3, 23.2, 23.1, 21.3, 14.3; HRMS (ESI-TOF) m/z 
535.2811 [M+H]
+
 calcd for C31H39N2O6 535.2803. Dipyrromethane 3a or 3b (1.00 mmol) was 
dissolved in THF/methanol 1:1 (12 mL) and a solution of KOH (504 mg, 8.98 mmol) in water 
(10 mL) was added. The final mixture was refluxing for 4 h before being cooled to room 
temperature, poured into 2 M HCl (50 mL) and stirred at room temperature for 15 min. The 
precipitate was collected under vacuum filtration and dissolved in 45 mL methanol. A solution of 
NaHCO3 (0.54 g) and I2 (0.50 g) in water (15 mL) was added, the mixture was sonicated for 5 
min and then stirred for 24 h under Ar. The mixture was filtered and the precipitate washed with 
cold hexanes to remove excess iodine. The precipitate was dissolved in dichloromethane (50 mL) 
and cooled with an ice bath. Triethylamine (2.0 mL) and BF3·OEt2 (3.0 mL) were added. After 5 
min the ice bath was removed and the solution was stirred at room temperature for 2 h. The 
solvents were removed under vacuum and the resulting residue was dissolved in ethyl acetate 
(100 mL) and washed with 1M HCl (1 x 100 mL), sat. NaHCO3 (1 x 50 mL) and sat. NaCl (1 x 
50 mL). Ethyl acetate was removed and the oily residue was purified by silica gel column 
chromatography (elution: hexanes/dichloromethane 1:2). 3,5-Diiodo-BODIPYs 6a and 6b were 
obtained in 40% and 42% yields, respectively, as brown solids. 
3,5-Diiodo-8-phenyl-BODIPY 1a. mp(°C) 220;
 1
H NMR (CDCl3, 400 MHz) δ 7.49 (dd, 
J = 5.1, 1.9 Hz, 3H), 7.26 – 7.20 (m, 2H), 2.30 (tt, J = 6.3, 1.3 Hz, 4H), 1.62 – 1.56 (m, 4H), 1.53 
(t, J = 6.3 Hz, 4H), 1.42 – 1.36 (m, 4H); 13C NMR (CDCl3, 125 MHz) δ 142.2, 139.1, 136.3, 
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134.6, 134.3, 129.5, 129.4, 127.7, 106.2, 24.4, 24.2, 23.1, 22.4; 
11
B NMR (CDCl3,128 MHz) δ 
0.47 (t, J = 30.7 Hz); HRMS (ESI-TOF) m/z 649.9796 [M +Na]
+
 calcd for C23H21BF2I2N2Na 
649.9784. 
3,5-Diiodo-8-(3,5-dimethoxyphenyl)-BODIPY 1b. mp(°C) 226; 
1
H NMR (CDCl3, 400 
MHz) δ 6.55 (t, J = 2.3 Hz, 1H), 6.39 (d, J = 2.3 Hz, 2H), 3.80 (s, 6H), 2.31 (t, J = 6.3 Hz, 4H), 
1.74 (t, J = 6.2 Hz, 4H), 1.65 – 1.59 (m, 4H), 1.48 – 1.40 (m, 4H); 13C NMR (CDCl3, 125 MHz) 
δ 161.7, 142.1, 138.6, 136.09, 136.06, 135.7, 134.2, 106.1, 105.4, 101.1, 55.6, 24.2, 23.8, 23.1, 
22.3; 
11
B NMR (CDCl3, 128 MHz) δ 0.44 (t, J = 30.6 Hz);
 
HRMS (ESI-TOF) m/z 668.0104 [M 
− F]+ calcd for C25H24BFI2N2O2 668.0113. 
Synthesis of unsubstituted meso-aryl BODIPYs 8a and 8b. 3.10 mL (45.0 mmol) pyrrole and 
15.0 mmol arylaldehyde were mixed and stirred in 100 ml of 0.18 M hydrochloric acid solution 
for 3 hours. The resulting dipyrromethane precipitates and was filtered. The solid was then 
dissolved in 100 mL and washed with 2 x 50 mL saturated sodium bicarbonate solution before 
being dried over anhydrous Na2SO4. The solution was concentrated down under vacuum to 20 
mL and then 1.1 equiv. (16.5 mmol) of p-chloranil was added slowly. The reaction was stirred 
under inert atmosphere for 2 hours and then 9.0 mL of triethylamine (75.0 mmol) was added. 
After 10 minutes, BF3·OEt2 (9.8 mL, 105 mmol) were added via a syringe dropwisely at 0
o
C. 
The ice bath was removed after the addition of BF3 etherate and the solution was allowed to stir 
in room temperature for 4 hours. The solvents were removed under vacuum and the resulting 
residue was dissolved in ethyl acetate (100 mL) and washed with 1M HCl (1 x 100 mL), sat. 
NaHCO3 (1 x 50 mL) and sat. NaCl (1 x 50 mL). Ethyl acetate was removed and the oily residue 
was purified by silica gel column chromatography. BODIPYs 8a and 8b were obtained in 36% 
and 31% yields, respectively, as brown and yellow solids. 
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BODIPY 8a: 
1
H NMR (500 MHz, CDCl3) δ 7.93 (s, 2H), 7.47 (d, J = 8.1 Hz, 2H), 7.34 
(d, J = 7.8 Hz, 2H), 6.96 (d, J = 4.2 Hz, 2H), 6.60 – 6.50 (m, 2H), 2.48 (s, 3H); HRMS (ESI-
TOF) m/z 283.1210 [M+H]
+
 calcd for C16H14BF2N2 283.1218.  
BODIPY 8b: 
1
H NMR (400 MHz, CD2Cl2) δ 7.91 (s, 2H), 7.06 (d, J = 4.2 Hz, 2H), 6.71 
(dd, J = 18.2, 2.3 Hz, 3H), 6.63 – 6.50 (m, 2H), 3.83 (s, 6H); HRMS (ESI-TOF) m/z 329.1262 
[M+H]
+
 calcd for C17H15BF2N2O2 329.1273. 
Tetra-iodination reaction conditions. 70.0 mg of BODIPY 8a (0.25 mmol) and 283.4 mg of 
iodine (1.12 mmol) were mixed and dissolved in 20 mL ethanol. 174.6 mg of iodic acid (1.0 
mmol) was dissolved in minimum amount of water and was added dropwisely into the solution. 
The brown solution was refluxing for 3 hours until TLC indicated all starting material was gone, 
and the solution’s color turned to dark pink. Ethanol was removed under vacuum, and the residue 
green solids were dissolved in 100 mL DCM, and washed with 2 x 50 mL of saturated sodium 
thiosulfate solution before being dried over anhydrous Na2SO4. DCM was removed under 
vacuum and the residue was purified by silica gel column chromatography. BODIPY 9a was 
obtained in 76% yield as a dark green solid. mp(°C) 283; 
1
H NMR (400 MHz, CD2Cl2) δ 7.41 (d, 
J = 8.2 Hz, 2H), 7.37 – 7.33 (m, 2H), 7.08 – 7.01 (m, 2H), 2.46 (s, 3H); 13C NMR (125 MHz, 
CD2Cl2) δ 142.4, 141.0, 139.3, 137.8, 130.6, 129.5, 129.0, 115.3, 90.6, 21.3; 
11
B NMR (128 
MHz, CD2Cl2) δ 0.00 (t, J = 29.2 Hz); HRMS (ESI-TOF) m/z 766.7034 [M-F]
+
 calcd for 
C16H9BFI4N2 766.7022. 
General Stille cross-coupling conditions on 3,5-diiodo-BODIPYs. For symmetric BODIPYs, 
62.8 mg (0.100 mmol) 6a, and 5.00 mg Pd(PPh3)2Cl2 and 5 equiv (0.500 mmol) of tin reagent 
were mixed under inert atmosphere. Toluene (2 mL) were added via syringe and the solution was 
heated at 90 
o
C in an oil bath for 3 min. Tin reagent was added via syringe and the reaction was 
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monitored by TLC until complete consumption of 3,5-diiodo-BODIPY. The cooled solution was 
filtered through celite to remove excess palladium, and the solvent was concentrated under 
vacuum. The residue was purified by silica gel column chromatography to afford the 
corresponding 3,5-diaryl-BODIPYs as red solids, which were recrystallized using 1:1 
dichloromethane/hexane. For the unsymmetric BODIPYs, 62.8 mg (0.100 mmol) BODIPY 6a 
and 5.00 mg Pd(PPh3)2Cl2 were mixed under inert atmosphere. Toluene (2 mL) was added via 
syringe and the solution was heated at 90 
o
C for 3 minutes. Three equivalents of the tin reagent 
were added via syringe and the reaction was heated at 70 
o
C for 25 min. The cooled solution was 
filtered through celite and the solvent removed under vacuum. The residue was purified by silica 
gel column chromatography. The second band corresponding to the 3-aryl-5-iodo-BODIPY was 
collected, and immediately reacted with 5.00 mg Pd(dppf)Cl2 and 5 equiv of 5-methyl-2-
thienylboronic acid under inert atmosphere. Toluene (2 mL) and THF (2 mL) were added via 
syringe and the solution was heated at 70 
o
C for 3 minutes. K2CO3 (1 M, 0.5 mL) solution was 
added via syringe and the reaction was heated at 70 
o
C for 30 min. The cooled solution was 
filtered through celite and the solvent removed under vacuum. The residue was purified by silica 
gel column chromatography and recrystallized using 1:1 dichloromethane/hexane. 
BODIPY 10a: Yield 78%. mp(°C)> 300; 
1
H NMR (400 MHz, CD2Cl2) δ 7.69 – 7.61 (m, 
2H), 7.58 – 7.45 (m, 5H), 7.41 – 7.30 (m, 2H), 7.20 – 7.10 (m, 2H), 2.51 (t, J = 6.2 Hz, 4H), 1.68 
(t, J = 6.3 Hz, 4H), 1.64 – 1.56 (m, 4H), 1.47 – 1.40 (m, 4H); 13C NMR (100 MHz, CD2Cl2) δ 
146.9, 142.1, 135.5, 132.6, 132.1, 131.4, 131.3, 130.7, 129.24, 129.15, 128.5, 128.3, 127.3, 24.5, 
23.8, 23.0, 22.8; 
11
B NMR (128 MHz, CDCl3) δ 1.10 (t, J = 32.8 Hz); HRMS (ESI-TOF) m/z 
540.1788 [M+H]
+
 calcd for C31H28BF2N2S2 540.1786. 
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BODIPY 10b: Yield 80%. mp(°C)> 300; 
1
H NMR (400 MHz, CD2Cl2) δ 7.64 (d, J = 1.7 
Hz, 1H), 7.59 (d, J = 3.6 Hz, 1H), 7.54 – 7.46 (m, 2H), 7.41 – 7.28 (m, 1H), 6.63 (dd, J = 3.6, 1.7 
Hz, 1H), 2.92 – 2.64 (m, 2H), 1.71 – 1.56 (m, 4H), 1.46 – 1.37 (m, 2H); 13C NMR (101 MHz, 
CDCl3) δ 147.6, 143.9, 142.0, 141.4, 138.5, 135.8, 132.4, 130.6, 129.0, 128.9, 128.5, 116.1, 
116.0, 115.9, 112.7, 24.4, 24.1, 22.8, 22.7; 
11
B NMR (128 MHz, CD2Cl2) δ 1.28 (t, J = 33.5 Hz); 
HRMS (ESI-TOF) m/z 530.2045 [M+Na]
+
 calcd for C31H27BF2N2O2Na 530.2062. 
BODIPY 10c: Yield 85%. mp(°C)> 300; 
1
H NMR (CD2Cl2, 400 MHz) δ 7.55 (dd, J = 
5.0, 1.9 Hz, 3H), 7.50 (dd, J = 7.4, 2.3 Hz, 4H), 7.43 – 7.36 (m, 8H), 2.28 (s, 4H), 1.72 (t, J = 6.1 
Hz, 4H), 1.54 (qd, J = 5.2, 2.9 Hz, 4H), 1.45 (ddp, J = 9.5, 6.4, 2.8 Hz, 4H); 
13
C NMR (CDCl3, 
125 MHz) δ 154.5, 141.6, 141.6, 135.7, 132.2, 131.3, 129.7, 129.62, 129.59, 129.57, 129.1, 
129.0, 128.5, 128.1, 127.7, 24.3, 23.1, 22.7, 22.6; 
11
B NMR (CDCl3, 128 MHz) δ 0.87 (t, J = 
32.0 Hz); HRMS (ESI-TOF) m/z 508.2638 [M-F]
+
 calcd for C35H31BFN2 508.2595. 
BODIPY 13: Yield 38%. mp(°C)> 300; 
1
H NMR (400 MHz, CD2Cl2) δ 7.62 (d, J = 1.7 
Hz, 1H), 7.54 (d, J = 3.7 Hz, 1H), 7.53 – 7.46 (m, 4H), 7.40 – 7.30 (m, 2H), 6.87 (dd, J = 3.7, 1.2 
Hz, 1H), 6.59 (dd, J = 3.7, 1.7 Hz, 1H), 2.76 (t, J = 6.2 Hz, 2H), 2.57 (s, 3H), 2.52 (t, J = 6.2 Hz, 
2H), 1.80 – 1.51 (m, 8H), 1.49 – 1.38 (m, 4H); 13C NMR (101 MHz, CD2Cl2) δ 147.6, 144.2, 
143.9, 141.6, 139.4, 135.7, 132.4, 131.7, 130.5, 129.2, 129.0, 128.7, 128.5, 126.4, 126.0, 116.0, 
112.5, 24.6, 24.4, 24.1, 23.0, 22.89, 22.86, 22.7, 15.2; 
11
B NMR (128 MHz, CDCl3) δ 1.22 (t, J = 
33.3 Hz); HRMS (ESI-TOF) m/z 560.2007 [M+Na]
+
 calcd for C32H29BF2N2NaOS 560.1990. 
General Stille cross-coupling conditions on 2,3,5,6-tetraiodo-BODIPYs. 78.6 mg (0.100 
mmol) 9a, and 10.00 mg Pd(PPh3)2Cl2 and 10 equiv (1.000 mmol) of tin reagent were mixed 
under inert atmosphere. Toluene (3 mL) were added via syringe and the solution was heated at 
90 
o
C in an oil bath for 3 min. Tin reagent was added via syringe and the reaction was monitored 
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by TLC until complete consumption of BODIPY 9a. The cooled solution was filtered through 
celite to remove excess palladium, and the solvent was concentrated under vacuum. The residue 
was purified by silica gel column chromatography to afford the corresponding 2,3,5,6-
tetraphenyl-BODIPY. Yield 53%. mp(°C)> 300; 
1
H NMR (400 MHz, CD2Cl2) δ 7.65 (d, J = 8.1 
Hz, 2H), 7.47 – 7.33 (m, 12H), 7.20 – 7.14 (m, 6H), 7.12 (d, J = 1.4 Hz, 2H), 7.08 – 7.00 (m, 
4H), 2.52 (s, 3H); 
13
C NMR (100 MHz, CD2Cl2) δ 156.1, 145.0, 141.3, 134.7, 134.6, 134.51, 
134.48, 133.9, 132.2, 131.5, 131.0, 130.42, 130.39, 130.37, 129.3, 129.1, 128.8, 128.3, 128.2, 
127.8, 127.0, 21.3; 
11
B NMR (128 MHz, CD2Cl2) δ 0.78 (t, J = 30.7 Hz); HRMS (ESI-TOF) m/z 
566.2435 [M-F]
+
 calcd for C40H29BFN2 566.2439. 
General Suzuki cross-coupling conditions. For symmetric BODIPYs, 62.8 mg (0.100 mmol) 
6a or 68.8 mg (0.100 mmol) 6b, 5.00 mg Pd(dppf)Cl2 and 5 equiv (0.500 mmol) of aryl boronic 
acid were mixed under inert atmosphere. Toluene (2 mL) and THF (2 mL) were added via 
syringe and the solution was heated at 70 
o
C in an oil bath for 3 min. K2CO3 (1 M, 0.5 mL) 
solution was added via syringe and the reaction was monitored by TLC until complete 
consumption of 3,5-diiodo-BODIPY. The cooled solution was filtered through celite to remove 
excess palladium and boronic acid, and the solvent was concentrated under vacuum. The residue 
was purified by silica gel column chromatography to afford the corresponding 3,5-diaryl-
BODIPYs as red solids, which were recrystallized using 1:1 dichloromethane/hexane. For the 
unsymmetric BODIPYs, 62.8 mg (0.100 mmol) BODIPY 6a or 68.8 mg (0.100 mmol) BODIPY 
6b, 5.00 mg Pd(dppf)Cl2 and 3 equiv (0.300 mmol) of 4-(benzyloxy)carbonyl)phenyl)boronic 
acid were mixed under inert atmosphere. Toluene (2 mL) and THF (2 mL) were added via 
syringe and the solution was heated at 70 
o
C for 3 minutes. K2CO3 (1 M, 0.5 mL) solution was 
added via syringe and the reaction was heated at 70 
o
C for 30 min. The cooled solution was 
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filtered through celite and the solvent removed under vacuum. The residue was purified by silica 
gel column chromatography. The second band corresponding to the 3-aryl-5-iodo-BODIPY was 
collected, and immediately reacted with 5.00 mg Pd(dppf)Cl2 and 5 equiv of 4-
(trifluoromethyl)phenylboronic acid under inert atmosphere. Toluene (2 mL) and THF (2 mL) 
were added via syringe and the solution was heated at 70 
o
C for 3 minutes. K2CO3 (1 M, 0.5 mL) 
solution was added via syringe and the reaction was heated at 70 
o
C for 30 min. The cooled 
solution was filtered through celite and the solvent removed under vacuum. The residue was 
purified by silica gel column chromatography and recrystallized using 1:1 
dichloromethane/hexane. 
BODIPY 15: Yield 83%. mp(°C)> 300; 
1
H NMR (CD2Cl2, 400 MHz) δ 8.25 – 8.18 (m, 
4H), 7.75 – 7.65 (m, 4H), 7.61 – 7.54 (m, 3H), 7.44 – 7.35 (m, 2H), 2.27 (t, J = 6.1 Hz, 4H), 1.74 
(t, J = 6.1 Hz, 4H), 1.56 (ddt, J = 8.1, 6.2, 2.4 Hz, 4H), 1.50 – 1.42 (m, 4H);13C NMR (CD2Cl2, 
100 MHz) δ 152.0, 147.8, 144.0, 143.4, 138.7, 134.8, 132.3, 130.79, 130.75, 130.7, 130.4, 
129.52, 129.46, 127.9, 122.9, 24.4, 23.0, 22.5, 22.4; 
11
B NMR (CD2Cl2, 128 MHz) δ 0.67 (t, J = 
32.5 Hz); HRMS (ESI-TOF) m/z 617.2260 [M]
+
 calcd for C35H29BF2N2O4 617.2281. 
BODIPY 17a: Yield 36%. mp(°C)> 300; 
1
H NMR (CDCl3, 400 MHz) δ 8.17 – 8.11 (m, 
2H), 7.75 – 7.64 (m, 6H), 7.58 (dd, J = 5.0Hz, 1.9 Hz, 3H), 7.51 – 7.46 (m, 2H), 7.45 – 7.36 (m, 
5H), 5.40 (s, 2H), 2.31 (dt, J = 6.5, 3.2 Hz, 4H), 1.75 (t, J = 6.0 Hz, 4H), 1.63 – 1.54 (m, 4H), 
1.50 (dp, J = 9.0, 3.4, 2.6 Hz, 4H); 
13
C NMR (CDCl3, 100 MHz) δ 166.0, 153.5, 152.7, 142.7, 
142.4, 142.2, 136.6, 135.9, 135.6, 135.1, 131.8, 131.6, 130.4, 130.0, 129.9, 129.6, 129.2, 129.1, 
128.5, 128.2, 128.1, 127.8, 124.7, 124.7, 66.7, 24.3, 22.9, 22.5, 22.4; 
11
B NMR (CDCl3, 128 
MHz) δ 0.82 (t, J = 32.1 Hz); HRMS (ESI-TOF) m/z 729.2839 [M]+ calcd for C44H36BF5N2O2 
729.2821. 
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BODIPY 17b: Yield 40%. mp(°C)> 300; 
1
H NMR (CD2Cl2, 400 MHz) δ 8.12 – 8.05 (m, 
2H), 7.65 (s, 4H), 7.63 – 7.57 (m, 2H), 7.48 – 7.43 (m, 2H), 7.42 – 7.33 (m, 3H), 6.62 (t, J = 2.3 
Hz, 1H), 6.55 (d, J = 2.3 Hz, 2H), 5.36 (s, 2H), 3.84 (s, 6H), 2.27 (t, J = 6.0 Hz, 4H), 1.95 (t, J = 
6.1 Hz, 4H), 1.61 – 1.49 (m, 8H); 13C NMR (CD2Cl2, 100 MHz) δ 165.9, 161.9, 153.6, 152.6, 
143.0, 142.9, 142.7, 136.9, 136.7, 136.3, 136.1, 131.6, 131.4, 130.4, 130.33, 130.25, 130.14, 
130.07, 129.8, 129.0, 128.62, 128.58, 128.2, 128.1, 127.3, 125.6, 124.69, 124.66, 122.9, 105.8, 
101.2, 66.8, 55.7, 24.2, 23.1, 22.6, 22.5, 22.4; 
11
B NMR (CD2Cl2, 128 MHz) δ 0.70 (t, J = 32.3 
Hz); HRMS (ESI-TOF) m/z 812.2922 [M+Na]
+
 calcd for C46H40BF5N2O4Na 812.2930. 
General Suzuki cross-coupling conditions on BODIPY 9a. 78.6 mg (0.100 mmol) 9a, 10.00 
mg Pd(dppf)Cl2 and 10 equiv (1.000 mmol) of aryl boronic acid were mixed under inert 
atmosphere. Toluene (2 mL) and THF (2 mL) were added via syringe and the solution was 
heated at 70 
o
C in an oil bath for 3 min. K2CO3 (1 M, 0.5 mL) solution was added via syringe 
and the reaction was monitored by TLC until complete consumption of BODIPY 9a. The cooled 
solution was filtered through celite to remove excess palladium and boronic acid, and the solvent 
was concentrated under vacuum. The residue was purified by silica gel column chromatography 
to afford the corresponding 2,3,5,6-tetraaryl-BODIPYs as purple solids. 
BODIPY 18: Yield 48%. mp(°C)> 300. 
1
H NMR (500 MHz, CDCl3) δ 7.56 (d, J = 7.8 
Hz, 2H), 7.38 (d, J = 7.8 Hz, 2H), 7.02 (s, 2H), 6.70 (d, J = 2.2 Hz, 4H), 6.46 (t, J = 2.3 Hz, 2H), 
6.26 (dd, J = 21.4, 2.2 Hz, 6H), 3.68 (s, 12H), 3.58 (s, 12H), 2.51 (s, 3H); 
13
C NMR (125 MHz, 
CDCl3) δ 160.4, 160.0, 155.9, 144.6, 140.9, 135.6, 134.4, 134.04, 134.02, 133.5, 131.4, 130.7, 
129.2, 128.4, 124.2, 108.48, 108.46, 108.4, 106.2, 102.1, 99.5, 55.4, 55.2; 
11
B NMR (128 MHz, 
CD2Cl2) δ 0.72 (t, J = 30.4 Hz); HRMS (ESI-TOF) m/z 807.3257 [M+H]
+
 calcd for 
C48H46BF2N2O8 826.3346. 
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BODIPY 19: Yield 48%. mp(°C)> 300; 
1
H NMR (400 MHz, CD2Cl2) δ 7.69 – 7.57 (m, 
2H), 7.43 (d, J = 7.8 Hz, 2H), 7.06 (d, J = 1.4 Hz, 2H), 6.77 (s, 4H), 6.30 (s, 4H), 3.80 (s, 6H), 
3.71 (s, 6H), 3.68 (s, 12H), 3.59 (s, 12H), 2.52 (s, 3H); 
13
C NMR (100 MHz, CD2Cl2) δ 155.8, 
153.1, 152.9, 141.3, 139.2, 137.6, 134.5, 134.4, 131.5, 131.0, 129.4, 129.3, 127.9, 127.2, 108.5, 
105.9, 60.63, 60.56, 56.5, 56.2, 56.0, 21.3; 
11
B NMR (128 MHz, CD2Cl2) δ 0.89 (t, J = 30.9 Hz); 
HRMS (ESI-TOF) m/z 946.3745 [M+H]
+
 calcd for C52H54BF2N2O12 946.3769. 
General Heck cross-coupling conditions. For symmetric BODIPYs, 68.8 mg (0.100 mmol) 6b 
and 5.00 mg Pd(dppf)Cl2 and were mixed under inert atmosphere. Toluene (4 mL) was added via 
syringe and the solution was heated at 100 
o
C in an oil bath for 3 min. 10 equiv (0.500 mmol) of 
styrene and one drop of triethylamine were added via syringe and the reaction was monitored by 
TLC until complete consumption of 3,5-diiodo-BODIPY 6b. The cooled solution was filtered 
through celite to remove excess palladium, and the solvent was concentrated under vacuum. The 
residue was purified by silica gel column chromatography to afford the corresponding 3,5-
distyryl-BODIPYs. For the unsymmetric BODIPYs, 68.8 mg (0.100 mmol) BODIPY 6b, 68.8 
mg (0.100 mmol) 6b and 5.00 mg Pd(dppf)Cl2 and were mixed under inert atmosphere. Toluene 
(4 mL) was added via syringe and the solution was heated at 100 
o
C in an oil bath for 3 min. 6 
equiv (0.500 mmol) of styrene and one drop of triethylamine were added via syringe and the 
reaction was monitored by TLC until the purple mono-coupling product was the major spot. The 
cooled solution was filtered through celite to remove excess palladium, and the solvent was 
concentrated under vacuum.  The residue was purified by silica gel column chromatography. The 
second band corresponding to the 3-styryl-5-iodo-BODIPY was collected, and immediately 
reacted with 5.00 mg Pd(dppf)Cl2 and 5 equiv. of 2-furanylboronic acid under inert atmosphere. 
Toluene (2 mL) and THF (2 mL) were added via syringe and the solution was heated at 70 
o
C for 
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3 minutes. K2CO3 (1 M, 0.5 mL) solution was added via syringe and the reaction was heated at 
70 
o
C for 30 min. The cooled solution was filtered through celite and the solvent removed under 
vacuum. The residue was purified by silica gel column chromatography. 
BODIPY 20: Yield 60%. mp (°C) 186 (decomposed); 
1
H NMR (400 MHz, CDCl3) δ 
7.90 (s, 1H), 7.85 (s, 1H), 7.63 (d, J = 7.2 Hz, 4H), 7.40 (t, J = 7.5 Hz, 4H), 7.31 (t, J = 7.5 Hz, 
2H), 7.25 (s, 1H), 7.21 (s, 1H), 6.56 (s, 1H), 6.46 (d, J = 2.3 Hz, 2H), 3.82 (s, 6H), 2.74 (t, J = 
6.3 Hz, 4H), 1.84 (t, J = 6.3 Hz, 4H), 1.69 (dq, J = 7.8, 5.4, 4.2 Hz, 4H), 1.52 – 1.45 (m, 4H); 13C 
NMR (100 MHz, CDCl3) δ 161.4, 149.7, 141.1, 137.32, 137.29, 136.5, 132.0, 129.6, 128.7, 
128.6, 127.3, 120.5, 106.4, 100.9, 55.6, 25.0, 23.9, 22.8; 
11
B NMR (128 MHz, CDCl3) δ 1.17 (t, 
J = 34.6 Hz); HRMS (ESI-TOF) m/z 620.3136 [M-F]
+
 calcd for C41H39BFN2O2 620.3119. 
BODIPY 21: Yield 64%. mp (°C) 170 (decomposed); 
1
H NMR (400 MHz, CDCl3) δ 
7.78 (s, 1H), 7.74 (s, 1H), 7.58 (d, J = 8.8 Hz, 4H), 7.21 (s, 1H), 7.17 (s, 1H), 6.93 (d, J = 8.8 Hz, 
4H), 6.55 (t, J = 2.4 Hz, 1H), 6.47 (d, J = 2.4 Hz, 2H), 3.86 (s, 6H), 3.82 (s, 6H), 2.73 (t, J = 6.2 
Hz, 4H), 1.83 (t, J = 6.2 Hz, 4H), 1.73 – 1.63 (m, 4H), 1.53 – 1.45 (m, 4H); 13C NMR (101 MHz, 
CDCl3) δ 161.4, 160.2, 149.7, 140.7, 137.5, 136.4, 136.0, 131.8, 130.3, 129.3, 128.7, 118.6, 
114.2, 106.5, 100.8, 55.6, 55.4, 25.1, 23.9, 22.8; 
11
B NMR (128 MHz, CDCl3) δ 1.22 (t, J = 34.8 
Hz); HRMS (ESI-TOF) m/z 701.3334 [M+H]
+
 calcd for C43H44BF2N2O4 701.3362. 
BODIPY 23: Yield 24%. mp (°C) 178 (decomposed); 
1
H NMR (400 MHz, CDCl3) δ 
7.76 (d, J = 16.8 Hz, 1H), 7.69 (d, J = 3.6 Hz, 1H), 7.64 – 7.52 (m, 2H), 7.51 – 7.39 (m, 2H), 
7.33 – 7.27 (m, 2H), 7.19 (d, J = 16.7 Hz, 1H), 6.92 (d, J = 8.8 Hz, 1H), 6.62 (dd, J = 3.6, 1.7 
Hz, 1H), 3.85 (s, 3H), 2.78 (t, J = 6.3 Hz, 2H), 2.71 (t, J = 6.2 Hz, 2H), 1.72 – 1.57 (m, 8H), 1.47 
– 1.36 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 160.3, 150.8, 147.8, 143.7, 141.4, 140.6, 137.6, 
136.5, 135.8, 130.2, 130.0, 129.0, 128.8, 128.5, 118.5, 115.3, 114.2, 112.6, 55.4, 25.1, 24.4, 24.2, 
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24.0, 22.9, 22.72, 22.69; 
11
B NMR (128 MHz, CDCl3) δ 1.28 (t, J = 33.9 Hz); HRMS (ESI-TOF) 
m/z 554.2654 [M-F]
+
 calcd for C36H33BFN2O2 554.2650. 
2.4.3 X-ray Determined Molecular Structures 
X-ray data were collected at low temperature with MoKα radiation on Bruker Kappa Apex-II 
DUO or Nonius KappaCCD diffactometers. data reduction: Bruker SAINT; program(s) used to 
solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 
(Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012); software used to 
prepare material for publication: SHELXL97 (Sheldrick, 2008). 
Crystal Data: 6a, C23H21BF2I2N2, CH2Cl2, M=712.95, orthorhombic, a=8.2966(4), 
b=23.4782(12), c=25.1750(11) Å, T=100 K, space group P212121, Z=8, 64679 reflections 
measured, 10489 unique (Rint=0.046), θmax=26.8°, final R=0.053, CCDC 1435988; 
Crystal Data: 10a: C31H27BF2N2S2, M=540.48, orthorhombic, a=25.3519(11), 
b=7.8512(3), c=25.1917(10) Å, T=100K, space group Pna21, Z=8, 19680 reflections measured, 
5672 unique (Rint=0.034), θmax=59.0°, final R=0.034; 
Crystal Data: 10b: C31H27BF2N2O2, M=508.36, orthorhombic, a=13,8100(13), 
b=21.839(2), c=7.9190(10) Å, T=100K, space group Pbcn, Z=4, 21079 reflections measured, 
2045 unique (Rint=0.035), θmax=69.8°, final R=0.035; 
Crystal Data: 10c, C35H31BF2N2, M=528.43, orthorhombic, a=11.0477(15), b=14.069(2), 
c=17.029(3) Å, T=100 K, space group P212121, Z=4, 79037 reflections measured, 5446 unique 
(Rint=0.055), θmax=25.4°, final R=0.033, CCDC 1435989; 
Crystal Data: 15, C35H29BF2N2O4, M=618.43, monoclinic, a=15.7880(6), b=12.5007(6), 
c=15.9397(7) Å,  β=116.931(4)°, T=90 K, space group C2/c, Z=4, 31542 reflections measured, 
5374 unique (Rint=0.042), θmax=33.2°, final R=0.047, CCDC 1435990. 
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2.4.4 Steady-state Absorption and Fluorescence Spectroscopy 
The photophysical properties of compounds 6a, 6b, 9a, 10a, 10b, 13, 14, 18, 19, 20, 21 
and 23 were determined by preparing a stock solution with a concentration of 1 × 10
-4
 M and 
diluting it to appropriate concentrations for absorbance and emission spectra measurements. All 
the absorption spectra were obtained using a Perkin Elmer Lambda 35 UV-visible 
spectrophotometer. The optical density, ε, were taken by preparing solution concentrations at 
1x10
-5
 M in order to get λmax between 0.5 and 1.0. Emission spectra were measured on a LS-55 
Perkin-Elmer spectro-fluorometer with the slit width set at 5 nm for BODIPYs 9a and 19, and 
2.5 nm for all other BODIPYs. All absorbance and emission spectra were acquired within 6 h of 
fresh solution preparation, at room temperature. Rhodamine 6G (Φ = 0.86 in MeOH)34 was used 
as the reference for compounds 6a and 6b in THF. Cresyl violet (Φ = 0.55 in MeOH)34 was used 
as the reference for compounds 9a, 10a, 14 and 18 in THF. Methylene blue (Φ = 0.03 in 
MeOH)
34
 was used as the reference for compounds 10b, 13, 19, 20, 21 and 23 in THF. Quartz 
spectrophotometric cells with path lengths of 10 mm were used. For the determination of 
quantum yields, dilute solutions with different absorbance between 0.02-0.08 at the particular 
excitation wavelength were used. Molar absorption coefficients (ε) was determined from the 
plots of integrated absorbance vs concentrations. The following equation was used for the 
calculations of the relative fluorescence quantum yields (Φf)
35: Φs = Φst × (Gradx/Grandst) × (nx
2
 
/nst
2
 ) where Φ and n are the fluorescence quantum yields and refractive indexes, respectively; 
Grad represents gradient of integrated fluorescence intensity vs absorbance at the particular 
wavelength, subscripts s and x refer to the standards and the tested samples. 
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Chapter III: AROMATIC SUBSTITUTION REACTIONS ON IODINATED-
BODIPYS 
3.1 Introduction 
Functionalization on BODIPY molecules opens a door to numerous BODIPY 
applications, particularly as chemeosensors. Numerous novel BODIPYs with a variety of 
physical, chemical and biological properties have been prepared via aromatic substitution 
reactions, thus this type of reaction has drawn tremendous attention in the last ten years. 
1-2
  
 
Scheme 3.1: Syntheses of a BODIPY with styryl groups from styrylated pyrrole
3
 
Arylated and styrylated BODIPYs can be prepared via post-functionalization reactions on 
halogenated BODIPYs, for example via Stille, Suzuki, Sonogashira and Heck cross-coupling 
reactions
4-14
, or they can be produced from condensations of arylated or styrylated pyrroles or 
isoindoles, as shown in Scheme 3.1. The introduction of heteroatoms at the 3,5-positions 
significantly changes a number of physical and chemical properties of BODIPY chromophores, 
such as water solubility, absorption and emission spectra and electron density. However the 
corresponding pyrroles are rarely reported and prepared, due to their relatively difficult 
preparation and low stability. Therefore, the investigation of functionalizing BODIPY at the 3, 5-
positions was attempted, by using 3, 5-dichloro- and 3, 5-dibromo-BODIPYs with various 
nucleophiles. 
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3.1.1 Advantages of aromatic substitution reactions on 3,5-dihalogenated BODIPYs 
In 2005, Boens and co-workers reported the synthesis of a novel fluorescent sensor. They 
prepared a 3-methoxy-5-chloro-BODIPY via an aromatic substitution reaction on a 3,5-dichloro-
BODIPY, and the second chlorine was replaced by aza-18-crown-6 to give the sensor molecule 
in the presence of an amine, as shown in Scheme 3.2.
15
 
 
Scheme 3.2: Synthesis of a K
+
 sensor via SNAr reactions on a3,5-Cl2-BODIPY
15
 
When the sensor is treated with potassium ion, significant changes in absorption and 
emission were observed, due to the coordination of the cation to the donor nitrogen atom of the 
aza-crown. This inhibits the intramolecular charge transfer (ICT) process to the acceptor 
BODIPY, thus after a fast ICT process, a large cation-induced fluorescence enhancement was 
observed.  
 
Scheme 3.3: Aromatic substitution reactions on a tetrabromo-BODIPY 
The Hao and Jiao research group reported the synthesis of polybrominated BODIPYs and 
their further substitution reactions. Several aromatic substitution reactions were performed on 
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tetra- and hepta-brominated BODIPYs, giving substituted BODIPYs in high yields and short 
reaction times, as shown in Scheme 3.3.
16
 They also discovered that pyrroles are reactive 
nucleophiles in the substitution chloro- and bromo- groups on BODIPYs to give the formation of 
new C-C bonds, in the presence or absence of Lewis acids.
17-19
 The highly regioselective 
substitution reactions did not require Pd catalysts, and they produced highly red-shifted 
BODIPYs, which were synthetic precursors of oligopyrroles for medicinal, material and 
supramolecular chemistry applications. In 2009, the syntheses of a water-soluble BODIPY was 
also reported by treating a 3,5-diiodo-BODIPY with N,N-bis(2-hydroxyethyl)amine. The 
resulting BODIPY detects Cu
2+
 in aqueous solution, showing a quenched emission with 0.1 
equiv. of Cu
2+
,
20
 as shown in Scheme 3.4. 
 
Scheme 3.4: Aromatic substitution on a 3,5-diiodoBODIPY to give a sensor for Cu
2+
 
3.1.2 SPECT and PET 
Positron emission tomography/computed tomography (PET/CT)
 
is a nuclear 
medicinal technique that is been used to observe various metabolic processes in clinical studies, 
which was commercially introduced in 2001. PET detects radiolabeled compounds containing a 
positron-emitting radionuclide (tracer), such as 
18
F and 
64
Cu, which is usually introduced into the 
body on a bio-molecule. The combined CT method improves quantitation of more accurate 
functional images. 
21
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Single-photon emission computed tomography (SPECT) is another nuclear medicine 
imaging technique that detects gamma rays, as in PET. However, the tracers used in SPECT are 
often prepared in situ, by using commercially available reagents and kits, followed by detection. 
As a result, SPECT scans are significantly cheaper than PET scans, mainly because SPECT uses 
longer-lived and easier obtained radio-isotopes, such as 
123
I and 
111
In. 
22
 
 
Scheme 3.5: BF2 unit’s activation with DMAP and TMSOTf
21
 
In 2012, Weissleder & Mazitschek employed TMSOTf and DMAP to functionalize 
BODIPY’s BF2 units, by replacing one fluoride atom with a DMAP molecule. The highly 
reactive intermediate was quickly replaced by 
18
F
-
 in DMF to give 
18
F
-
 radiolabeled BODIPYs, 
as shown in Scheme 3.5. With a stable N-hydroxysuccinimide ester (unreactive in the presence 
of TMSOTf) at the meso- position, the radioactive BODIPY was conjugated with Trastuzumab at 
room temperature in a PBS-solution.
21
 In 2012, Denat et al reported similar research with 
18
F
-
 
labeled BODIPY. However, instead of using a NHS group at the meso- position, they employed 
isothiocyanate or azide group at the meso- position. Gabbai et al not only developed BODIPYs 
with an NHS group at the 3-position, but also employed ionized p-dimethylaminophenyl groups 
at the meso- position to enhance the water solubilitity.
23
 
Denat et al reported the synthesis of BODIPY-DOTA (1,4,5,10-tetraazacyclododecane-
1,4,7,10-tetraacetic acid) derivatives, and a DOTA unit was installed at the meso- phenyl groups. 
The 
111
In-DOTA-BODIPY-LPS was visualized over 24 hours in a whole animal by SPECT-CT, 
and a major amount was localized in the liver.
22
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3.1.4 Research goals 
Since 3,5-diiodo-BODIPYs and 2,3,5,6-tetraiodo-BODIPYs are important precursors, we 
performed various aromatic substitution reactions to prepare a variety of functionalized 
BODIPYs. The substitution reactions, particularly between the iodinated BODIPY and the 
123
I 
anion, is also a potential method for radiolabeling BODIPY with 
123
I for future SPECT studies. 
 
Figure 3.1: BODIPY-DOTA derivatives for SPECT-CT studies 
In 2013 and 2015, our research group reported the synthesis and biological evaluation of 
a series of BODIPYs containing iodine at the 2,6-positions, and in vitro studies indicated that 
meso-methoxyphenyl groups enhanced phototoxicity significantly, while unsymmetric BODIPYs 
tended to show higher photoxicity. In this Chapter, we will also study aromatic substitution 
reactions to produce potential BODIPY photosensitizers with heteroatoms at the 3- and/or 5-
positions. 
3.2 Results and Discussion 
3,5-Diiodo-BODIPY 1a and 1b’s synthesis was described in Chapter II. Herein we 
employed them as major platforms to perform aromatic substitution reactions. 2,3,5,6-Tetraiodo-
meso-tolyl-BODIPY 2, also prepared in Chapter II, was expected to be more reactive toward 
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aromatic substitution conditions, due to the electro-withdrawing effect from the iodine groups at 
the 2,6-positions. 
3.2.1 SNAr substitution on 3,5-diiodo-BODIPYs 
3.2.1.1 SNAr substitution of 3,5-diiodo-BODIPY with S nucleophiles 
Based on the developed methods of SNAr reactions performed on chlorinated and 
brominated BODIPYs, BODIPY 1a was treated with excess benzenethiol in anhydrous 
dichloromethane. When no base was present, no desired substitution product was obtained. 
Triethylamine and potassium carbonate were both attempted as the organic and inorganic base 
with similar pKa values, and the reactions were performed at room temperature and monitored by 
TLC. When one drop (~0.05 mL) of triethylamine was used, the desired BODIPY 3a was 
obtained within 10 minutes in 88% yield. Ten equivalents of potassium carbonate were also able 
to produce BODIPY 3a after 12 hours, in 81% yield, which indicated that the inorganic base is 
less efficient in catalyzing the thiol substitution reaction, mainly due to its low solubility. A 
crystal of BODIPY 3a was obtained, and X-ray crystallography analysis gave the structure 
shown in Figure 3.2. The two thiol groups sit on the same side of the BODIPY molecule, and the 
average C-S bond length of C-S bonds is 1.750 Å. The aryl groups from thiol form an average 
dihedral angle of 80.9º with the BODIPY core, and the meso-aryl group is almost perpendicular 
with the C3N2B plane. 
 
Figure 3.2: Molecular structure of BODIPY 3a from X-ray crystal structure. 
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4-Methylbenzenethiol was also employed as another aryl thiol, and in presence of one 
drop of triethylamine, BODIPY 3b was obtained in a similar yield of 86% in 10 minutes. 
Benzene mercaptan was further investigated as an alkyl thiol to substitute at the 3,5-positions, 
and BODIPY 3c was obtained in a 75% yield after 2 hours. One or less equivalent of aryl and 
alkyl thiols were used with BODIPY 1a to prepare unsymmetrical BODIPYs with only one 
iodine atom replaced, but all attempts failed, and the products were a mixture of starting material 
1a and disubstituted BODIPYs. This was probably due to the fast reaction rate of the di-
substitution reaction, and all nucleophiles were consumed before the reaction stopped at the 
mono-substituted intermediate stage. 
 
Scheme 3.5: SNAr reactions on 3,5-diiodo-BODIPY 1a with thiol nucleophiles 
3.2.1.2 SNAr substitution of 3,5-diiodo-BODIPY with O nucleophiles  
 
Scheme 3.6: Mono- and di-SNAr reactions between 3,5-diiodo-BODIPY 1a and 4-OMe-phenol 
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4-Methoxyphenol was employed as an oxygen nucleophile, but no desired substitution 
product was obtained, following identical conditions from the thiol SNAr reactions, probably 
because the phenolic nucleophiles are less reactive. Acetonitrile is a common solvent for most 
SNAr reactions on brominated and chlorinated BODIPYs due to its relatively high polarity,
16, 24
 
but since it only dissolved BODIPY 1a slightly, toluene was added as a co-solvent to enhance 
the solubility. Three equivalents of 4-methoxyphenol were able to replace two iodine atoms on 
BODIPY 1a, in the presence of 10 equivalents of potassium carbonate, to give BODIPY 4 in 76% 
yield, after heating at 60 
o
C for 3 hours. Additional equivalents of 4-methoxyphenol were even 
more efficient to push the equilibrium to the products, but the removal of the excess nucleophile 
was difficulty. When BODIPY 1a was treated with one equivalent of 4-methoxyphenol, 
unsymmetrical BODIPY 5 was prepared and isolated after 12 hours in 63% yield, as shown in 
Scheme 3.6. 
The reactivity of BODIPY 5’s iodic-position was then investigated. BODIPY 5 was 
mixed with one equivalent of 4-methylbenzenethiol, in the presence of one drop of triethylamine, 
and the completion of reaction was achieved within one minute, which was confirmed by TLC. 
However, 
1
H-NMR, and UV-Vis spectroscopy demonstrated the product was 
 
                            4                                                    5                                               7 
Figure 3.3: Molecular structures of BODIPYs 4, 5 and 7 from X-ray crystallography. 
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BODIPY 3b in an 82% yield. This result indicated that the phenoxide ion is a better 
leaving group, and sulfur-substituted BODIPYs are more stable. Palladium-catalyzed cross 
coupling reactions were also attempted, including Stille and Suzuki coupling reactions, 
developed in Chapter II. A typical Stille reaction conditions, including 5 equivalents of 2-
(tributylstannyl)thiophene and catalytic amount of Pd(dppf)Cl2, were applied on BODIPY 5 in 
refluxing toluene, but the corresponding BODIPY 6 was isolated in only a trace amount. This 
result might be due to decomposition of BODIPY 5 under the high temperature during the Stille 
reaction. A Suzuki reaction between BODIPY 5 and five equivalents of 4-trifluoromethylphenyl 
boronic acid was performed, in the presence of a catalytic amount of Pd(dppf)Cl2 and ten 
equivalents of potassium carbonate, and BODIPY 7 was isolated in 88% yield, as shown in 
Scheme 3.7. 
 
Scheme 3.7: Stille, Suzuki cross-coupling reactions and a thiol SNAr reaction on BODIPY 5 
BODIPYs 4, 5 and 7 were characterized by X-ray crystallography, and their structures 
are shown in Figure 3.3. The lengths of the C-O bonds are in the range 1.345-1.360 Å, which are 
relatively shorter than the C-S bond. BODIPY 5’s C-I bond is fairly long with 2.066 Å, and this 
also explains the high efficiency of the Suzuki cross coupling reaction, but not the Stille reaction. 
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The meso-phenyl rings form dihedral angles in the range 72.4-79.1º with the C3N2B planes, and 
the phenyl groups from the phenols form dihedral angles in the range 76.6-88.4º with the central 
cores. The phenyl group with trifluoromethyl unit forms a 72.4º angle with the BODIPY core, 
which is similar to the previous report. 
6
 
3.2.1.3 SNAr substitution of 3,5-diiodo-BODIPY with C nucleophiles 
Since the aromatic substitution reaction between 3,5-diiodo-BODIPY and amine 
nucleophiles were studied and reported in 2007,
20
 carbon nucleophiles were then employed to 
functionalize BODIPY 1a, and sodium hydride was employed as the base to deprotonate the α-
proton from the malonate molecule. The reaction was performed in refluxing acetonitrile and 
toluene (1:1) mixture by treating BODIPY 1a with 3 equivalents of diethyl malonate. The mono-
substituted BODIPY was collected in 5% yield after 2 hours, and this low yield is probably due 
to the relatively low solubility. BODIPY 1b was employed to react with three equivalents of 
diethyl malonate under the same conditions, and mono-substituted BODIPY 8a was produced in 
65% yield after overnight reflux. Ten equivalents of ethyl malonate after 24 hours were able to 
give di-substituted BODIPY 8b in 33% yield, and more than twenty equivalents of diethyl 
malonate were able to facilitate the di-substitution reaction much faster, but the removal of the 
unreacted malonate was difficult. The conditions and yields are shown in Scheme 3.8. 
 
Scheme 3.8: Mono- and di-SNAr reactions between 3,5-diiodo-BODIPY and ethyl malonate 
3.2.1.4 SNAr substitution of 3,5-iodinated BODIPY with phenyl and OMe on the boron 
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To further investigate the reactivity of the 3,5-diiodo-BODIPYs, we also substituted 
BODIPY’s BF2 unit with a phenyl and a methoxy group. Diiodo-dipyrromethene 9 was activated 
with triethylamine in anhydrous DCM, and then phenyl boron dichloride was added to give a 
reactive intermediate with the chlorine atom as a good leaving group. The boron was then 
substituted with methoxy group by reacting with sodium methoxide, and BODIPY 10 was 
obtained in 58% yield.  
 
Figure 3.4: Molecular structure of BODIPY 10 from X-ray crystallography 
A suitable crystal structure for X-ray crystallography was obtained, as shown in Figure 
3.4, demonstrating that the iodine atoms at the 3,5-positions of the BODIPY were not replaced 
by methoxide ions. The meso-phenyl ring forms a dihedral angle of 72.4º, while the phenyl and 
methoxy units on the boron atom are almost perpendicular with the main core. The relatively 
long C-I bonds (average: 2.064 Å) promote the reactivity of the 3,5-positions of the BODIPY 
molecule. 
 
Scheme 3.9: Preparation of boron substituted BODIPY 10 and its SNAr reaction 
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BODIPY 10’s reactivity under aromatic substitution conditions was studied via thiol 
substitution, by treating BODIPY 10 with excess 4-methyl-benzenethiol, in the presence of  an 
organic base. The substitution reaction was much slower than the one of BODIPY 1a, but the 
targeting product was still produced and isolated after a 3-day reaction at room temperature in 63% 
yield, as shown in Scheme 3.9. 
3.2.1.5 Radiolabeling of 3,5-Diiodo-BODIPYs 1a,b with 
123
I 
Since 3,5-diiodo-BODIPY 1a and 1b show relatively high reactivity under most aromatic 
substitutions, we also apply this result to obtain 
123
I
-
 labeled BODIPYs for potential SPECT 
studies, by treating 1a,b with 
123
I sources as shown in Scheme 3.10. The only commercial source 
of 
123
I is 1.0 mCi Na
123
I (< 10
-6
 M) in 0.1 N NaOH, which is a challenge due to potential side 
reactions at the boron atom. 
 
Scheme 3.10: Proposed radio-labeling reaction of 3,5-diiodo-BODIPYs 1a,b 
 
Scheme 3.11: Preparation of a meso-iodo-BODIPY from a meso-chloro-BODIPY 
In 2012, Dehaen et al reported that meso-chloro-BODIPY was able to be substituted by 
iodide ions in acetone, giving meso-iodo-BODIPY in 66% yield, as shown in Scheme 3.11. 
BODIPY 1b reacted with NaCl or NaBr in acetone, respectively, and 1 hour later mass 
spectroscopy results indicated the formation of mono- and di-substituted BODIPYs. This result 
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demonstrated partial substitution reaction occurred between 3,5-diiodo-BODIPY and halide 
anions, as shown in Scheme 3.12.  
Although the iodine atoms at the 3,5-position are relatively stable in the presence of 
oxygen nucleophiles (NaOMe and 4-methoxy-phenol) at room temperature, the stability of the 
BODIPY under basic conditions needed to be confirmed. The BF2 units of BODIPYs could 
potentially be substituted with hydroxyl groups to give B(OH)2 units, and the B(OH)2 units 
would chelate with another hydroxyl group to leave as a boronic acid and give low fluorescent 
dipyrromethene, as shown in Scheme 3.13. BODIPY 1b reacted with 1 equivalent of sodium 
hydroxide in acetone, and after one hour, both 
11
B NMR and fluorescence emission 
measurements demonstrated almost no decomposition occurred. 
 
Scheme 3.12: Reactivity studies on 3,5-diiodo-BODIPY 1b 
BODIPY 1b was then dissolved in acetone, and different concentrations at BODIPY 1b 
solutions were reacted with Na
123
I in the presence of NaOH. Time-dependent TLC and film 
visualization results indicated that 
123
I was successfully loaded onto the BODIPY platform, as 
shown in Figure 3.5. The iodinated BODIPY showed an approximately Rf value≈0.5 in 
EtOAc:Hex=1:4, and the radiolabeled molecules were visualized on the film after overnight 
exposure. As the spots were getting darker, higher amounts of iodinated BODIPYs were 
successfully replaced with 
123
I anion, from 5 minutes to 1 hour. 
3.2.2 SNAr Substitution on 2,3,5,6-Tetraiodo-BODIPYs 
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Scheme 3.13: Potential decomposition reactions caused by NaOH 
Among the reported 2,3,5,6-tetrabromo-BODIPY and 2,3,5,6,8-pentachloro-BODIPY, 
the halogen atoms at the 2,6-positions are unreactive under SNAr conditions, because of the 
partially negative charge at the 2,6-positions.
14, 16
 Some 2,6-dibromo- and 2,6-diiodo-BODIPYs 
are reported as photosensitizers and singlet oxygen generators, but most of their 3,5-positions are 
blocked or substituted by alkyl, aryl or styryl units. 
 
Figure 3.5: Film-visualization demonstration of 
123
I radio-labeling 
3.2.2.1 SNAr substitution of 2,3,5,6-tetraiodo-BODIPY with S nucleophiles 
4-Methyl-benzenethiol was first employed as the nucleophile, and similar conditions to 
those used for 3,5-diiodo-BODIPY 1a,b were applied. BODIPY 2 reacted with two equivalents 
of thiol in acetonitrile, in the presence of triethylamine. The reaction was rapidly completed upon 
addition of triethylamine and the resulting 3,5-disubstituted BODIPY 12 was isolated in 94% 
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yield, as shown in Scheme 3.14. Mono-substitution was also attempted too, by treating one 
equivalent of thiol with BODIPY 2, but TLC indicated the resulting solution was a mixture of 
starting material and di-substituted product 12. This is probably due to the very high reactivity of 
the 3,5-positions towards thiol substitution reactions. 
3.2.2.2 SNAr substitution of 2,3,5,6-tetraiodo-BODIPY with O nucleophiles 
Oxygen nucleophiles were then studied, following similar conditions to those described 
earlier for BODIPY 1a, b’s substitution. Excess amount of 4-methoxyphenol were added into a 
solution of BODIPY 2 in CH3CN in the presence of potassium carbonate, and TLC indicated the 
consumption of BODIPY 2 within 5 minutes, affording BODIPY 13 in 89% yield. To investigate 
the mono-substitution reaction, BODIPY 2 was treated with one equivalent of 4-methoxyphenol, 
followed by addition of two equivalents of potassium carbonate. The completion of this reaction 
was detected after five minutes, and BODIPY 14 was obtained in 89% yield, as shown in 
Scheme 3.15. Instead of requirements of prolonged reaction time, heat, and large excess of base, 
tetraiodo-BODIPY 2 showed much higher reactivity in SNAr reactions, and both mono- and di-
substitution reactions were accomplished at room temperature and shorter time.  
 
Scheme 3.14: SNAr reactions between tetraiodo-BODIPY 2 and 4-methyl-benzenethiol 
3.2.2.3 SNAr substitution of 2,3,5,6-tetraiodo-BODIPY with N nucleophiles 
Aniline was employed as the nitrogen nucleophile to investigate the reactivity of 
tetraiodo-BODIPY 2. One equivalent of aniline was mixed with BODIPY 2, and it afforded 
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mono-substituted BODIPY 15 in 78% yield after 30 minutes, without the presence of an 
additional base, as shown in Scheme 3.16. However, the aromatic substitution reaction stopped 
at the mono-substitution product, even when a large excess of aniline or additional organic base, 
and heating conditions were employed. This observation is in agreement with previous published 
results by Ortiz et al.
25
  
3.2.2.4 SNAr substitution of 2,3,5,6-tetraiodo-BODIPY with C nucleophiles 
Tetraiodo-BODIPY’s reactivity was also studied with carbon nucleophile, and ethyl 
malonate was employed as the nucleophile. The mono-substitution reaction was performed in 
refluxing acetonitrile, in the presence of one equivalent of ethyl malonate and sodium hydride, 
and BODIPY 16 was produced after 10 minutes in 72% yield. Changing the ethyl malonate’s 
equivalents to 2.5 equivalents afforded BODIPY 17 in 69% yield after 5 hour reaction time.  
 
Scheme 3.15: Mono- and di-SNAr reactions between tetraiodo-BODIPY 2 and 4-OMe-phenol 
For BODIPY 16, although one iodine atom was replaced by the malonate, the other iodo-
position was expected to be relatively reactive, due to the electron withdrawing effect of the 
iodines at the 2,6-positions. BODIPY 16 reacted with one equivalent of 4-methyl-benzenethiol, 
4-methoxy-phenol and aniline, respectively, and all three reactions were performed in 
acetonitrile in room temperature. Unsymmetric BODIPYs 18, 19 and 20 were produced in 68%, 
66% and 58% yields, respectively, as shown in Scheme 3.18. The second SNAr reactions all 
required longer time, probably due to the less reactivity and steric hindering effect from the first 
substituent malonate group.   
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3.2.3 Structural Characterization 
All BODIPYs were characterized by 
1
H-, 
13
C- and 
11
B-NMR, HRMS, UV-Vis and 
fluorescence spectroscopy. All 
11
B-NMR except those for BODIPYs 10 and 11, show triplets for 
the BF2 units, demonstrating that among our developed conditions, no nucleophiles replaced the 
fluoride atoms on the boron. Boron functionalized BODIPYs 10 and 11 show a broad singlet in 
their 
11
B-NMR spectra because there is no more fluoride atom that split the boron signal. 
 
Scheme 3.16: Mono SNAr reaction between BODIPY 2 and aniline 
In proton NMR of 3,5-diiodo-BODIPYs 1a and 1b’s derivatives, the bicyclic units gave 
CH2 peaks between 2.8 to 1.3 ppm. In the 2.8 ppm to 2.4 ppm region, symmetric BODIPYs 
showed a triplet of four protons, while unsymmetric BODIPYs produced two triplets signals, 
indicating those two CH2 units are in different environment. The carbon NMR also agreed with 
this observation, because the sp
3
-C region showed four signals for the symmetric BODIPYs and 
eight signals for the unsymmetric BODIPYs, with two different groups at the 3,5-positions. 
3.2.4 Spectroscopic Studies 
The spectroscopic properties of BODIPYs were investigated in THF. BODIPY 1a and 
1b’s derivatives showed absorption bands between 528 and 580 nm and emission bands between 
542 and 600 nm in THF with strong absorption bands (log ε= 4.6-5.0), as Table 3.1 summarizes. 
We noticed that thiol substitution was the only reaction to red-shift BODIPY’s absorption and 
emission spectra, and phenol and malonate di-substitution gave blue-shifts. Thiol and malonate 
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substitution produced higher fluorescent quantum yields. 4-Trifluoromethylphenyl group not 
only increased the quantum yield of BODIPY 5, but also increased the Stokes shift slightly. 
Scheme 3.17: Mono- and di-SNAr reactions between tetraiodo-BODIPY 2 and ethyl malonate 
BODIPY 2 and its derivatives showed absorption bands between 543 nm and 605 nm and 
emission bands between 575 nm and 637 nm (log ε= 4.7-5.2), as Table 3.2 shows. All 
compounds show relatively low fluorescent quantum yields, and this is because of the heavy 
atom effect that facilitates the S1 to T1 intersystem crossing process. Thiol substitution also 
produced the largest bathochromic shifts in the absorption and emission spectra. Aniline 
substitution products 15 and 20’s absorption and emission spectra were broader than the ones of 
other BODIPYs and their Stokes’ shifts are surprisingly higher than others. This observation is in 
agreement with previous papers,
26
 and probably can be explained by the hydrogen bonding 
between the N-H and fluoride atoms from the BF2 units. 
 
Scheme 3.18: Further SNAr reactions on BODIPY 16 with S, O and N nucleophiles 
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Figure 3.6: Normalized absorption spectra of BODIPYs 3b (black), 4 (red), 5 (blue), 7 (cyan), 8a 
(magenta) and 8b (dark yellow) in THF at RT 
 
Figure 3.7: Normalized emission spectra of 3b (black), 4 (red), 5 (blue), 7 (cyan), 8a (magenta) 
and 8b (dark yellow) in THF at RT 
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Figure 3.8: Normalized absorption spectra of BODIPYs 2 (black), 12 (red), 13 (cyan), 14 
(magenta), 15 (blue), 16 (yellow), 17 (navy), 18(olive), 19 (pink) and 20 (wine) in THF at RT 
 
Figure 3.9: Normalized emission spectra of BODIPYs 2 (black), 12 (red), 13 (cyan), 14 
(magenta), 15 (blue), 16 (yellow), 17 (navy), 18(olive), 19 (pink) and 20 (wine) in THF at RT 
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Table 3.1: Absorption and emission spectral properties of BODIPYs 1a and 1b’s derivatives in 
THF at RT 
BODIPY Abs. λmax (nm) THF log ε (M-1cm-1) Emission λmax (nm) THF Φf  Stokes shift (nm) 
3b 580 4.58 600 0.74 20 
4 528 4.68 542 0.34 14 
5 532 4.87 550 0.18 18 
7 533 4.75 556 0.43 23 
8a 528 4.82 542 0.23 14 
8b 538 4.86 550 0.41 12 
 
3.3 Conclusions 
In summary, two 3,5-diiodo-BODIPYs and one 2,3,5,6-tetraiodo-BODIPY were studied 
on their reactivity towards unsymmetric and symmetric aromatic substitution reactions with S, O, 
N and C nucleophiles. Sulfur nucleophiles show the highest reactivity, affording the most red-
shifted substituted BODIPYs. The BODIPY’s boron unit was stable during the substitution 
conditions, indicating the iodide groups at the 3,5-positions were fairly reactive among most 
functionalization reactions. The high reactivity of iodinated BODIPYs was further applied for 
123
I-radiolabeling with significant transformation observed. The very low fluorescence quantum 
yields of BODIPY 2’s derivatives suggested that they might be promising photodynamic therapy 
agents.  
3.4 Experimental 
3.4.1 General Information 
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Table 3.2: Absorption and emission spectral properties of BODIPYs 2’s derivatives in THF at 
room temperature 
BODIPYs Abs. λmax (nm) THF log ε (M-1cm-1) Emission λmax (nm) THF Φf Stokes shift (nm) 
12 605 5.12 637 0.02 32 
13 562 5.23 587 0.09 25 
14 554 5.21 575 0.11 21 
15 543 4.97 612 0.05 69 
16 564 4.79 589 0.12 25 
17 553 4.74 581 0.15 28 
18 580 4.97 614 0.07 34 
19 552 4.93 578 0.04 26 
20 541 4.82 601 0.01 60 
 
All the reagents and solvents were purchased from Sigma-Aldrich and VWR and were 
used without further purification. All reactions were carried out with oven-dried glassware under 
a dry argon atmosphere. All the reactions were monitored using Sorbent Technologies 0.2 mm 
silica gel TLC plates with UV-254 nm indicator. Flash column chromatography was performed 
using Sorbent Technologies 60 Å silica gel (230-400 mesh). Prep-TLC 60 Å silica gel 20 x 20 
cm (210-270 μm) was used. All 1H-, 13C-, and 11B-NMR spectra were collected on a Bruker AV-
400 and AV-500 spectrometer in deuterated chloroform or dichloromethane. The CDCl3 
chemical shifts (δ) are reported in ppm using as reference 7.26 for proton and 77.00 for carbon 
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and BF3•OEt2 was used as reference (0.00 δ) for boron NMR. The CD2Cl2 chemical shifts (δ) are 
reported in ppm using as reference 5.32 for proton and 53.50 for carbon. 
Coupling constants are reported in Hertz (Hz). All the mass spectra were collected using 
an Agilent 6210 ESI-TOF mass spectrometer. All melting points were recorded using a MEL-
TEMP electrothermal instrument. 
2.4.2 Synthesis 
SNAr reactions between BODIPY 1a and thiols: 
Organic base method: To a mixture of 31.4 mg (0.05 mmol) BODIPY 1a and 0.11 mmol 
thiol, 10 mL dichloromethane was added. 1 drop of triethylamine was added via syringe and the 
reaction was allowed to stir in room temperature under inert atmosphere for 10 minutes. After 
thin layer chromatography confirmed the consumption of BODIPY 1a, the reaction was poured 
to 100 mL dichloromethane, and was washed with 2 x 50 mL saturated sodium bicarbonate 
solution. Dichloromethane was removed under vacuum. The dark purple residue was purified by 
silica gel column chromatography (elution: hexane/dichloromethane=1:2) and recrystallized 
using 1:1 dichloromethane/hexane.    
Inorganic base method: To a mixture of 31.4 mg (0.05 mmol) BODIPY 1a, 0.11 g (1.0 
mmol) potassium carbonate and 0.11 mmol thiol, 10 mL dichloromethane was added. The 
reaction was allowed to stir in room temperature under inert atmosphere for 12 hours. The work-
up and purifying procedure are the same with the organic base method. 
BODIPY 3a: Yield 86%. mp (°C) 235; 
1
H NMR (500 MHz, CDCl3) δ 7.43 – 7.38 (m, 
3H), 7.35 (dd, J = 7.5, 1.8 Hz, 4H), 7.26 – 7.10 (m, 8H), 1.80 (t, J = 6.1 Hz, 4H), 1.49 (t, J = 6.1 
Hz, 4H), 1.34 – 1.27 (m, 4H), 1.23 – 1.19 (m, 4H); 13C NMR (126 MHz, CDCl3) δ 147.9, 141.5, 
139.0, 134.9, 133.7, 133.42, 133.39, 133.38, 132.1, 131.99, 130.96, 129.1, 129.98, 128.95, 127.9, 
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127.6, 127.1, 24.1, 22.6, 22.2, 22.1; 
11
B NMR (128 MHz, CDCl3) δ 0.72 (t, J = 31.0 Hz); HRMS 
(ESI-TOF) m/z 592.1998 [M]
+
 calcd for C35H31BF2N2S2 592.1990. 
BODIPY 3b: Yield 88%. mp (°C) 278; 
1
H NMR (400 MHz, CD2Cl2) δ 7.49 (q, J = 3.7 
Hz, 3H), 7.36 – 7.26 (m, 6H), 7.13 (d, J = 7.9 Hz, 4H), 2.33 (s, 6H), 1.89 (t, J = 6.2 Hz, 4H), 
1.59 (t, J = 6.8 Hz, 4H), 1.44 – 1.36 (m, 4H), 1.31 – 1.26 (m, 4H); 13C NMR (100 MHz, CD2Cl2) 
δ 148.0, 141.8, 139.1, 137.8, 134.9, 133.5, 133.4, 132.1, 131.3, 129.93, 129.85, 129.2, 129.1, 
128.1, 24.3, 22.8, 22.5, 22.3, 20.9; 
11
B NMR (128 MHz, CDCl3) δ 0.73 (t, J = 31.1 Hz); HRMS 
(ESI-TOF) m/z 601.2300 [M-F]
+
 calcd for C37H35BFN2S2 601.2319. 
BODIPY 3c: Yield 75%. mp (°C) 150 (decomposed); 
1
H NMR (500 MHz, CD2Cl2) δ 
7.50 (q, J = 2.7 Hz, 3H), 7.39 – 7.19 (m, 12H), 4.29 (s, 4H), 2.23 – 2.13 (m, 4H), 1.65 – 1.53 (m, 
4H), 1.49 – 1.41 (m, 4H), 1.36 – 1.27 (m, 4H); 13C NMR (125 MHz, CD2Cl2) δ 148.5, 141.4, 
139.7, 137.7, 135.04, 135.01, 134.9, 132.8, 129.20, 129.17, 129.1, 128.5, 128.0, 127.3, 40.3, 24.2, 
22.9, 22.5, 22.4; 
11
B NMR (128 MHz, CDCl3) δ 0.80 (t, J = 31.0 Hz); HRMS (ESI-TOF) m/z 
601.2327 [M-FH]
+
 calcd for C37H35BFN2S2 601.2319. 
SNAr reactions between BODIPY 1a and 4-OMe-phenol 
For the di-substitution, to a mixture of 31.4 mg (0.05 mmol) BODIPY 1a, 18.6 mg (0.15 
mmol) 4-methoxyphenol and 0.11 g (1.0 mmol) potassium carbonate, 5 mL toluene and 5 mL 
acetonitrile were added. The reaction was heated under 60 
o
C under inert atmosphere until thin 
layer chromatography confirmed the consumption of BODIPY 1a, and the solvents were 
removed under vacuum. The residue was dissolved in 100 mL dichloromethane and washed with 
2 x 50 mL water. Dichloromethane was removed under vacuum. The residue was purified by 
silica gel column chromatography (elution: 100% dichloromethane) and recrystallized using 
dichloromethane/hexane=1:1. BODIPY 4 was obtained in 76% yield. For the mono-substitution, 
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to a mixture of 31.4 mg (0.05 mmol) BODIPY 1a, 9.3 mg (0.08 mmol) 4-methoxyphenol and 
0.11 g (1.0 mmol) potassium carbonate, 5 mL toluene and 5 mL acetonitrile were added. The 
reaction was heated under 60 
o
C under inert atmosphere for 6 hours. After thin layer 
chromatography confirmed the consumption of BODIPY 1a, the rest work-up procedure was all 
similar to the one of di-substitution reactions. 
BODIPY 4: Yield 76%. mp (°C) 264; 
1
H NMR (400 MHz, CDCl3) δ 7.50 – 7.42 (m, 3H), 
7.36 – 7.29 (m, 2H), 7.12 – 7.04 (m, 4H), 6.85 – 6.76 (m, 4H), 3.77 (s, 6H), 1.79 (t, J = 6.1 Hz, 
4H), 1.39 – 1.28 (m, 8H); 13C NMR (126 MHz, CDCl3) δ 158.2, 156.1, 149.5, 142.3, 138.1, 
135.5, 128.9, 128.8, 128.4, 123.9, 119.6, 116.0, 114.4, 55.6, 24.2, 22.7, 22.1, 21.3; 
11
B NMR 
(128 MHz, CDCl3) δ 0.28 (t, J = 29.0 Hz); HRMS (ESI-TOF) m/z 601.2675 [M+H]
+
 calcd for 
C37H35BFN2O4 601.2674. 
BODIPY 5: Yield 63%. mp (°C) 150 (decomposed); 
1
H NMR (400 MHz, CDCl3) δ 7.50 
– 7.42 (m, 3H), 7.30 – 7.24 (m, 2H), 7.16 – 7.10 (m, 2H), 6.88 – 6.82 (m, 2H), 3.80 (s, 3H), 2.30 
(t, J = 6.2 Hz, 2H), 1.68 (t, J = 6.2 Hz, 2H), 1.56 (q, J = 6.2 Hz, 6H), 1.40 – 1.28 (m, 6H); 13C 
NMR (100 MHz, CDCl3) δ 162.7, 156.9, 148.4, 146.6, 137.9, 137.6, 134.8, 133.6, 133.5, 132.6, 
129.04, 129.02, 128.1, 126.4, 120.6, 119.2, 114.5, 95.7, 55.6, 24.4, 24.3, 23.8, 23.4, 22.5, 22.2, 
21.8, 21.6; 
11
B NMR (128 MHz, CDCl3) δ 0.33 (t, J = 29.9 Hz); HRMS (ESI-TOF) m/z 
605.1289 [M-F]
+
 calcd for C30H28BFIN2O2 605.1273. 
Suzuki cross-coupling reaction on BODIPY 5 
To a mixture of 62.4 mg (0.1 mmol) BODIPY 5, 5 mg Pd(dppf)Cl2 and 95.0 mg (0.5 
mmol) 4-CF3-phenylboronic acid, 2 mL toluene and 2 mL tetrahydrofuran were added under 
inert atmosphere. The reaction was heated under 75
o
C for 2 minutes and 0.1 mL 1M potassium 
carbonate solution was added via syringe. The reaction was monitored by thin layer 
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chromatography until complete consumption of BODIPY 5. The cooled solution was filtered 
through celite cake to remove excess palladium catalyst and boronic acid, and the solvent was 
then evaporated under vacuum. The residue was purified by silica gel column chromatography 
(elution: hexane/dichloromethane=1:2) to afford BODIPY 7 in 88% yield, and was recrystallized 
using dichloromethane/hexane=1:1.BODIPY 7: mp (°C) >300; 
1
H NMR (400 MHz, CD2Cl2) δ 
7.75 (d, J = 8.2 Hz, 2H), 7.68 (d, J = 8.2 Hz, 2H), 7.56 – 7.49 (m, 3H), 7.41 – 7.34 (m, 2H), 7.09 
– 7.03 (m, 2H), 6.89 – 6.83 (m, 2H), 3.78 (s, 3H), 2.33 (t, J = 6.1 Hz, 2H), 1.74 – 1.62 (m, 6H), 
1.60 – 1.51 (m, 2H), 1.50 – 1.41 (m, 2H), 1.41 – 1.28 (m, 4H); 13C NMR (126 MHz, CD2Cl2) δ 
162.0, 157.0, 148.4, 147.2, 146.7, 139.8, 138.6, 136.9, 135.2, 130.4, 130.34, 130.31, 129.72, 
129.67, 129.5, 129.2, 129.1, 128.4, 127.63, 127.61, 126.3, 125.5, 124.63, 124.60, 124.57, 124.5, 
123.3, 120.2, 119.3, 114.7, 55.6, 24.6, 24.1, 23.3, 22.9, 22.5, 22.4, 21.9, 21.6; 
11
B NMR (128 
MHz, CD2Cl2) δ 0.50 (t, J = 30.9 Hz); HRMS (ESI-TOF) m/z 623.2501 [M+H]
+
 calcd for 
C37H32BF4N2O2 623.2493. 
SNAr reactions between BODIPY 1b and ethyl malonate 
For the di-substitution, to a mixture of 34.4 mg (0.05 mmol) BODIPY 1b, 113.9 μL (0.75 
mmol) ethyl malonate and 18.0 mg (0.75 mmol) sodium hydride, 5 mL toluene and 5 mL 
acetonitrile were added. The reaction was refluxed at 82 
o
C under inert atmosphere until thin 
layer chromatography confirmed the consumption of BODIPY 1b, and the solvents were 
removed under vacuum. The residue was dissolved in 100 mL dichloromethane and washed with 
2 x 50 mL water. Dichloromethane was removed under vacuum. The residue was purified by 
silica gel column chromatography. BODIPY 8a was obtained in 33% yield. For the mono-
substitution, to a mixture of 34.4 mg (0.05 mmol) BODIPY 1b, 22.7 μL (0.15 mmol) 4-
methoxyphenol and 3.6 mg (0.15 mmol) sodium hydride, 5 mL toluene and 5 mL acetonitrile 
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were added. The following reaction condition, work up and purification procedure were all 
similar to the ones of di-substitution reactions. 
BODIPY 8a: mp (°C) 260; 
1
H NMR (400 MHz, CDCl3) δ 6.54 (t, J = 2.3 Hz, 1H), 6.45 
(d, J = 2.3 Hz, 2H), 5.52 (s, 2H), 4.26 (q, J = 7.1 Hz, 8H), 3.81 (s, 6H), 2.35 (t, J = 6.2 Hz, 4H), 
1.81 (t, J = 6.2 Hz, 4H), 1.55 (s, 4H), 1.43 (s, 4H), 1.29 (t, J = 7.1 Hz, 12H); 
13
C NMR (126 
MHz, CDCl3) δ 166.5, 161.6, 146.3, 142.9, 142.5, 136.5, 130.3, 130.0, 105.3, 101.2, 62.1, 55.6, 
51.5, 23.9, 22.8, 22.2, 21.7, 14.0; 
11
B NMR (128 MHz, CDCl3) δ 0.54 (t, J = 35.3 Hz); HRMS 
(ESI-TOF) m/z 774.3216 [M+Na]
+
 calc. C39H47BF2N2NaO10 774.3220. 
BODIPY 8b: mp (°C) 186; 
1
H NMR (400 MHz, CDCl3) δ 6.55 (s, 1H), 6.42 (d, J = 2.2 
Hz, 2H), 5.60 (s, 1H), 4.41 – 4.11 (m, 4H), 3.80 (s, 6H), 2.37 (t, J = 6.2 Hz, 2H), 2.30 (t, J = 6.2 
Hz, 2H), 1.95 – 1.71 (m, 4H), 1.65 – 1.52 (m, 4H), 1.52 – 1.40 (m, 4H), 1.30 (t, J = 7.1 Hz, 6H); 
13
C NMR (101 MHz, CDCl3) δ 166.4, 161.6, 147.8, 143.4, 141.6, 140.6, 136.1, 135.5, 134.0, 
130.7, 105.4, 103.9, 101.2, 62.1, 55.6, 51.5, 24.2, 24.0, 23.7, 23.1, 22.7, 22.3, 22.2, 21.7, 14.1; 
11
B NMR (128 MHz, CDCl3) δ 0.47 (t, J = 32.9 Hz); HRMS (ESI-TOF) m/z 701.1698 [M-F]
+
 
calc. C32H36BFIN2O6 701.1695. 
Synthesis of BODIPY with phenyl and methoxy units on the boron 
57.9 mg (0.1 mmol) dipyrromethene 9 was dissolved in 10 mL anhydrous DCM, and 69.6 
μL (0.5 mmol) triethylamine was added. The solution was stirred under inert atmosphere for 5 
minutes, and then 68.2 μL (0.5 mmol) PhBCl2 was added via a syringe dropwisely, and 2.1 mL 
of 0.5 M NaOMe in methanol solution was added one hour later. The reaction was quenched 
after 10 minutes by removing all solvents under vacuum, and the crude product was directly 
purified by silica gel column chromatography to afford BODIPY 10 in 58% yield, and was 
recrystallized using EtOAc/hexane=1:1. BODIPY 10: mp (°C) 100 (decomposed); 
1
H NMR 
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(400 MHz, CDCl3) δ 7.75 – 7.45 (m, 5H), 7.46 – 7.35 (m, 2H), 7.24 – 7.07 (m, 3H), 3.25 (s, 3H), 
2.50 – 2.08 (m, 4H), 1.75 – 1.50 (m, 8H), 1.47 – 1.32 (m, 4H); 13C NMR (101 MHz, CDCl3) δ 
140.1, 139.1, 135.5, 134.9, 134.4, 133.8, 129.2, 129.1, 129.0, 127.91, 127.86, 126.1, 125.9, 107.0, 
49.2, 24.5, 24.1, 23.2, 22.3; 
11
B NMR (128 MHz, CDCl3) δ 4.01 (s); HRMS (ESI-TOF) m/z 
736.0132 [M+K]
+
 calc. C30H29BI2KN2O10 736.0130. 
SNAr reactions between BODIPY 10 and thiols: 
To a mixture of 34.9 mg (0.05 mmol) BODIPY 10 and 18.6 mg (0.15 mmol) 4-methyl-
benzenethiol, 10 mL dichloromethane was added. One drop of triethylamine was added via 
syringe and the reaction was allowed to stir in room temperature under inert atmosphere for 3 
days. After thin layer chromatography confirmed the consumption of BODIPY 10, the reaction 
was quenched by removing all solvent under vacuum. The dark purple residue was purified by 
silica gel column chromatography to give BODIPY 11 in a 63% yield. BODIPY 11: mp (°C) 80 
(decomposed);
 1
H NMR (400 MHz, CD2Cl2) δ 7.85 – 7.27 (m, 8H), 7.25 – 7.03 (m, 4H), 6.92 (d, 
J = 7.8 Hz, 3H), 6.74 (dd, J = 15.8, 7.8 Hz, 3H), 3.45 – 2.99 (m, 3H), 2.24 (s, 6H), 1.88 – 1.48 
(m, 8H), 1.48 – 1.30 (m, 8H); 13C NMR (100 MHz, CD2Cl2) δ 152.0, 141.2, 140.6, 138.9, 138.6, 
137.7, 137.3, 135.7, 135.5, 134.4, 134.1, 133.9, 133.6, 133.2, 133.1, 132.6, 132.5, 132.0, 131.5, 
131.1, 130.7, 130.6, 129.8, 129.6, 129.62, 129.59, 129.5, 129.3, 129.20, 129.15, 129.13, 129.10, 
129.1, 129.99, 128.97, 128.9, 128.83, 128.79, 128.4, 128.3, 128.0, 126.7, 126.6, 126.3, 126.2, 
126.2, 126.0, 125.9, 125.7, 125.5, 106.5, 102.4, 49.4, 49.1, 48.9, 24.72, 24.66, 24.5, 24.4, 24.3, 
24.2, 23.6, 23.4, 23.00, 22.97, 22.9, 22.8, 22.6, 22.44, 22.42, 22.39, 22.3, 20.88, 20.85; 
11
B NMR 
(128 MHz, CD2Cl2) δ 3.38 (s) ; HRMS (ESI-TOF) m/z 712.2795 [M+Na]+ calc. 
C44H43BN2NaOS2 712.2838. 
SNAr reactions between BODIPY 2 and thiols: 
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To a mixture of 38.8 mg (0.05 mmol) BODIPY 2 and 13.6 mg (0.11 mmol) 4-methyl-
benzenethiol, 10 mL dichloromethane was added. 1 drop of triethylamine was added via syringe 
and the reaction was allowed to stir in room temperature under inert atmosphere for one minute. 
After thin layer chromatography confirmed the consumption of BODIPY 2, the reaction was 
poured to 100 mL dichloromethane, and was washed with 2 x 50 mL saturated sodium 
bicarbonate solution. Dichloromethane was removed under vacuum. The dark purple residue was 
purified by silica gel column chromatography in a 94% yield. BODIPY 12: mp (°C) >300; 
1
H 
NMR (400 MHz, CD2Cl2) δ 7.44 (d, J = 8.1 Hz, 2H), 7.40 – 7.27 (m, 6H), 7.15 (d, J = 8.6 Hz, 
6H), 2.47 (s, 3H), 2.33 (s, 6H); 
13
C NMR (101 MHz, CD2Cl2) δ 153.0, 142.1, 142.0, 138.8, 
138.1, 137.2, 131.3, 130.7, 130.2, 130.1, 129.9, 129.5, 21.3, 21.0; 
11
B NMR (128 MHz, CD2Cl2) 
δ 0.34 (t, J = 28.6 Hz); HRMS (ESI-TOF) m/z 776.9502 [M]- calc. C30H23BF2I2S2 776.9495. 
SNAr reactions between BODIPY 2 and 4-OMe-phenol 
For the di-substitution, to a mixture of 38.8 mg (0.05 mmol) BODIPY 2, 13.6 mg (0.11 
mmol) 4-methoxyphenol and 0.11 g (1.0 mmol) potassium carbonate, and 5 mL acetonitrile were 
added. The reaction was stirred in room temperature for 30 minutes under inert atmosphere until 
thin layer chromatography confirmed the consumption of BODIPY 2, and the solvents were 
removed under vacuum. The residue was dissolved in 100 mL dichloromethane and washed with 
2 x 50 mL water. Dichloromethane was removed under vacuum. The residue was purified by 
silica gel column chromatography and BODIPY 14 was obtained in 89% yield. For the mono-
substitution, to a mixture of 38.8 mg (0.05 mmol) BODIPY 2, 7.4 mg (0.06 mmol) 4-
methoxyphenol and 0.11 g (1.0 mmol) potassium carbonate, and 5 mL acetonitrile were added. 
The reaction was stirred in room temperature for 5 minutes. After thin layer chromatography 
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confirmed the consumption of BODIPY 2, the rest work-up procedure was all similar to the one 
of di-substitution reactions, and BODIPY 13 was isolated in an 85% yield. 
BODIPY 13: mp (°C) 120 (decomposed); 
1
H NMR (400 MHz, CD2Cl2) δ 7.45 – 7.39 (m, 
2H), 7.35 (d, J = 7.7 Hz, 2H), 7.23 (s, 1H), 7.11 – 7.07 (m, 2H), 6.95 – 6.90 (m, 3H), 3.81 (s, 
3H), 2.46 (s, 3H); 
13
C NMR (126 MHz, CD2Cl2) δ 163.1, 157.29, 157.27, 148.60, 148.59, 142.1, 
141.82, 141.81, 140.5, 138.3, 134.6, 131.2, 130.6, 130.52, 130.50, 129.5, 129.4, 129.28, 129.26, 
120.10, 120.08, 114.79, 114.78, 107.4, 87.4, 64.0, 55.7, 21.3; 
11
B NMR (128 MHz, CD2Cl2) δ -
0.14 (t, J = 28.0 Hz); HRMS (ESI-TOF) m/z 777.9808 [M]
-
 calc. C30H23BF2I2N2O4 776.9850. 
BODIPY 14: mp (°C)>300; 
1
H NMR (400 MHz, CD2Cl2) δ 7.48 – 7.42 (m, 2H), 7.39 – 
7.34 (m, 2H), 7.10 (s, 2H), 7.05 – 6.99 (m, 4H), 6.92 – 6.84 (m, 4H), 3.78 (s, 6H), 2.47 (s, 3H); 
13
C NMR (126 MHz, CD2Cl2) δ 160.3, 156.6, 149.6, 141.6, 141.5, 138.4, 130.6, 129.8, 129.42, 
129.40, 119.1, 114.6, 55.7; 
11
B NMR (128 MHz, CD2Cl2) δ -0.24 (t, J = 27.2 Hz); HRMS (ESI-
TOF) m/z 780.8441 [M]
-
 calc. C23H16BF2I3N2O2 780.8433. 
SNAr reactions between BODIPY 2 and aniline 
38.8 mg (0.05 mmol) BODIPY 2 and 45.1 μL (0.75 mmol) aniline were mixed in 5 mL 
acetonitrile and stirred at room temperature for 30 minutes under inert atmosphere until thin 
layer chromatography confirmed the consumption of BODIPY 2, and the solvents were removed 
under vacuum. The residue was dissolved in 30 mL dichloromethane and washed with 2 x 15 mL 
water. Dichloromethane was removed under vacuum. The residue was purified by silica gel 
column chromatography to give BODIPY 15 in a 78% yield.  
BODIPY 15: mp (°C) 110 (decomposed); 
1
H NMR (400 MHz, CD2Cl2) δ 8.19 (s, 1H), 
7.45 (dd, J = 8.3, 6.8 Hz, 2H), 7.40 – 7.34 (m, 3H), 7.33 – 7.22 (m, 5H), 6.64 (s, 1H), 2.44 (s, 
3H); 13C NMR (126 MHz, CD2Cl2) δ 157.1, 145.3, 140.5, 137.8, 135.6, 134.5, 131.8, 130.3, 
93 
 
130.0, 129.4, 129.3, 128.9, 127.8, 127.1, 53.9, 53.7, 53.5, 53.3, 53.1, 21.2; 
11
B NMR (128 MHz, 
CD2Cl2) δ 0.33 (t, J = 33.3 Hz); HRMS (ESI-TOF) m/z 789.8115 [M+K]
+
 calc. C22H15BF2I3N3K 
789.8104. 
SNAr reactions between BODIPY 2 and ethyl malonate 
For the di-substitution, to a mixture of 38.8 mg (0.05 mmol) BODIPY 2, 22.8 μL (0.15 
mmol) ethyl malonate and 3.6 mg (0.15 mmol) sodium hydride, and 5 mL acetonitrile were 
added. The reaction was refluxed at 82 
o
C under inert atmosphere until thin layer 
chromatography confirmed the consumption of BODIPY 2, and the solvents were removed 
under vacuum. The residue was dissolved in 50 mL dichloromethane and washed with 2 x 25 mL 
water. Dichloromethane was removed under vacuum. The residue was purified by silica gel 
column chromatography. BODIPY 17 was obtained in 69% yield. For the mono-substitution, to a 
mixture of 38.8 mg (0.05 mmol) BODIPY 1b, 9.1 μL (0.06 mmol) ethyl malonate and 2.4 mg 
(0.06 mmol) sodium hydride, and 5 mL acetonitrile were added. The following reaction 
condition, work up and purification procedure were all similar to the ones of di-substitution 
reactions, and BODIPY 16 was produced in a 72% yield.  
BODIPY 16: mp (°C) 150 (decomposed); 
1
H NMR (400 MHz, CD2Cl2) δ 7.44 (d, J = 8.0 
Hz, 2H), 7.37 (d, J = 7.9 Hz, 2H), 7.22 – 7.12 (m, 1H), 7.04 (d, J = 1.3 Hz, 1H), 5.51 (s, 1H), 
4.29 (q, J = 7.1 Hz, 4H), 2.47 (s, 3H), 1.31 (t, J = 7.1 Hz, 6H); 
13
C NMR (126 MHz, CD2Cl2) δ 
164.9, 143.4, 142.5, 139.9, 139.2, 137.7, 135.4, 130.7, 129.5, 129.5, 62.7, 21.3, 13.9; 
11
B NMR 
(128 MHz, CD2Cl2) δ 0.09 (t, J = 31.3 Hz); HRMS (ESI-TOF) m/z 817.8622 [M]
-
 calc. 
C23H20BF2I3N2O4 817.8618. 
BODIPY 17: mp (°C) >300; 
1
H NMR (400 MHz, CDCl3) δ 7.44 (d, J = 8.1 Hz, 2H), 
7.35 (d, J = 7.9 Hz, 2H), 7.12 (d, J = 1.5 Hz, 2H), 5.55 (s, 2H), 4.30 (q, J = 7.1, 2.3 Hz, 8H), 2.48 
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(s, 3H), 1.31 (t, J = 7.2 Hz, 12H); 
13
C NMR (101 MHz, CDCl3) δ 165.0, 151.2, 145.3, 142.1, 
139.4, 135.1, 130.6, 129.9, 129.5, 62.6, 52.1, 29.7, 21.5, 14.0; 
11
B NMR (128 MHz, CDCl3) δ 
0.21 (t, J = 33.8 Hz); HRMS (ESI-TOF) m/z 850.0210 [M]
-
 calc. C30H31BF2I2N2O8 774.3220. 
SNAr reactions between BODIPY 16 and thiols: 
To a mixture of 41.4 mg (0.05 mmol) BODIPY 16 and 12.4 mg (0.10 mmol) 4-methyl-
benzenethiol, 10 mL dichloromethane was added. 1 drop of triethylamine was added via syringe 
and the reaction was allowed to stir in room temperature under inert atmosphere for 12 hours. 
After thin layer chromatography confirmed the consumption of BODIPY 16, the reaction was 
poured to 100 mL dichloromethane, and was washed with 2 x 50 mL saturated sodium 
bicarbonate solution. Dichloromethane was removed under vacuum. The dark purple residue was 
purified by silica gel column chromatography to give BODIPY 18 in a 68% yield. BODIPY 18: 
mp (°C) 170 (decomposed); 
1
H NMR (400 MHz, CD2Cl2) δ 7.49 – 7.41 (m, 2H), 7.37 (d, J = 7.9 
Hz, 2H), 7.34 – 7.25 (m, 2H), 7.21 – 7.08 (m, 4H), 5.55 (s, 1H), 4.29 (q, J = 7.2 Hz, 4H), 2.47 (s, 
3H), 2.33 (s, 3H), 1.33 – 1.28 (m, 6H); 13C NMR (101 MHz, CD2Cl2) δ 165.2, 152.8, 151.5, 
144.1, 142.3, 139.4, 139.3, 138.2, 137.0, 135.5, 131.2, 130.8, 130.1, 129.9, 129.8, 129.6, 129.5, 
62.7, 21.3, 21.0, 13.9; 
11
B NMR (128 MHz, CD2Cl2) δ 0.25 (t, J = 31.2 Hz); HRMS (ESI-TOF) 
m/z 835.9770 [M+Na]
+
 calc. C30H27BF2I2N2NaO4 774.3220. 
SNAr reactions between BODIPY 16 and 4-OMe-phenol 
To a mixture of 41.4 mg (0.05 mmol) BODIPY 16, 12.4 mg (0.10 mmol) 4-
methoxyphenol and 0.11 g (1.0 mmol) potassium carbonate, and 5 mL acetonitrile were added. 
The reaction was stirred in room temperature for 12 hours under inert atmosphere until thin layer 
chromatography confirmed the consumption of BODIPY 16, and the solvents were removed 
under vacuum. The residue was dissolved in 100 mL dichloromethane and washed with 2 x 50 
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mL water. Dichloromethane was removed under vacuum. The residue was purified by silica gel 
column chromatography and BODIPY 19 was obtained in 89% yield. BODIPY 19: mp (°C) 213; 
1
H NMR (400 MHz, CD2Cl2) δ 7.44 (d, J = 8.1 Hz, 2H), 7.36 (d, J = 7.9 Hz, 2H), 7.23 (s, 1H), 
7.13 – 7.01 (m, 3H), 6.96 – 6.85 (m, 2H), 5.44 (s, 1H), 4.26 (q, J = 7.1 Hz, 4H), 3.81 (s, 3H), 
2.47 (s, 3H), 1.29 (t, J = 7.1 Hz, 6H); 
13
C NMR (100 MHz, CD2Cl2) δ 165.5, 162.5, 157.2, 148.6, 
146.9, 142.7, 141.9, 141.7, 136.4, 134.1, 130.8, 130.5, 129.6, 129.3, 119.9, 114.8, 62.4, 55.6, 
21.2, 13.8; 
11
B NMR (128 MHz, CD2Cl2) δ 0.01 (t, J = 30.8 Hz); HRMS (ESI-TOF) m/z 
794.0012 [M-F]
+
 calc. C30H27BFI2N2O6 794.0066. 
SNAr reactions between BODIPY 16 and aniline 
41.4 mg (0.05 mmol) BODIPY 16 and 10.0 μL (0.15 mmol) aniline were mixed in 5 mL 
acetonitrile and stirred at room temperature for 12 hours under inert atmosphere until thin layer 
chromatography confirmed the consumption of BODIPY 2, and the solvents were removed 
under vacuum. The residue was dissolved in 30 mL dichloromethane and washed with 2 x 15 mL 
water. Dichloromethane was removed under vacuum. The residue was purified by silica gel 
column chromatography to give BODIPY 20 in a 78% yield. BODIPY 20: mp (°C) 142; 
1
H 
NMR (400 MHz, CD2Cl2) δ 8.07 (s, 1H), 7.59 – 7.06 (m, 10H), 6.73 (s, 1H), 5.36 (s, 1H), 4.27 
(q, J = 7.1 Hz, 4H), 2.45 (s, 3H), 1.30 (t, J = 7.1 Hz, 6H); 
13
C NMR (101 MHz, CD2Cl2) δ 166.3, 
156.9, 145.3, 140.6, 139.6, 135.8, 134.1, 133.8, 133.5, 130.4, 130.3, 129.4, 129.3, 127.8, 127.1, 
62.3, 21.2, 14.0; 
11
B NMR (128 MHz, CD2Cl2) δ 0.60 (t, J = 35.9 Hz); HRMS (ESI-TOF) m/z 
784.0141 [M+H]
+
 calc. C29H27BF2I2N3O4 784.0152. 
3.4.3 X-ray Determined Molecular Structures 
X-ray data were collected at low temperature with MoKα radiation on Bruker Kappa 
Apex-II DUO or Nonius KappaCCD diffactometers. Data reduction: Bruker SAINT; program(s) 
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used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012); 
software used to prepare material for publication: SHELXL97 (Sheldrick, 2008). 
Crystal Data: 3b, C37H35BF2N2S2, M=620.60, monoclinic, a=17.1401(9), b=10.6673(5), 
c=18.0721(9) Å, T=100 K, space group P21/n, Z=4, 167674 reflections measured, 12394 unique 
(Rint=0.039), θmax=36.4°, final R=0.037; 
Crystal Data: 4, C37H35BF2N2O4, M=620.48, monoclinic, a=11.0091(9), b=24.4103(18), 
c=12.6266(11) Å, T=150 K, space group P21/n, Z=4, 37510 reflections measured, 4712 unique 
(Rint=0.063), θmax=28.3°, final R=0.050; 
Crystal Data: 5, C30H28BF2IN2O2, M=624.25, Triclinic, a=9.8023(4), b=11.1021(4), 
c=13.2217(5) Å, T=90 K, space group P1, Z=2, 22581 reflections measured, 8829 unique 
(Rint=0.031), θmax=33.2°, final R=0.030; 
Crystal Data: 6, C37H32BF5N2O2, M=642.45, monoclinic, a=13.2597(9), b=8.4023(5), 
c=14.1888(7) Å, T=90 K, space group P21, Z=2, 12821 reflections measured, 5228 unique 
(Rint=0.020), θmax=25.7°, final R=0.039; 
Crystal Data: 10, C30H29BI2N2O, M=698.16, Triclinic, a=11.5055(6), b=16.1724(10), 
c=16.5198(8) Å, T=90 K, space group P1, Z=4, 59600 reflections measured, 9238 unique 
(Rint=0.042), θmax=27.2°, final R=0.034. 
3.4.4 Steady-state Absorption and Fluorescence Spectroscopy 
The photophysical properties of compounds 3b, 4, 5, 7, 8a, 8b, and 12-23 were 
determined by preparing a stock solution with a concentration of 1 × 10
-4
 M and diluting it to 
appropriate concentrations for absorbance and emission spectra measurements. All the 
absorption spectra were obtained using a Perkin Elmer Lambda 35 UV-visible 
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spectrophotometer. The optical density, ε, were taken by preparing solution concentrations at 
1x10
-5
 M in order to get λmax between 0.5 and 1.0. Emission spectra were measured on a LS-55 
Perkin-Elmer spectro-fluorometer with the slit width set at 2.5 nm for all other BODIPYs. All 
absorbance and emission spectra were acquired within 6 h of fresh solution preparation, at room 
temperature. Cresyl violet (Φ = 0.55 in MeOH)27 was used as the reference for compounds 3b, 
12, 13 and 18 in THF. Rhodamine 6G (Φ = 0.86 in MeOH)27 was used as the reference for all 
rest compounds in THF. Quartz spectrophotometric cells with path lengths of 10 mm were used. 
For the determination of quantum yields, dilute solutions with different absorbance between 
0.02-0.08 at the particular excitation wavelength were used. Molar absorption coefficients (ε) 
were determined from the plots of integrated absorbance vs concentrations. The following 
equation was used for the calculations of the relative fluorescence quantum yields (Φf)
28: Φs = 
Φstx(Gradx/Grandst)x(nx
2
 /nst
2
 ) where Φ and n are the fluorescence quantum yields and refractive 
indexes, respectively; Grad represents gradient of integrated fluorescence intensity vs absorbance 
at the particular wavelength, subscripts s and x refer to the standards and the tested samples. 
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CHAPTER IV: PREPARATION OF NEAR-IR BODIPYS VIA BENZO-
FUSIONS 
4.1 Introduction 
4.1.1 Overview 
In the last decade, research in the synthesis of organic chromophores with absorption and 
fluorescence spectra in the near infrared (NIR) region became popular, because such 
chromophores have many applications such as in imaging,
1-5
, electrophoresis,
6-7
 labels
8
 and 
sensors.
9-11
 The biological window is in the 650–1000 nm region, where auto-fluorescence, and 
absorption by water and tissues are minimized, so laser light could penetrate deeper. The 
development of low-cost instruments for NIR excitation sources and detectors, have inspired the 
design of new fluorophores with high molar absorption coefficients and fluorescence quantum 
yield. 
 
Figure 4.1: Cyanine dyes and rhodamine dyes 
So far cyanine dyes, such as Cy3 or Cy5, have been the most common choice in many 
applications, but their low photostability and low quantum yields are the major drawbacks. 
Though some rigid or bridged cyanines have been developed, the flexible bonds can still cause 
non-emissive deactivation.
12-13
 Rhodamine dyes are occasionally employed as alternatives due to 
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their relatively higher structural rigidity and high quantum yields in aqueous solvents, as shown 
in Figure 4.1. However, their absorption and emission peaks are below 600 nm. In addition, since 
rhodamine dyes are with positively charged ions, the solubility of rhodamines is restricted to 
polar solvents.
14
 
4.1.2 BODIPY’s Wavelength Tuning Strategies 
Classical BODIPY’s spectral properties are typically within the 470–530 nm region. 
Around 50 nm red-shifts of the absorption and emission maxima have been achieved through 
functionalization at the BODIPY periphery. Our research goal is to synthesize near infrared 
BODIPY dyes with high stability, solubility and fluorescence quantum yields. A great number of 
papers are published on the synthesis, properties and applications of near infrared BODIPY dyes, 
and their major red-shifting methods are listed below. 
 
Scheme 4.1: A 3,5-Knovenagel condensation reaction that red-shifts the BODIPY
15
 
4.1.2.1 Functionalizations with aryl, styryl and arylethynyl units 
The introduction of aryl substituents is a common method in BODIPY’s synthetic 
chemistry, and the aryl units can be installed either on the pyrrole precursors or at the 
postfunctionalization stage of BODIPYs. This method to produces significant red-shifts due to a 
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destabilization of the HOMO orbitals while phenyl groups are incorporated at the 3,5-positions, 
where large MO coefficients are anticipated.
16-17
 
 
Scheme 4.2: Sonogashira cross-coupling reactions to give arylethynyl BODIPYs
18
 
 
Figure 4.2: Calculated MO diagrams of BODIPY and aza-BODIPY
19
 Reprint with permission 
from Elsevier (2008). 
Styryl groups are commonly introduced to BODIPYs by Knoevenagel condensations, or 
are able to be installed with Heck cross-coupling reactions, as Chapter II describes. When indole-
3-carbaldehyde was employed in Knoevenagel reactions, the 3,5-distyryl groups induced red-
shifts in the order of 178 nm in the absorption and 198 nm in the emission spectra, as shown in 
Scheme 4.1.
15
 Arylethynyl functionalization, particularly with thiophene, gives BODIPYs that 
absorb up to 649 nm and emit up to 681 nm, as shown in Scheme 4.2 shows.
18
 
4.1.2.2 Replacing the meso-carbon atom with a nitrogen atom to form aza-BODIPYs 
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Computational studies show that the red-shifted absorption band mainly comes from a 
transition from HOMO to LUMO.
19
 The energies of the HOMO and LUMO are both stabilized, 
but the stabilization of the HOMO of the aza-BODIPY is less than that of LUMO, since the 
LUMO is delocalized over the meso-position by the stronger electron-withdrawing effect of the 
nitrogen atom. The HOMO–LUMO gap for the aza-BODIPY is smaller than that for the meso-
carbon BODIPY, resulting in obvious red-shifts, as shown in Figure 4.2. 
 
Scheme 4.3: Rigidification of the 2,6-aryl groups to produce red-shifts
20
 
4.1.2.3 Rigidification of free-rotatable moieties 
 
Scheme 4.4: Rigidification of 3,5-diaryl groups to produce red-shifts
21 
Various rotatable moieties were attempted to be prevented on BODIPY molecules, 
mainly including the ones from meso-, 3,5- and 2,6-positions. Wu et al used FeCl3/MeNO2/DCM 
conditions to rigidify the anthracene unit on BODIPY’s 1,7-positions and the new dye shows 
four major bands above 600 nm: 606, 650, 760, and 826 nm.
22
 The Burgess group first installed 
two 2-methoxy-phenyl on the 3,5-positions of BODIPY, and then employed BBr3 to hydrolyze 
the OMe to hydroxyl group following by chelation with boron atom, as shown in Scheme 4.4. 
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The BODIPY showed red-shifted 80 nm in the absorption spectra and 47 nm in the emission 
spectra.
21
 Ziessel et al prepared a BODIPY with dithienyl units and through FeCl3/DCM 
condition, the β-position of the thiophene was coupled with the BODIPY’s 3,5-positions to give 
a near-IR BODIPY that absorbs at 665 nm, as shown in Scheme 4.3.
23
 
4.1.2.4 Push-pull Effects 
Aza-BODIPYs with 4-methoxy-phenyl groups at the 3,5-positions and 4-cyano-phenyl 
groups at the 1,7-positions show 28 nm red-shifts in the absorption and 32 nm red-shifts in the 
emission spectra, as shown in Figure 4.3.
24
 This phenomenon is probably due to the reducing of 
the band gap by increasing the HOMO, and decreasing the LUMO energy. BODIPYs bearing 
electron donating groups at the 2,3,5-positions, and electron withdrawing groups at the 6,8-
positions show the λmax absorption at 635-653 nm, and emission at 706-707 nm and the largest 
Stokes shift (54−71 nm) in different solvents, as shown in Figure 4.4 show.25 
 
Scheme 4.5: Rigidification of the meso-aryl group to produce red-shifting
22
 
4.1.2.5 Benzo-fusions 
 
Figure 4.3: Push-pull effect to produce bathochromic shifts of aza-BODIPYs
24
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Figure 4.4: Push-pull effect to produce bathochromic shifts on BODIPYs
25
 
Π-extented BODIPYs, with aromatic ring fusion at the β, β’-pyrrolic positions, are highly 
constrained, planar and hydrophobic. The rigid aromatic rings largely red-shift BODIPY’s 
absorption and emission spectra (ca. 50 nm per annulated benzene ring), and the quantum yields 
are also enhanced.
26
  Several π-extented BODIPYs have been synthesized via different methods 
and high cell permeability was shown, particularly the meso-aryl-substituted benzo-BODIPYs. 
The Ono method starts from an α-free bicyclo-octadiene-fused pyrrole with methyl, ester or aryl 
groups on the other α-position, as Route A shows in Figure 4.5, and a series of BODIPY’s 
benzo-fusions were generated from retro-Diels-Alder reactions under harsh conditions.
27-28
 On 
the other hand the isoindole precursors required by Route B are relatively unstable, so only the 
Hao&Jiao method reported a total synthesis of monobenzo-fused BODIPYs from 2-chloro-5-
formyl-isoindole
29-30
 and Ziessel method reported a total synthesis of meso-free dibenzo-
BODIPYs via a bis-isoindolylmethane retro-aldol formaldehyde elimination.
31
 Furthermore, as 
di- and/or tetra-hydroisoindole pyrroles have been used as precursors for the synthesis of 
tetrabenzoporphyrins,
32
 they were reported in preparation of π-extended dipyrrins and BODIPYs. 
In 2010, π-extended dipyrrins were prepared from dihydroisoindole’s aromatization with DDQ in 
THF and room temperature, as Route C shows.
33
 In 2012, our group reported the synthesis of a 
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series of π-extended BODIPYs from a more readily prepared tetrahydroisoindole, with 
ethoxycarbonyl substituent on the 3,5-positions, as shown by route E, which decreases the 
quantum yields due to its high flexibility and limits further chemical and biological 
functionalization.
26
 Route D and Route F both form isoindole intermediates that produce 
dibenzo-dipyrromethene in “one-pot” synthesis, thus they are efficient methods to prepare 
symmetric dibenzo-BODIPYs as well.
31, 34
 
 
Figure 4.5: Synthetic strategies to prepare β,β’-benzo-fused BODIPYs and precursors 
4.1.3 Epidermal Growth Factor Receptor 
Epidermal growth factor receptor (EGFR) is employed in tumor targeted diagnosis and 
therapy, since its overexpression was reported to be found in breast, colon, and ovarian cancers. 
Colorectal cancer (CRC) is causing the second leading cancer-related deaths in the US. Colon 
cancer develops over several years from adenomatous polyps to carcinoma, and colon screening, 
detection, and removal of polyp adenomas or early stage cancer reduces the incidence of CRC. 
Current detecting methods for CRC include flexible sigmoidoscopy, radiography, standard 
colonoscopy, and computer tomography (CT) colonoscopy. EGFR has strong association with 
colorectal cancer, so it has been targeted by various ligands such as peptides, antibodies and 
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conjugates.
35
 Our group prepared a series of phthalocyanine-peptide and porphyrin-peptide 
conjugates, and via in vitro and in vivo studies we found that those conjugates targeted EGFR 
selectively.
37-38
 
4.1.4 Research Prospective 
Based on the results from Chapter II and III, we have synthesized and characterized a 
number of BODIPY dyes that can be further transformed to near-IR BODIPY derivatives, and 
we are investigating their further bio-conjugation reactions to produce novel near-IR imaging 
reagents. 
4.2 Results and Discussion 
4.2.1 Syntheses 
All sample prepared in Chapters II and III with bicyclo-moieties at the 1,2,6,7-positions, 
were investigated in oxidation reaction to produce dibenzo moieties to induce red-shifts. 
Bicyclo-BODIPYs and DDQ were dissolved in toluene, and the solutions were refluxed and 
monitored by TLC and by UV-Vis, as shown in Scheme 4.6. Only BODIPYs with phenyl and 4-
nitro-phenyl groups were successfully oxidized to their dibenzo-derivatives. The solutions of 
BODIPYs with 3,5-electron-rich aryl groups red-shifted by approximately 70-90 nm, but TLC 
indicated the new formed compounds were insoluble and very polar, requiring 100% acetone as 
the eluent. Previous experience indicated that most BODIPY molecules were relatively non-polar 
and very soluble in DCM. Thus we think the aromatized BODIPYs formed, but they were 
quickly polymerized to polymers immediately, due to the high electron density on the 3,5-groups. 
The other BODIPYs with hetero-substituents, styryl and arylethynyl groups decomposed within 
30 minutes, as observed by lack of the UV-Vis absorption bands, and the solutions completely 
lost the fluorescence. Other milder aromatizing conditions were also attempted on all bicyclo 
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BODIPYs, including FeCl3, H2O2 and I2/DMSO,
39
 but the results still turned out to be either 
polymerization or decomposition. 
 
Scheme 4.6: Attempts to aromatize bicyclo-BODIPYs bearing substituents at the 3,5-positions 
Since bicyclo-BODIPYs bearing phenyl, 4-nitrophenyl and ethyl ester groups
26
 were 
successfully aromatized under DDQ conditions, we then plan to prepare a series of symmetric 
and unsymmetric bicyclo-BODIPYs bearing aryl groups containing electro-withdrawing units. 
The targeted molecules are expected to have three “handles” at the meso-, 3- and 5-positions for 
three different purposes, as Figure 4.6 shows, and these molecules are expected to retain high 
stability due to the strong sp
2
C-sp
2
C bonding. 
 
Figure 4.6: A designed near-IR BODIPY structure with three “handles” 
4.2.1.1 Synthesis of bicyclo-BODIPYs with 3,5-diaryl groups 
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The optimized conditions from Chapter II were then used for the coupling of boronic 
acids (4-cyanophenyl-, 4-(trifluoromethyl)phenyl- and 4-(benzyloxycarbonyl)phenyl boronic 
acids) and the products from these reactions, BODIPYs 2a–i were isolated consistently in high 
yields, and the highest yield (92%) was obtained for 2i due to the enhanced solubility in organic 
solvents. The yields of all prepared bicyclo-BODIPYs, including 2a and 2b which were 
investigated in Chapter II, are ummarized in Table 4.1.  
 
Scheme 4.7: Symmetric Suzuki cross-coupling reactions on 3,5-diiodo-BODIPY 1a and 1b 
Crystals suitable for X-ray analysis were obtained for BODIPYs 2b, 2c, 2d, 2e, 2f, 2h 
and 2i, as shown in Figure 4.7. In BODIPY 2a, the C3N2B ring is almost planar. Its meso-phenyl 
ring forms a dihedral angle of 79.8° with the central ring, and its 3,5-diphenyl rings form a 
dihedral angle of 56.2° with the central C3N2B ring. BODIPY 2b’s central ring is slightly twisted, 
with carbon atoms lying 0.076 Å out of the plane, and the nitrogen atoms 0.072 Å. Its meso-
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phenyl group forms a dihedral angle of 60.4° with the central plane, and the 3,5-daryl groups 
47.2°. In BODIPY 2c, the central C3N2B ring is non-planar, as the boron atom lies out of the 
C3N2 best plane. The meso-phenyl group forms a dihedral angle of 72.8° with the central plane, 
and the 3,5-diaryl groups form an average of 61.0° with the central plane. In BODIPY 2d, the 
central C3N2B ring is highly planar. Its meso-phenyl ring forms a dihedral angle of 74.4° with the 
central plane, and the 3,5-diaryl groups an average of 52.9°. In BODIPY 2e, the central C3N2B 
ring is also highly planar. Its meso-phenyl group forms a dihedral angle of 82.4° with the central 
plane, and the 3,5-diphenyl rings an average of 59.8° with it. 
 
 
Figure 4.7: Crystal structure of BODIPYs 2b, 2c, 2d, 2e, 2f, and 2h
41
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4.2.1.2 DDQ aromatization 
To obtaining the best aromatizing conditions, bicyclo-BODIPY 2b reacted with 9 
equivalents of DDQ in refluxing toluene. In the first attempt, BODIPY 2b was dissolved in 
approximately 20 mL toluene, and DDQ was added. The reaction took 3 hours to be completed 
and the yield was only 15%. Polar byproducts were observed in this reaction, probably as a result 
of a radical polymerization process. Such polar compounds were the major products obtained 
from the DDQ aromatization of BODIPYs bearing electron-donating groups at the 3,5-positions. 
To avoid the intermolecular polymerization, we then diluted the reaction solution to 50 mL, but 
the yield was even lower (4%), after longer time (5 hours). Considering the aromatization 
reaction rate is highly related with the concentration, BODIPY 2b was dissolved in only 5 mL of 
toluene, and the reaction was successfully completed within 30 minutes, with a highest yield of 
32%. The same conditions were applied for all other BODIPYs 2a, 2c-i, as well as two 
unsymmetric BODIPYs from Chapter II, 3a and 3b, and all aromatization reactions were 
successful, producing BODIPYs 4a-k in 32-56%. The lowest yield was obtained for BODIPY 4b, 
due to the strongest electron-withdrawing character of the nitro units, and its lowest solubility 
compared with the other BODIPYs. 
Table 2.1: Products and yields obtained in the Suzuki cross-couplings (2a-f) and DDQ 
aromatization (4a-f) of BODIPYs 1a and 1b. 
BODIPY Ar group R group Yield of 5 (%) Yield of 6 (%) 
2a/4a Ph H 85 50 
2b/4b Ph NO2 83 32 
2c/4c Ph CN 85 52 
2d/4d Ph CF3 82 48 
2e/4e Ph CO2Bn 86 54 
2f/2f 3,5-(OMe)2Ph CO2Bn 92 52 
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BODIPYs 4a, 4b and 4c were characterized by X-ray crystallography, as shown in Figure 
4.8. BODIPY 4a has a similar twisted conformation from 2b, although the BODIPY only has the 
C2 symmetry. The meso-phenyl group forms a dihedral angle of 68.3° with the central plane, and 
the 3,5-phenyl groups 60.6°. The central ring of BODIPY 4b is as non-planar as 2c, with the 
boron atom lying out of the plane. The meso-phenyl ring forms a dihedral angle of 76.8° with the 
central plane, and the 3,5-diphenyl groups 57.2°. The central ring of both independent BODIPY 
4c has the boron atom lying out of the central plane. The meso-phenyl group forms a dihedral 
angle of 82.2° with the central plane, and the 3,5-diaryl groups 50.2°. 
 
Scheme 4.8: Aromatization reactions to produce dibenzo-BODIPYs 
4.2.1.3 Conversion of nitrophenyl-BODIPYs to isothiocyanate-BODIPYs 
Nitrophenyl BODIPYs 4b and 4f were further functionalized since nitro groups are 
relatively easy to be reduced to amino groups via a variety of reducing conditions, and amino-
BODIPYs are promising candidates for further bio-conjugations. Since nitrophenyl units on the 
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meso-position were reported to be reduced by hydrazine and Pd/C in refluxed ethanol,
42
 
BODIPYs 4b and 4f were treated with excess hydrazine hydrate in the presence of 10 % Pd/C, 
and the solution was refluxed in a co-solvent of THF and ethanol, since ethanol wasn’t able to 
dissolve 4b and 4f. The reduction reactions were completed after two to three hours, producing 
diaminophenyl-BODIPY 5a and 5b in 21 and 87 % yield, respectively, as shown in Scheme 4.9. 
The lower yield of 5a was mainly due to its low solubility. However, the stability of 5a and 5b 
were both relatively low, and even during purification and characterization time they were 
partially decomposed to dark insoluble solids. 
 
Figure 4.8: Crystal structure of BODIPYs 4a, 4b, 4c,
40
 4f, and 4i 
4a 
4b 
4c 
4f 4i 
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Scheme 4.9: Reduction of nitrophenyl BODIPYs to aminophenyl-BODIPYs 
Due to the low stability of diaminophenyl-BODIPYs, we decided to convert them to 
more stable peptide conjugating precursor isothiocyanate BODIPYs, which also requires mild 
conjugation conditions, and readily prepared peptides with free amino groups. Diaminophenyl 
BODIPYs 5a and 5b were then converted to isothiocyanate BODIPYs 6a and 6b, by reacting 
with excess amounts of 1,1′-thiocarbonyldi-2(1H)-pyridone for 24 hours.43 Diisothiocyanate 
BODIPYs 7a and 7b were produced in 21 and 87% yields, as shown in Scheme 4.10. The lower 
yield of 7a was also due to its low solubility. We then chose BODIPY 7b as the candidate for 
further bio-conjugation, because its overall yield from the dinitrophenyl BODIPY is much higher. 
 
Scheme 4.10: Conversion of diaminophenyl-BODIPYs to diisothiocyanate BODIPYs 
4.2.1.4 Conjugation between PEGylated EGFR-L1 and isothiocyanate-BODIPY 
BODIPY 7b was then employed for conjugation reaction, and we chose PEGylated 
EGFR-L1(LARLLT) due to its better cellular properties
36-37
 and its PEGylated linker to reduce 
the steric hindering effect. By treating BODIPY 7b with 2 equivalents of (PEG)3-EGFR-L1 in 
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anhydrous DMF in the presence of triethylamine, mono-conjugated BODIPY 8 was obtained in 
86% after 30 minutes, as shown in Scheme 4.11, and after HPLC purification using 100% 
acetonitrile as the eluent, as shown in Figure 4.9. To obtain a bis(EGFR-L1)-BODIPY, larger 
equivalents of EGFG-L1 were treated with BODIPY 7b, or BODIPY 8 was reacted with another 
2 equivalents of EGFR-L1, but MALDI-MS spectrometry result didn’t present any 
corresponding product. 
 
Figure 4.9: An HPLC purification spectra of BODIPY 8 
4.2.2 Structural Characterization 
 
Scheme 4.11: Conjugation reactions between BODIPY 7b and (PEG)3-EGFR-L1 
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All BODIPYs were characterized by 
1
H-, 
13
C- 
11
B- and 
19
F-NMR, HRMS, UV-Vis and 
fluorescence. The products from the Suzuki cross-coupling reactions, the β,β’-bicyclo-3,5,8-
triaryl-BODIPYs 2a-i and 3a,b showed 
1
H and 
13
C chemical shifts for the 3,5-aryl groups 
characteristically. After aromatization to the β,β’-dibenzo-BODIPYs, the chemical shifts for the 
3,5-aryl groups almost did not shift. However, the 
1
H and 
13
C chemical shifts for the fused 
benzene rings characteristically moved to the aromatic regions. 
Table 4.2: 
11
B- and 
19
F-NMR chemical shifts of BF2 group. In 
11
B-NMR the signal is a triplet 
and in 
19
F-NMR the signals are a quartet and septet (J11BF =32 Hz, J10BF = 10 Hz) 
BODIPY 
11
B NMR (ppm) 
19
F NMR (ppm) 
2a 0.87 -131.45, -131.53 
2b 0.67 -131.81, -130.89 
2c 0.70 -131.06, -131.13 
2d 0.78 -131.48, -131.55 
2e 0.77 -131.40, -131.47 
2i 0.73 -131.25, -131.32 
4a 1.81 -129.13, -129.20 
4b 1.67 -128.20, -128.28 
4c 1.68 -128.19, -128.26 
4d 1.74 -128.56, -128.64 
4e 1.76 -128.56, -129.63 
4i 1.70 -129.34, -129.41    
3a 1.72 -131.28, -131.35 
3b 1.68 -131.25, -131.32 
4j 0.82 -128.52, -128.60 
4k 0.70 -128.59, -128.67 
 
Differences were also seen in the 
11
B and 
19
F NMR spectra of the BODIPYs, as shown in 
Table 4.2. All BODIPYs showed a triplet signal in 
11
B-NMR with ca. JBF = 32 Hz. In 
19
F-NMR 
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the isotopes 
11
B (I = 3/2, 80%) and 
10
B (I = 3, 20%) split the BF2 signals into a mixture of a 
quartet (J11BF = 32 Hz) and a septet (J10BF = 10 Hz). The signals in 
11
B-NMR shifted downfield 
from ca. 0.5 ppm for the β,β’-bicyclo-3,5-diiodo-BODIPYs to ca. 0.8 ppm for the β,β’-bicyclo-
3,5,8-triaryl-BODIPYs, and finally about 1.7 ppm for the β,β’-dibenzo-3,5,8-triaryl-BODIPYs. 
In 
19
F-NMR the signals shifted downfield too, following the same trend. These changes are due 
to interactions of the aryl groups with the BF2 unit, and to the extension of π-conjugation systems. 
4.2.3 Spectroscopic study 
The spectroscopic properties of BODIPYs 2a-2e, 2i, 4a-e, 4i, 3a,b and 4a,j in THF, 
including their maximum absorption and emission wavelengths, molar coefficients, Stokes shifts, 
and fluorescence quantum yields, were investigated and are shown in Table 4.3. Figures 4.11 and 
4.12 show the normalized absorption and emission spectra of some selected BODIPYs, 
respectively. The BODIPYs show characteristic absorption and emission spectra, with high 
molar absorption coefficients (log ε = 4.63-5.00) and Stokes-shifted narrow fluorescent emission 
bands. BODIPY 2b bearing two nitro groups showed the most red-shifted absorption and 
emission bands, and the largest Stokes shift. However, BODIPY 2b with two nitro groups shows 
the lowest fluorescence quantum yield and BODIPY 2d bearing two trifluoromethyl groups 
shows the highest fluorescence quatum yield. p-Nitrophenyl groups have been reported to 
quench the fluorescence of BODIPYs via PET process, due to the strong electron-withdrawing 
effect of the nitro. The presence of a trifluoromethyl at the meso-position of BODIPYs was 
previously reported to induce high fluorescence quantum yields.
44
  
The β,β’-dibenzo-BODIPYs showed 77-89 nm red-shifts in the absorption and emission 
bands, compared with the corresponding β,β’-bicyclo-BODIPYs as expected. In general, the 
fluorescence quantum yields were higher for the β,β’-dibenzo-BODIPYs compared with the 
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corresponding β,β’-bicyclo-BODIPYs, except in the case of the 3,5-dinitrophenyl-BODIPY 2b. 
Diisothiocyanate BODIPY 7b’s emission spectra show the highest peak in 683nm, indicating it’s 
an excellent near-IR conjugation precursor. 
4.3 Conclusions 
The functionalization of 3,5-diiodo-BODIPYs via Suzuki cross-coupling reactions gave 
the β,β’-bicyclo-3,5,8-triaryl-BODIPYs in 82-92% yields. DDQ aromatization of these β,β’-
bicyclo-3,5,8-triaryl-BODIPYs produced the corresponding β,β’-dibenzo-3,5,8-triaryl-BODIPYs 
in 32-54% yields. Downfield shifts were observed in their 
11
B and 
19
F-NMR spectra. The β,β’-
dibenzo-3,5,8-triaryl-BODIPYs showed 77-89 nm red-shifted absorptions and fluorescence 
emissions, decreased Stokes shifts, and in general higher quantum yields, compared with their 
corresponding β,β’-bicyclo-BODIPYs. The 3,5-(p-nitrophenyl) groups caused the largest red-
shifts and Stokes shifts, although they slightly quenched the fluorescence quantum yield of the 
BODIPYs. On the other hand, BODIPYs bearing 3,5-(p-trifluoromethylphenyl) groups showed 
the highest fluorescence quantum yields among this series. Nitrophenyl BODIPYs were 
successfully converted to diisothiocyanate BODIPYs and the following bio-conjugating 
reactions were performed to give BODIPY-peptide conjugates for further imaging studies. 
4.4 Experimental 
4.4.1 General Information 
All the reagents and solvents were purchased from Sigma-Aldrich and were used without 
further purification. All reactions were carried out with oven-dried glassware under a dry argon 
atmosphere. All the reactions were monitored using Sorbent Technologies 0.2 mm silica gel TLC 
plates with UV-254 nm indicator. Flash column chromatography was performed using Sorbent 
Technologies 60 Å silica gel (230-400 mesh). Prep-TLC 60 Å silica gel 20 x 20 cm (210-270 μm) 
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was used. All 
1
H-, 
13
C-, 
11
B- and 
19
F-NMR spectra were collected on a Bruker AV-400 and AV-
500 spectrometer in deuterated chloroform or dichloromethane. The CDCl3 chemical shifts (δ) 
are reported in ppm using as reference 7.26 for proton and 77.00 for carbon and BF3•OEt2 was 
used as reference (0.00 δ) for boron NMR. The CD2Cl2 chemical shifts (δ) are reported in ppm 
using as reference 5.32 for proton and 53.50 for carbon. Coupling constants are reported in Hertz 
(Hz). All the mass spectra were collected using an Agilent 6210 ESI-TOF mass spectrometer. All 
melting points were recorded using a MEL-TEMP electrothermal instrument. 
 
Figure 4.11: Normalized UV-Vis spectra of selected BODIPYs 2b (black), 2c (blue), 2d (purple), 
2b (red), 2c (cyan) and 2d (dark yellow) in THF at room temperature. 
4.4.2 Synthesis 
General Suzuki cross-coupling conditions. For symmetric BODIPYs, 62.8 mg (0.100 mmol) 
1a or 68.8 mg (0.100 mmol) 1b, 5.00 mg Pd(dppf)Cl2 and 5 equiv (0.500 mmol) of aryl boronic 
acid were mixed under inert atmosphere. Toluene (2 mL) and THF (2 mL) were added via 
syringe and the solution was heated at 70 
o
C in an oil bath for 3 min. K2CO3 (1 M, 0.5 mL) 
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solution was added via syringe and the reaction was monitored by TLC until complete 
consumption of 3,5-diiodo-BODIPY. The cooled solution was filtered through celite to remove 
excess palladium and boronic acid, and the solvent was concentrated under vacuum. The residue 
was purified by silica gel column chromatography to afford the corresponding 3,5-diaryl-
BODIPYs as red solids, which were recrystallized using 1:1 dichloromethane/hexane.  
 
Figure 4.11 Normalized fluorescent emission spectra of selected BODIPYs 2b (black), 2c (blue), 
2d (purple), 2b (red), 2c (cyan) and 2d (dark yellow) in THF at room temperature. 
BODIPY 2c: Yield 85%. mp(°C)> 300; 
1
H NMR (CD2Cl2, 400 MHz)
 
 δ 7.72 – 7.60 (m, 
8H), 7.60 – 7.53 (m, 3H), 7.42 – 7.35 (m, 2H), 2.25 (t, J = 5.9 Hz, 4H), 1.72 (t, J = 6.1 Hz, 4H), 
1.57 – 1.52 (m, 4H), 1.46 (d, J = 5.6 Hz, 4H); 13C NMR (CD2Cl2, 100 MHz) δ 152.3, 143.8, 
143.2, 136.7, 134.9, 132.1, 131.6, 130.4, 130.40, 130.37, 130.3, 129.5, 129.4, 127.9, 118.6, 112.4, 
24.4, 23.0, 22.5, 22.4; 
11
B NMR (CDCl3, 128 MHz) δ 0.70 (t, J = 32.3 Hz); 
19
F NMR (CDCl3, 
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376 MHz) δ -131.00-131.26 (m); HRMS (ESI-TOF) m/z 600.2407 [M+Na]+ calcd for 
C37H29BF2N4Na 600.2382. 
Table 4.3: Spectroscopic properties of BODIPYs in THF. 
BODIPY Abs λmax (nm) log ε (M
-1
cm
-1
) Emi λmax (nm) Φf Stokes shift (cm
-1
) 
5a 548 4.74 574 0.42 827 
5b 558 4.66 597 0.35 1171 
5c 554 4.63 585 0.43 957 
5d 548 4.75 575 0.52 857 
5e 554 4.74 586 0.42 986 
5i 555 4.76 585 0.40 924 
6a 631 4.78 651 0.64 487 
6b 651 4.72 683 0.23 720 
6c 643 4.77 670 0.48 627 
6d 635 4.79 656 0.67 504 
6e 641 4.94 667 0.48 608 
6i 642 4.99 667 0.46 584 
3a 638 4.94 664 0.55 614 
3b 638 4.89 663 0.55 591 
4j 551 4.79 579 0.45 878 
4k 551 4.75 580 0.46 907 
 
BODIPY 2d: Yield 82%. mp(°C)> 300; 
1
H NMR (CDCl3, 400 MHz) δ 7.65 (q, J = 8.4 
Hz, 8H), 7.55 (dd, J = 4.9, 1.9 Hz, 3H), 7.42 – 7.33 (m, 2H), 2.26 (t, J = 6.0 Hz, 4H), 1.70 (t, J = 
6.1 Hz, 4H), 1.57 – 1.52 (m, 4H), 1.49 – 1.42 (m, 4H); 13C NMR (CDCl3, 125 MHz) δ 154.6, 
141.72, 135.8, 132.3, 131.4, 129.9, 129.8, 129.2, 129.1, 128.7, 128.3, 127.9, 24.4, 23.3, 22.84, 
22.77; 
11
B NMR (CDCl3, 128 MHz) δ 0.78 (t, J = 32.1 Hz); 
19
F NMR (CDCl3, 376 MHz) δ -
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62.70(s), δ -131.42-131.68 (m); HRMS (ESI-TOF) m/z 644.2352 [M-F]+ calcd for C37H29BF7N2 
644.2343. 
BODIPY 2e: Yield 86%. mp(°C)> 300; 
1
H NMR (CD2Cl2, 400 MHz) δ 8.22 (s, 2H), 
8.11 (dt, J = 8.0, 1.5 Hz, 2H), 7.81 (dt, J = 7.9, 1.4 Hz, 2H), 7.58 (dd, J = 5.2, 1.9 Hz, 3H), 7.53 – 
7.45 (m, 6H), 7.45 – 7.34 (m, 8H), 5.37 (s, 4H), 2.29 (t, J = 6.0 Hz, 4H), 1.76 (t, J = 6.1 Hz, 4H), 
1.61 – 1.53 (m, 4H), 1.48 (dp, J = 9.4, 3.6, 2.7 Hz, 4H); 13C NMR (CD2Cl2, 100 MHz) δ 165.9, 
153.3, 143.1, 142.7, 137.0, 136.4, 135.2, 131.9, 130.3, 130.2, 129.80, 129.77, 129.3, 129.0, 128.6, 
128.2, 128.09, 128.06, 66.7, 24.5, 23.1, 22.6, 22.5; 
11
B NMR (CD2Cl2, 128 MHz) δ 0.77 (t, J = 
32.3 Hz); 
19
F NMR (CDCl3, 376 MHz) δ -131.34-131.60 (m); HRMS (ESI-TOF) m/z 818.3172 
[M+Na]
+
 calcd for C51H43BF2N2O4Na 818.3212. 
BODIPY 2f: Yield 91%. mp(°C)> 300; 
1
H NMR (CDCl3, 400 MHz) δ 8.22 (d, J = 8.4 
Hz, 4H), 7.71 (d, J = 8.4 Hz, 4H), 6.62 (s, 1H), 6.52 (d, J = 2.2 Hz, 2H), 3.86 (s, 6H), 2.27 (d, J = 
6.1 Hz, 4H), 1.92 (d, J = 6.1 Hz, 4H), 1.73 – 1.44 (m, 8H); 13C NMR (CDCl3, 100 MHz) δ 161.8, 
152.1, 147.7, 143.3, 143.1, 138.4, 136.4, 131.8, 130.64, 130.60, 130.57, 130.1, 123.0, 105.6, 
101.2, 55.6, 24.0, 22.9, 22.42, 22.36; 
11
B NMR (CDCl3, 128 MHz) δ 0.69 (t, J = 32.4 Hz); 
HRMS (ESI-TOF) m/z 659.2489 [M-F]
+
 calcd for C37H33BFN4O6 659.2477. 
BODIPY 2g: Yield 88%. mp(°C)> 300; 
1
H NMR (400 MHz, CD2Cl2) δ 7.77 – 7.46 (m, 
8H), 6.64 (t, J = 2.3 Hz, 1H), 6.54 (d, J = 2.3 Hz, 2H), 3.85 (s, 6H), 2.27 (t, J = 6.0 Hz, 4H), 1.95 
(d, J = 6.0 Hz, 4H), 1.63 – 1.47 (m, 8H); 13C NMR (100 MHz, CD2Cl2) δ 162.0, 152.3, 143.4, 
143.2, 136.7, 136.4, 131.8, 131.5, 130.41, 130.38, 130.35, 130.23, 130.20, 118.6, 112.4, 105.7, 
101.2, 55.7, 24.1, 23.0, 22.5, 22.4; 
11
B NMR (128 MHz, CD2Cl2) δ 0.67 (t, J = 32.5 Hz); HRMS 
(ESI-TOF) m/z 619.2666 [M-F]
+
 calcd for C39H33BFN4O2 619.2681. 
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BODIPY 2h: Yield 86%. mp(°C)> 300; 
1H NMR (400 MHz, CDCl3) δ 7.65 (q, J = 8.4 
Hz, 8H), 6.60 (t, J = 2.3 Hz, 1H), 6.53 (d, J = 2.3 Hz, 2H), 3.85 (s, 6H), 2.27 (t, J = 6.0 Hz, 4H), 
1.91 (t, J = 6.0 Hz, 4H), 1.55 (m, 6H); 
13
C NMR (100 MHz, CD2Cl2) δ 162.0, 152.9, 143.1, 142.9, 
136.7, 136.1, 131.5, 130.5, 130.19, 130.16, 130.1, 125.6, 124.80, 124.76, 124.72, 124.68, 122.9, 
105.8, 101.3, 55.7, 24.2, 23.1, 22.6, 22.5;
 11
B NMR (128 MHz, CD2Cl2) δ 0.70 (t, J = 32.3 Hz); 
HRMS (ESI-TOF) m/z 705.2551 [M-F]
+
 calcd for C39H33BF7N2O2 705.2523. 
BODIPY 2i: Yield 92%. mp(°C)> 300; 
1
H NMR (CDCl3, 400 MHz) δ 8.06 (d, J = 8.0 
Hz, 4H), 7.59 (d, J = 8.1 Hz, 4H), 7.45 (d, J = 7.2 Hz, 4H), 7.42 – 7.31 (m, 6H), 6.61 (t, J = 2.2 
Hz, 1H), 6.54 (d, J = 2.2 Hz, 2H), 5.35 (s, 4H), 3.84 (s, 6H), 2.27 (t, J = 5.9 Hz, 4H), 1.93 (t, J = 
6.0 Hz, 4H), 1.67 – 1.37 (m, 8H); 13C NMR (CD2Cl2, 125 MHz) δ 165.9, 161.9, 153.3, 142.7, 
136.9, 136.7, 136.3, 131.5, 130.3, 130.1, 129.77, 129.75, 129.7, 128.9, 128.6, 128.2, 128.1, 124.9, 
105.8, 101.2, 66.7, 55.7, 24.1, 23.1, 22.6, 22.5; 
11
B NMR (CDCl3, 128 MHz) δ 0.73 (t, J = 32.0 
Hz); 
19
F NMR (CD2Cl2, 376 MHz) δ -131.19-131.45 (m); HRMS (ESI-TOF) m/z 836.3535 [M-
F]
+
 calcd for C53H47BFN2O6 836.3542. 
General procedure for DDQ aromatization. 0.100 mmol bicyclo-3,5-diaryl-BODIPYs 
and 204 mg (0.900 mmol) of DDQ were dissolved in 5 mL toluene. The solution was then 
refluxed under inert atmosphere for 30 min. The reaction was monitored by TLC and UV-Vis 
spectroscopy. The solvent was removed under vacuum and the residue was dissolved in 100 mL 
dichloromethane and washed with sat. NaHCO3 (1 x 100 mL). The aqueous solution was 
extracted with dichloromethane (2 x 50 mL) and the organic solvent was removed under vacuum. 
The residue was purified by silica gel column chromatography and the product was recrystallized 
in 1:1 dichloromethane/hexane. 
125 
 
BODIPY 4a: Yield 50%. mp(°C)> 300; 
1
H NMR (CD2Cl2, 400 MHz) δ 7.80 (d, J = 7.0 
Hz, 4H), 7.72 (d, J = 6.8 Hz, 3H), 7.64 (d, J = 6.9 Hz, 2H), 7.51 (dd, J = 14.3, 7.7 Hz, 8H), 7.07 
(dt, J = 23.6, 7.3 Hz, 4H), 6.24 (d, J = 8.3 Hz, 2H); 
13
C NMR (CD2Cl2, 100 MHz) δ 151.7, 135.3, 
134.3, 131.2, 131.0, 130.3, 129.6, 129.5, 129.4, 129.1, 128.8, 128.2, 126.4, 124.7, 123.6, 121.4; 
11
B NMR (CDCl3, 128 MHz) δ 1.81 (t, J = 31.2 Hz); 
19
F NMR (CDCl3, 376 MHz) δ -129.0-
129.33 (m); HRMS (ESI-TOF) m/z 519.1960 [M]+ calcd for C35H23BF2N2 519.1953. 
BODIPY 4b: Yield 32%. mp(°C)> 300; 
1
H NMR (CD2Cl2, 400 MHz) δ 8.39 – 8.28 (m, 
4H), 7.99 – 7.91 (m, 4H), 7.80 – 7.74 (m, 3H), 7.66 (dq, J = 6.5, 2.2 Hz, 2H), 7.52 (dt, J = 8.2, 
1.1 Hz, 2H), 7.20 (ddd, J = 8.1, 6.9, 1.1 Hz, 2H), 7.13 (ddd, J = 8.1, 6.9, 1.1 Hz, 2H), 6.32 (dd, J 
= 8.3, 1.1 Hz, 2H); 
13
C NMR (CD2Cl2, 125MHz) δ 149.2, 148.3, 138.1, 137.4, 134.62, 134.55, 
131.5, 131.42, 131.39, 131.0, 130.9, 130.0, 129.9, 129.6, 128.9, 128.8, 127.7, 125.8, 124.9, 123.4, 
122.8, 121.9; 
11
B NMR (CDCl3, 128MHz) δ 1.67 (t, J = 31.8 Hz); 
19
F NMR (CD2Cl2, 376MHz) 
δ -128.1-128.40 (m); HRMS (ESI-TOF) m/z 610.1739 [M+H]+ calcd for C35H22BF2N2O4 
611.1739. 
BODIPY 4c: Yield 52%. mp(°C)> 300; 
1
H NMR (CD2Cl2, 400 MHz) δ 7.89 (d, J = 8.0 
Hz, 4H), 7.84 – 7.74 (m, 7H), 7.64 (d, J = 6.4 Hz, 2H), 7.49 (d, J = 8.1 Hz, 2H), 7.18 (t, J = 7.5 
Hz, 2H), 7.11 (t, J = 7.6 Hz, 2H), 6.31 (d, J = 8.3 Hz, 2H); 
13
C NMR (CD2Cl2, 100 MHz) δ 149.4, 
135.5, 134.6, 132.0, 131.04, 131.01, 130.97, 129.92, 129.86, 129.5, 128.9, 125.7, 122.8, 121.8, 
118.5, 113.2; 
11
B NMR (CDCl3, 128 MHz) δ 1.68 (t, J = 31.7 Hz); 
19
F NMR (CDCl3, 376 MHz) 
δ -128.13-128.39 (m); HRMS (ESI-TOF) m/z 550.1918 [M-F]+ calcd for C37H20BFN4 550.1874. 
BODIPY 4d: Yield 48%. mp(°C)> 300; 
1
H NMR (CD2Cl2, 400 MHz) δ 7.91 (d, J = 8.1 
Hz, 4H), 7.82 – 7.74 (m, 7H), 7.67 – 7.62 (m, 2H), 7.51 – 7.46 (m, 2H), 7.17 (m, 2H), 7.10 (ddd, 
J = 8.1, 6.8, 1.2 Hz, 2H), 6.34 – 6.27 (m, 2H); 13C NMR (CD2Cl2, 100 MHz) δ 150.0, 134.8, 
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134.5, 131.1, 130.8, 129.8, 129.4, 128.9, 127.1, 125.4, 125.2, 125.1, 123.0, 121.7; 
11
B NMR 
(CDCl3, 128 MHz) δ 1.74 (t, J = 31.6 Hz); 
19
F NMR (CD2Cl2, 376 MHz) δ -63.02, δ -128.51-
128.76 (m); HRMS (ESI-TOF) m/z 636.1695 [M-F]
+
 calcd for C37H21BF7N2 636.1717. 
BODIPY 4e: Yield 54%. mp(°C)> 300; 
1
H NMR (CD2Cl2, 400 MHz) δ 8.22 (d, J = 8.0 
Hz, 4H), 7.87 (d, J = 8.1 Hz, 4H), 7.80 – 7.72 (m, 3H), 7.64 (d, J = 6.7 Hz, 2H), 7.52 (dd, J = 8.0, 
3.2 Hz, 6H), 7.42 (dt, J = 12.7, 6.7 Hz, 6H), 7.12 (dt, J = 25.4, 7.2 Hz, 4H), 6.32 (d, J = 8.3 Hz, 
2H), 5.43 (s, 4H); 
13
C NMR (CD2Cl2, 100 MHz) δ 165.8, 136.3, 135.6, 134.9, 134.5, 131.0, 
130.4, 129.80, 129.78, 129.3, 129.2, 129.0, 128.6, 128.3, 128.2, 125.3, 123.1, 121.7, 66.9;
 11
B 
NMR (CD2Cl2, 128 MHz) δ 1.76 (t, J = 31.5 Hz); 
19
F NMR (CD2Cl2, 376 MHz) δ -128.51-
128.76 (m); HRMS (ESI-TOF) m/z 787.2701 [M]
+
 calcd for C51H35BF2N2O4 787.2689. 
BODIPY 4f: Yield 34%. mp(°C)> 300; 
1
H NMR (400 MHz, CD2Cl2) δ 8.41 – 8.26 (m, 
4H), 8.05 – 7.79 (m, 4H), 7.58 – 7.47 (m, 2H), 7.27 – 7.15 (m, 4H), 6.85 (t, J = 2.3 Hz, 1H), 6.80 
(d, J = 2.3 Hz, 2H), 6.66 – 6.49 (m, 2H), 3.88 (s, 6H); 13C NMR (126 MHz, CD2Cl2) δ 162.2, 
149.1, 148.3, 137.7, 137.3, 136.1, 134.4, 134.4, 131.42, 131.39, 131.37, 131.0, 130.94, 130.92, 
130.90, 129.8, 127.4, 125.9, 123.3, 122.7, 122.2, 106.6, 101.8, 55.8; 
11
B NMR (128 MHz, 
CD2Cl2) δ 1.66 (t, J = 31.9 Hz); HRMS (ESI-TOF) m/z 693.1731 [M+Na]
+
 calcd for 
C37H25BF2N4O6Na 693.1733. 
BODIPY 4g: Yield 54%. mp(°C)> 300; 
1
H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 8.2 
Hz, 4H), 7.79 (d, J = 8.3 Hz, 4H), 7.53 – 7.45 (m, 2H), 7.25 – 7.16 (m, 4H), 6.83 (d, J = 2.3 Hz, 
1H), 6.79 (d, J = 2.3 Hz, 2H), 6.61 – 6.50 (m, 2H), 3.88 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 
162.0, 149.4, 137.4, 136.1, 135.3, 134.29, 134.26, 132.0, 130.93, 130.89, 130.86, 130.81, 130.77, 
129.7, 127.0, 125.7, 122.7, 122.1, 118.5, 113.2, 106.5, 102.1, 55.7; 
11
B NMR (128 MHz, CDCl3) 
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δ 1.64 (t, J = 31.8 Hz); HRMS (ESI-TOF) m/z 630.2033 [M]+ calcd for C39H25BF2N4O2 
630.2039. 
BODIPY 4h: Yield 49%. mp(°C)> 300; 
1
H NMR (400 MHz, CD2Cl2) δ 7.90 (d, J = 8.1 
Hz, 4H), 7.79 (d, J = 8.1 Hz, 4H), 7.53 – 7.46 (m, 2H), 7.23 – 7.15 (m, 4H), 6.82 (dd, J = 13.9, 
2.3 Hz, 3H), 6.61 – 6.53 (m, 2H), 3.87 (s, 6H); 13C NMR (101 MHz, CD2Cl2) δ 162.2, 150.0, 
137.4, 136.4, 134.8, 134.3, 131.2, 131.1, 130.9, 130.82, 130.79, 129.6, 127.8, 126.8, 125.6, 125.5, 
125.23, 125.19, 125.16, 125.1, 122.93, 122.85, 122.0, 106.7, 101.9, 55.8;
 11
B NMR (128 MHz, 
CD2Cl2) δ 1.67 (t, J = 31.6 Hz); HRMS (ESI-TOF) m/z 697.1882 [M-F]
+
 calcd for 
C39H25BF7N2O2 697.1897. 
BODIPY 4i: Yield 52%. mp(°C)> 300; 
1
H NMR (CD2Cl2, 400 MHz) δ 8.19 (d, J = 8.1 
Hz, 4H), 7.84 (d, J = 8.0 Hz, 4H), 7.50 – 7.46 (m, 4H), 7.44 – 7.33 (m, 6H), 7.20 – 7.14 (m, 3H), 
6.83 (t, J = 2.3 Hz, 1H), 6.79 (d, J = 2.3 Hz, 2H), 5.40 (s, 4H), 3.86 (s, 6H); 
13
C NMR (CD2Cl2, 
125 MHz) δ 165.8, 162.1, 136.3, 131.0, 130.4, 129.4, 129.3, 128.6, 128.24, 128.15, 125.4, 123.0, 
122.0, 106.6, 101.8, 66.9, 55.8; 
11
B NMR (CDCl3, 128 MHz) δ 1.70 (t, J = 31.5 Hz); 
19
F NMR 
(CDCl3, 376 MHz) δ -129.28-129.54 (m); HRMS (ESI-TOF) m/z 848.2931 [M+H]
+
 calcd for 
C53H40BF2N2O6 848.2978. 
BODIPY 4j: Yield 54%. mp(°C)> 300; 
1
H NMR (CD2Cl2, 400 MHz) δ 8.25 – 8.17 (m, 
2H), 7.94 – 7.83 (m, 4H), 7.81 – 7.71 (m, 5H), 7.67 – 7.60 (m, 2H), 7.55 – 7.46 (m, 4H), 7.45 – 
7.33 (m, 3H), 7.19 – 7.06 (m, 4H), 6.30 (d, J = 8.3 Hz, 2H), 5.41 (s, 2H); 13C NMR (CD2Cl2, 125 
MHz) δ 166.3, 151.3, 150.2, 138.0, 136.8, 136.0, 135.3, 135.1, 134.9, 131.6, 131.5, 131.34, 
131.31, 131.0, 130.3, 129.9, 129.7, 129.4, 129.1, 128.8, 128.7, 125.91, 125.85, 125.64, 125.61, 
123.6, 123.4, 122.17; 
11
B NMR (CDCl3, 128 MHz) δ 1.72 (t, J = 31.5 Hz); 
19
F NMR (CD2Cl2, 
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376 MHz) δ -62.98(s), -128.47-128.72 (m); HRMS (ESI-TOF) m/z 702.2183 [M-F]+ calcd for 
C44H28BF4N2O2 702.2211. 
BODIPY 4k: Yield 51%. mp(°C)> 300; 
1
H NMR (CD2Cl2, 400 MHz) δ 8.25 – 8.16 (m, 
2H), 7.92 – 7.82 (m, 4H), 7.82 – 7.75 (m, 2H), 7.55 – 7.46 (m, 4H), 7.45 – 7.34 (m, 3H), 7.21 – 
7.15 (m, 4H), 6.84 (t, J = 2.3 Hz, 1H), 6.61 – 6.52 (m, 2H), 5.40 (s, 2H), 3.87 (s, 6H); 13C NMR 
(CD2Cl2, 100 MHz) δ 165.8, 162.2, 136.4, 136.3, 135.5, 131.1, 131.0, 130.8, 130.4, 129.5, 
129.42, 129.35, 128.6, 128.3, 128.2, 125.5, 125.4, 125.2, 125.14, 125.10, 125.06, 123.1, 122.9, 
122.0, 106.7, 101.8, 66.9, 55.8; 
11
B NMR (CD2Cl2, 128 MHz) δ 1.68 (t, J = 31.5 Hz); 
19
F NMR 
(CD2Cl2, 376 MHz) δ -63.0 (s), δ -128.54-128.79 (m); HRMS (ESI-TOF) m/z 820.2039 [M+K]
+
 
calcd for C46H32BF5N2O4K 820.2043. 
Preparation of isothiocyanate BODIPYs: To a mixture of 3,5-dinitrophenyl BODIPY 
4a or 4f (0.09 mmol) and 0.45 mL (0.9 mmol) hydrazine hydrate, 5 mL ethanol and 5 mL THF 
were added. After all solids were dissolved, 0.24 g (0.23 mmol) of 10% Pd/C was added. The 
solution was refluxed until TLC indicated the consumption of the starting material. All solvents 
were removed under vacuum and the residue was dissolved in DCM to pass through a celite cake 
to remove all Pd/C. After DCM was removed under vacuum, a flash column using 
EtOAc:DCM=1:1 was able to isolate the diaminophenyl BODIPYs 5a and 5b, in 21 and 86% 
yield, respectively. BODIPY 5a’s solubility was too low to be characterized. BODIPY 5b: 
mp(°C)> 100 (decom.); 
1
H NMR (400 MHz, CD2Cl2) δ 7.61 (d, J = 7.6 Hz, 6H), 7.12 (t, J = 5.5 
Hz, 4H), 6.80 (d, J = 8.4 Hz, 7H), 6.51 (d, J = 7.6 Hz, 2H), 4.05 (d, J = 13.4 Hz, 4H), 3.85 (s, 
6H); HRMS (ESI-TOF) m/z 590.2399 [M-F]
+
 calcd for C37H29BFN4O2 590.2398. 47.2 mg 
(0.077 mmol) BODIPY 5b and 71.8 mg (0.31 mmol) 1,1′-thiocarbonyldi-2(1H)-pyridone were 
dissolved in 10 mL anhydrous DCM, and the solution was stirred for 24 hours. Then DCM was 
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removed under vacuum and the residue was purified by silica gel column chromatography. 
BODIPY 6b: Yield 86%. mp(°C)> 90(decom.);
 1
H NMR (400 MHz, CD2Cl2) δ 7.78 (d, J = 8.1 
Hz, 4H), 7.55 – 7.48 (m, 2H), 7.39 (d, J = 8.1 Hz, 4H), 7.18 (dq, J = 6.0, 3.9, 2.2 Hz, 4H), 6.83 (t, 
J = 2.3 Hz, 1H), 6.78 (d, J = 2.3 Hz, 2H), 6.58 – 6.51 (m, 2H), 3.86 (s, 6H); 13C NMR (101 MHz, 
CD2Cl2) δ 162.2, 150.1, 136.7, 136.5, 134.3, 132.4, 131.7, 131.0, 130.1, 129.4, 126.7, 125.6, 
125.4, 123.0, 122.0, 106.7, 101.8, 55.8;
11
B NMR (128 MHz, CDCl3) δ 0.68 (t, J = 32.4 Hz).; 
HRMS (ESI-TOF) m/z 674.1540 [M-F]
+
 calcd for C39H25BFN4O2S2 674.1527. 
4.4.3 X-ray Determined Molecular Structures 
X-ray data were collected at low temperature with MoKα radiation on Bruker Kappa 
Apex-II DUO or Nonius KappaCCD diffactometers. data reduction: Bruker SAINT; program(s) 
used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012); 
software used to prepare material for publication: SHELXL97 (Sheldrick, 2008). 
2c: C37H29BF2N4 . CH2Cl2, M=663.38, triclinic, a=9.7694(8), b=13.1321(10), 
c=13.2027(8) Å,  α=93.757(5), β=104.793(4), γ=102.323(4)°, T=90 K, space group P-1, Z=2, 
24995 reflections measured, 8128 unique (Rint=0.062), θmax=28.8°, final R=0.058, CCDC 
1435991; 
2d: C37H29BF8N2, M=664.43, triclinic, a=8.1559(9), b=13.0389(14), c=15.7981(18) Å,  
α=114.011(4), β=91.649(5), γ=102.179(5)°, T=90 K, space group P-1, Z=2, 35888 reflections 
measured, 11819 unique (Rint=0.028), θmax=33.7°, final R=0.041, CCDC 1435992; 
2e: C51H43BF2N2O4, . CH2Cl2, M=881.61, monoclinic, a=9.5919(2), b=34.4320(6), 
c=13.4607(2) Å, β=107.8990(10)°, T=90 K, space group P21/n, Z=4, 50441 reflections measured, 
20106 unique (Rint=0.037), θmax=36.4°, final R=0.054, CCDC 1435993; 
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2f: C37H33BF2N4O6•1.5(CH2Cl2), M=805.87, monoclinic, a=14.4025(11), b=8.5485(6), 
c=30.007(2) Å, β=98.229(2)°, T=90 K, space group P21/n, Z=4, 61391 reflections measured, 
10885 unique (Rint=0.043), θmax=33.2°, final R=0.060; 
2h: C40H35BCl2F8N2O2, M=809.41, triclinic, a=11.1804(19), b=12.928(2), c=13.910(4) Å, 
β=76.767(15)°, T=90 K, space group P1, Z=2, 25162 reflections measured, 6505 unique 
(Rint=0.056), θmax=30.5°, final R=0.059; 
4a: C35H23BF2N2, M=520.36, triclinic, a=8.9607(14), b=10.4013(15), c=14.964(3) Å, 
α=98.262(9), β=106.170(6), γ=107.413(9)°, T=90 K, space group P-1, Z=2, 22864 reflections 
measured, 5881 unique (Rint=0.034), θmax=27.9°, final R=0.044, CCDC 1435994; 
4b: C35H21BF2N2O4, M=610.37, monoclinic, a=12.2985(6), b=12.9578(6), c=18.4622(9) 
Å, β=108.407(2)°, T=90 K, space group P21/c, Z=4, 27177 reflections measured, 26528 unique 
(Rint=0.048), θmax=27.3°, final R=0.053, CCDC 1435995; 
4c: C37H20.95BCl0.05F2N2O4, M=572.02, monoclinic, a=13.2913(16), b=16.431(2), 
c=13.4762(16) Å, β=107.238(2)°, T=90 K, space group P21, Z=4, 21435 reflections measured, 
12492 unique (Rint=0.023), θmax=29.2°, final R=0.040, CCDC 1435996; 
4f: C37H25BF2N4O6, M=797.81, monoclinic, a=14.508(4), b=8.281(2), c=30.115(8) Å, 
β=99.189(10)°, T=90 K, space group P21/n, Z=4, 26932 reflections measured, 2931 unique 
(Rint=0.088), θmax=25.1°, final R=0.073; 
4i: C53H39BF2N2O6, M=848.67, trichlinic, a=13.058(3), b=17.920(3), c=18.845(3) Å, 
β=107.450(12)°, T=90 K, space group P1, Z=4, 38985 reflections measured, 9107 unique 
(Rint=0.080), θmax=26.6°, final R=0.060. 
4.4.4 Steady-state Absorption and Fluorescence Spectroscopy 
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The photophysical properties of compounds were determined by preparing a stock 
solution with a concentration of 1 × 10
-4
 M and diluting it to appropriate concentrations for 
absorbance and emission spectra measurements. All the absorption spectra were obtained using a 
Perkin Elmer Lambda 35 UV-visible spectrophotometer. The optical density, ε, were taken by 
preparing solution concentrations at 1x10
-5
 M in order to get λmax between 0.5 and 1.0. Emission 
spectra were measured on a LS-55 Perkin-Elmer spectro-fluorometer with the slit width set at 2.5 
nm for all BODIPYs. All absorbance and emission spectra were acquired within 6 h of fresh 
solution preparation, at room temperature. Rhodamine 6G (Φ = 0.86 in MeOH)44 was used as the 
reference for β,β’-bicyclo-BODIPYs in THF. Methylene blue (Φ = 0.03 in MeOH)44 was used as 
the reference for β,β’-dibenzo-BODIPY in THF. Quartz spectrophotometric cells with path 
lengths of 10 mm were used. For the determination of quantum yields, dilute solutions with 
different absorbance between 0.02-0.08 at the particular excitation wavelength were used. Molar 
absorption coefficients (ε) was determined from the plots of integrated absorbance vs 
concentrations. The following equation was used for the calculations of the relative fluorescence 
quantum yields (Φf): Φs = Φst × (Gradx/Grandst) × (nx
2
 /nst
2
 ) where Φ and n are the fluorescence 
quantum yields and refractive indexes, respectively; Grad represents gradient of integrated 
fluorescence intensity vs absorbance at the particular wavelength, subscripts s and x refer to the 
standards and the tested samples. 
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CHAPTER V: PREPARATION OF NITROPHENYL FUNCTIONALIZED 
BODIPYS FOR ELECTRO-CHEMICAL STUDIES 
5.1 Introduction 
Various modern analytical chemistry methods and techniques are being utilized to 
investigate fluorophore’s physical and chemical properties. Cyclic voltammetry (CV) has been 
employed as an excellent method to investigate electron transfer reactions of metalloporphyrins, 
for a better understanding of the energy transfer process in cytochromes and other respiratory 
enzymes.
1-2
 In the last two decades, CV is widely used to characterize porphyrin, corroles and 
their derivatives. 
The relationship between BODIPY structure and its electrochemical properties was 
studied in the last ten years mainly by Bard et al. By investigating the electrochemistry of a 
number of BODIPY dyes, they reported the presence of radical ions from unblocked BODIPYs, 
and large splitting (>1V) was seen between the first and second oxidation and reduction waves, 
compared to the observations from other aromatic molecules.
3
 An interesting study was 
performed through electrogenerated chemiluminescent research, and they were able to detect the 
presence of dimers, trimers and polymers during electrochemical reactions.
4-5
 By installing 
bipyridine units at the BODIPY’s meso-positions, electrogenerated chemiluminescence was 
observed.
6
 
5.1.1 Effects of nitrophenyl substitution on corrole’s electrochemical properties 
In 2014, Kadish et al investigated a series of nitrophenyl functionalized cobalt corroles, 
and their electrochemical properties were significantly modified, compared to normal cobalt 
corroles.
7
 In both meso-nitrophenyl and β-nitrophenyl corroles, additional reduction processes 
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were observed, indicating that the nitrophenyl units on corroles are highly electroactive, as 
shown in Figure 5.1. 
 
Figure 5.1: Cyclic voltammograms of nitrophenyl corroles in DCM containing 0.1 M TBAP at a 
scan rate of 0.1V/s.
7
 Reprinted with permission from Copyright (2014) Elsevier. 
5.1.2 Electro-Chemistry Study of Nitrophenyl Functionalized BODIPY Fluorophore: 
3,5-DiPhNO2-BODIPYs have been examined by CV in THF and CH2Cl2, and the cyclic 
voltammograms are given in Figure 5.2. As seen in the Figure, both 3,5-diPhNO2-BODIPYs 
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undergo three reversible one-electron reductions. The first reductions located at -0.74 and -0.64 
V, are assigned to the BODIPY anion radical. The following two reactions located at -1.04, -1.31 
and -0.95 and -1.29 V are assigned to the reduction of the nitrophenyl groups. Nitrophenyl 
groups on porphyrin and corrole macrocycles can gain multi-electron reductions as previous 
studies show, but this is the first time for BODIPY molecules bearing nitrophenyl to be studied 
by CV. The two reductions of 3,5-nitrophenyl were separately emerging, which may be 
interpreted that the two groups in these positions have intramolecular interactions. The dibenzo-
BODIPY was easier to be reduced than the bicyclo- BODIPY because the benzo units expand 
the π-conjugation system of the molecule. 
 
Figure 5.2: Cyclic voltammograms of investigated di-PhNO2-BODIPYs in THF with 0.1 M 
TBAP, scan rate at 0.1V/s. 
Due to the knowledge from nitrophenyl porphyrins and our preliminary discovery from 
3,5-dinitrophenyl-BODIPYs, we wanted to investigate whether BODIPYs containing “N” 
nitrophenyl units would give “N+1” reversible peaks on the reductive parts of the cyclic 
voltammetry spectra. To further demonstrate our hypothesis, we prepared a series of nitrophenyl-
functionalized BODIPYs for electrochemical studies. 
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Scheme 5.1: Synthesis of 1,3,5,7-tetramethyl-2,6-diethyl-8-nitrophenyl BODIPY 
5.2 Results and Discussion 
5.2.1 Design and Synthesis of Nitrophenyl BODIPYs 
 
Scheme 5.2: Synthesis of 2,6-dinitrophenyl BODIPY 
Nitrophenyl functionalized BODIPYs were designed to be prepared via a number of 
reactions, mainly by cross-coupling reactions between halogenated BODIPYs and 4-nitrophenyl 
boronic acids, since the Pd-catalyzed Suzuki cross-coupling reaction conditions are developed in 
previous Chapters with suitable Pd catalysts and solvents. For the installation of the meso- 
nitrophenyl groups, 4-nitro-benzaldehyde was condensed with pyrroles during the step of 
producing dipyrromethanes. 
To demonstrate our hypothesis, we prepared a series of BODIPYs with mono-, di-, tri-, 
and tetranitrophenyl functionalized BODIPYs with nitrophenyl units at the meso-, 2, 3, 5, 6-
positions. Mononitrophenyl BODIPYs were designed as the meso-PhNO2-BODIPYs, and it was 
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prepared by reacting 2,4-dimethyl-3-ethyl-pyrrole and 4-nitro-benzaldehyde under acidic 
conditions, and the resulting dipyrromethane was then treated with DDQ and complexed to give 
meso-PhNO2-BODIPY 2 in 12 % overall yield, as shown in Scheme 5.1.  
 
Scheme 5.3: Synthesis of 2,6,8-trinitrophenyl BODIPY 9 
Since 3,5-(PhNO2)2-BODIPYs were prepared and analyzed, we then designed 2,6-
(PhNO2)2-BODIPY. BODIPY 4 was iodinated at the 2,6-positions with excess iodic acid and 
iodine to give 2,6-diiodo-BODIPY 5 in 80% yield, followed by a Suzuki cross-coupling reaction 
to give 2,6-(PhNO2)2-BODIPY 6 in 72% yield, as shown in Scheme 5.2. 
There were two different trinitrophenyl-BODIPYs designed and synthesized in our 
research. A direct bromination or iodination on unsubstituted BODIPYs would functionalize at 
the 2,6-positions, and via this method we were able to produce 2,6,8-(PhNO2)3-BODIPY. The 
3,5,8-(PhNO2)3-BODIPY’s precursor, the 3,5-dihalogenated BODIPY, is prepared from α-
halogenated dipyrromethanes. Meso-nitrophenyl-1,3,5,7-tetramethyl-BODIPY 7 was prepared 
from a classical “one-pot” route in 16% yield, and it was then iodinated at the 2,6-positions with 
excess iodic acid and iodine, in refluxing ethanol. The reactive 8-nitrophenyl-2,6-diiodo-
BODIPY was subjected to a Suzuki cross-coupling reaction to produce 2,6,8-tri(nitrophenyl)-
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BODIPY 9 in 77% yield, as shown in Scheme 5.3. 3,5-Dibromo-8-nitrophenyl-BODIPY 13 was 
prepared by treating dipyrromethane 11 with 2 equivalents of N-bromosuccinimide at -78
o
C, and 
the resulting dipyrromethane 12 was then oxidized and complexed to give BODIPY 13 in 7% 
overall yield from dipyrromethane. Then BODIPY 13 was postfunctionalized with a Suzuki 
cross-coupling reaction, using Pd(PPh3)2Cl2 as the catalyst, and 3,5,8-(PhNO2)3-BODIPY 14 was 
isolated in 60% yield, as shown in Scheme 5.4. The low yielding of the preparation of 13 and 14 
is probably due to their low solubility, and partial amounts were lost during work up and 
purification. 
 
Scheme 5.4: Synthesis of 3,5,8-trinitrophenyl BODIPY 14 
Synthesis of tetranitrophenyl-BODIPY was attempted by reacting 2,3,5,6-tetraiodo-
BODIPY 15 with 15 equivalents of 4-nitrophenyl boronic acid, in a typical Suzuki cross-
coupling reaction condition, as shown in Scheme 5.5. However, no desired product was observed, 
and intermediates mono-, di- and tri-nitrophenyl BODIPYs precipitated, due to their relatively 
low solubility. 
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Scheme 5.5: Attempted synthesis of 2,3,5,6-tetranitrophenyl BODIPY 16 
To further confirm that only nitrophenyl units would give reversible peaks, we also 
prepared BODIPY with anisole units at 2,6- and 3,5-positions, respectively. 2,6-Dianisole-8-
nitrophenyl-BODIPY 17 was prepared via a Suzuki cross-coupling reaction from BODIPY 8 in 
82% yield, and 3,5-dianisole-8-nitrophenyl-BODIPY 18 was synthesized by post-functionalizing 
3,5-dibromo-BODIPY 12 in 89% yield, as shown in Scheme 5.6. 
 
 
Scheme 5.6: Synthesis of 8-nitrophenyl BODIPYs with anisole units 
5.2.2 Electrochemical Studies 
The electrochemistry study of synthesized BODIPYs was carried out in CH2Cl2 and THF 
with 0.1M tetrabutylammonium perchlorate (TBAP) and a summary of potential values are 
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shown in Table 5.1. The representative cyclic voltammograms for selected BODIPY are shown 
in Figure 5.3 for BODIPYs 6, 12, 14, 18 which all have multiple reductions. 
 
Figure 5.3: Cyclic voltammograms of (a) Multi-NO2Ph BODIPY 14, 6 and (b) Mono-NO2Ph 
BODIPY 18, 12 in THF containing 0.1M TBAP. 
As shown in Figure 5.3 (a), compound 14 has three nitrophenyl substituted groups 
located at the 3,5,8-positions of BODIPY, thus this compound has three reversible reductions. 
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Table 5.1:  Half-wave potentials (V vs SCE) for investigated BODIPYs in THF and CH2Cl2, 
0.1M TBAP. Scan rate = 0.1 V/s. 
  Oxidation  Reduction 
Solvent Cpd # 2nd 1st  1st 2nd 3rd 
CH2Cl2 2 1.86
a 1.15  -1.02a, b   
 6  1.34  -0.98 -1.13 -1.21 
 7 1.64a 1.30  -1.00a, b   
 8 1.86a 1.42  -0.84a, b   
 9  1.37  -0.89a -1.21  
 13  1.76a  -0.49 -0.77  
 14  1.60  -0.32 -0.73 -1.18b 
 17 1.57a 1.17  -1.00a, b   
 18 1.54 1.14  -0.72 -0.79  
        
THF 6    -0.88 -1.19b  
 12    -0.40 -0.81  
 14    -0.30 -0.72 -1.21b 
 18    -0.67 -0.84  
a
Peak potential, 
b
overlapped peak (two electron transfer). 
According to the current height of these three peaks showing in the Figure, the first two 
reductions were one-electron transfer processes, and the third one was a two-electron transfer 
reaction. The conjectural nitrophenyl reductions are also labeled in the Figure: the first reduction 
is assigned to generate the BODIPY anion radical, while the 2
nd
 and the 3
rd
 reductions described 
the reduction of the nitrophenyl groups. The 2
nd
 reduction was due to the process of nitrophenyl 
located at the meso- position, and the 3
rd
 reduction was due to the processes of nitrophenyls 
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located at 3,5- positions. The reason is probably that the nitrophenyl group is a fairly strong 
electron-withdrawing group, and it leads to all reactions shift. 
 
 
Figure 5.4: Crystal structures of mono-nitrophenyl BODIPYs 7, 8 ,13, 17 and 18 
BODIPY 6 showed two reversible processes, and the first one corresponds to the 
BODIPY anion and the second reduction belongs to the reductions of two nitrophenyl groups at 
the 2,6-positions. In Figure 5.3 (b), the two compounds studied were mononitrophenyl-
BODIPYs, which are less electron withdrawing than the multi-substituted nitrophenyl BODIPYs. 
The first reductions (-0.67, -0.40 V) of BODIPY 18 and 12 belong to the BODIPY core, and the 
reductions of the nitrophenyl groups were at -0.81 and -0.84 V, which were 200 mV easier than 
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nitrobenzene.
7
 This result gives the quantitatively potential difference of the positive shift values 
when the nitrophenyl groups are connected to the BODIPY core. 
5.2.3 Structural Characterization 
 
Figure 5.5: Crystal structures of tri-nitrophenyl BODIPYs 9 and 14 
All BODIPYs were characterized by 
1
H-, 
13
C-, and 
11
B-NMR, HRMS, and in the case of 
7, 8, 9, 13, 14, 17 and 18 also by X-ray crystallography. All BODIPYs contain triplets for the 
BF2 in the 
11
B-NMR, indicating that the BF2 units were unreactive under the cross-coupling 
reactions. Other than BODIPY 14 and 18 that give downfield boron shifts (1.1 to 1.4 ppm), all 
rest BODIPYs’ boron shifts are around 0.4-0.8 ppm. The nitrophenyl groups show two 
symmetric signals in 
1
H-NMR around the 7.0-7.5 ppm region, and electron-withdrawing groups 
at the 3,5-positions downfield them to 7.5-8.5 ppm region. 
Full structural confirmation of all compounds was obtained from the X-ray crystal 
structures. Crystals suitable for X-ray analysis were grown from slow evaporation of hexane 
diffused in dichloromethane. As expected, the meso-aryl groups are oriented perpendicular to the 
dipyrromethene core to avoid steric congestion caused by the 1,7-methyl groups in the structure 
of 7, 8, 9 and 17. 3,5-Nitrophenyl units form dihedral 47-55° angles with the main BODIPY 
planes. 
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5.3 Conclusions 
In summary, we have synthesized a series of nitrophenyl-functionalized BODIPYs 
containing nitrophenyl units at the meso, 2,3,5,6-positions in relatively high yields and efficient 
routes. Nitrophenyl installation at the meso-positions were achieved by using 4-nitro-
benzaldehyde during preparation of starting BODIPYs, and the installation at the 2,3,5,6-
positions were accomplished by regio-selective halogenation on BODIPYs or dipyrromethanes 
with bromine or iodine atoms, and then performing Suzuki cross-coupling reactions, using 
Pd(PPh3)2Cl2 or Pd(dppf)Cl2 as catalysts. A detailed electrochemistry study was carried out for 
selected nitrophenyl BODIPYs. In addition to get the anion radical for the BODIPY molecule, all 
the substituted nitrophenyl groups on the BODIPY periphery showed well-defined reversible 
reaction. The reductions overlapped or successively obtained based on the different structures for 
the multi-nitrophenyl BODIPYs.  
5.4 Experimental 
5.4.1 General Information 
All the reagents and solvents were purchased from Sigma-Aldrich and were used without 
further purification. All reactions were carried out with oven-dried glassware under a dry argon 
atmosphere. All the reactions were monitored using Sorbent Technologies 0.2 mm silica gel TLC 
plates with UV-254 nm indicator. Flash column chromatography was performed using Sorbent 
Technologies 60 Å silica gel (230-400 mesh). Prep-TLC 60 Å silica gel 20 x 20 cm (210-270 μm) 
was used. Dichloromethane for electrochemistry (CH2Cl2, anhydrous, 99.8%, EMD Chemicals 
Inc.) were used as received. Tetrahydrofuran (THF, for HPLC, 99.9%) for electrochemistry was 
purchased from Sigma-Aldrich and freshly distilled using a Solvent System PS-MD-5-13-495 
from Innovative Technology. Tetra-n-butylammonium perchlorate (TBAP) was purchased from 
148 
 
Sigma-Aldrich and stored in a drying oven at 40 °C. All 
1
H-, 
13
C-, and 
11
B-NMR spectra were 
collected on Bruker AV-400 and AV-500 spectrometer in deuterated chloroform or deuterated 
dichloromethane. The CDCl3 chemical shifts (δ) are reported in ppm using as reference 7.26 for 
proton and 77.0 for carbon and BF3•OEt2 was used as reference (0.00 δ) for boron NMR. The 
CD2Cl2 chemical shifts (δ) are reported in ppm using as reference 5.32 for proton and 53.50 for 
carbon. Coupling constants are reported in Hertz (Hz). BODIPY 2, 6, 8, and 14’s 13C-NMR 
spectra is missing due to the low solubility. All the mass spectra were collected using an Agilent 
6210 ESI-TOF mass spectrometer. All melting points were recorded using a MEL-TEMP 
electrothermal instrument. 
5.4.2 Syntheses 
“One-pot” synthesis of BODIPYs from alkylated pyrroles: 
8.40 mmol pyrrole and 4.20 mmol arylaldyde were dissolved in 50 mL anhydrous DCM, 
and one drop of TFA was added. The reaction was stirred overnight until TLC indicated a 
consumption of the starting pyrroles. 0.95 g (4.20 mmol) DDQ was dissolved in a minimum 
amount of DCM and added slowly into the solution. The reaction was stirred for another 2 hours 
and 2.93 mL (21.0 mmol) triethylamine was added. Then BF3 etherate was added dropwisely 
under iced water bath. The complexation reaction was allowed to stir for 4 hours, and the solvent 
was removed vacuum. The black residue was dissolved in 100 mL ethyl acetate, and then 
washed by 100 mL 1N HCl (aq), 100 mL saturated NaHCO3 (aq) and 100 mL saturated NaCl 
(aq). Ethyl acetate was removed under vacuum after the solution was dried over anhydrous 
Na2SO4. The oily residue was purified by silica gel column chromatography and recrystallized in 
1:1 DCM/Hexane. 
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BODIPY 2: Yield 12%. mp(°C) 248;
 1
H NMR (400 MHz, CD2Cl2) δ 8.40 – 8.33 (m, 2H), 
7.60 – 7.52 (m, 2H), 2.50 (s, 6H), 2.32 (q, J = 7.5 Hz, 4H), 1.28 (s, 6H), 0.98 (t, J = 7.6 Hz, 6H); 
11
B NMR (128 MHz, CD2Cl2) δ 0.56 (t, J = 33.1 Hz); HRMS (ESI-TOF) m/z 406.2106  [M-F]
+
 
calcd for C23H26BFN3O2 406.2107. 
BODIPY 4: Yield 16%. mp(°C) 287; 
1
H NMR (400 MHz, CDCl3) δ 7.48 (dd, J = 5.2, 
2.0 Hz, 3H), 7.31 – 7.26 (m, 2H), 5.97 (s, 2H), 2.55 (d, J = 1.2 Hz, 6H), 1.37 (s, 6H); HRMS 
(ESI-TOF) m/z 305.1633 [M-F]
+
 calcd for C19H19BFN2 305.1625. 
BODIPY 7: Yield 13%. mp(°C)>200 (decom.);
 1
H NMR (400 MHz, CD2Cl2) δ 8.41 – 
8.34 (m, 2H), 7.57 (d, J = 8.6 Hz, 2H), 6.05 (s, 2H), 2.52 (s, 6H), 1.38 (s, 6H); 
13
C NMR (101 
MHz, CD2Cl2) δ 156.5, 148.5, 143.0, 141.8, 138.8, 130.7, 129.8, 124.5, 121.8, 14.5; 
11
B NMR 
(128 MHz, CD2Cl2) δ 0.54 (t, J = 32.7 Hz); HRMS (ESI-TOF) m/z 349.1504 [M-F]
+
 calcd for 
C19H18BFN3O2 349.1507. 
Synthesis of 2,6-diiodo-BODIPYs 
0.27 mmol 2,6-unsubstituted BODIPY was dissolved in 10 mL ethanol. 0.17 g (0.68 
mmol) iodine was added, followed by addition of 95.0 mg (0.54 mmol) iodic acid in minimum 
amount of water. The solution was refluxed for 2 to 3 hours until TLC indicated a consumption 
of the starting BODIPY. Solvents were removed under vacuum, and the residue was dissolved in 
100 mL DCM, and washed by 2 x 50 mL sat. sodium thiosulfate solution. DCM was removed 
under vacuum after being dried through anhydrous sodium sulfate. The residue was purified by 
silica gel column chromatography and recrystallized in 1:1 DCM/Hexane. 
BODIPY 5: Yield 75%. mp(°C) 187;
 
 
1
H NMR (400 MHz, CD2Cl2) δ 7.60 – 7.48 (m, 
3H), 7.35 – 7.23 (m, 2H), 2.62 (s, 6H), 1.40 (s, 6H); 13C NMR (101 MHz, CD2Cl2) δ 156.7, 
145.6, 141.8, 134.7, 131.4, 129.58, 129.56, 127.9, 85.5, 16.9, 15.9; 
11
B NMR (128 MHz, CD2Cl2) 
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δ 0.43 (t, J = 32.2 Hz); HRMS (ESI-TOF) m/z 573.9512 [M-H]- calcd for C19H16BF2I2N2 
573.9506. 
BODIPY 8: Yield 88%. mp(°C) 223;
 1
H NMR (400 MHz, CDCl3) δ 8.46 – 8.36 (m, 2H), 
7.57 – 7.48 (m, 2H), 2.66 (s, 6H), 1.38 (s, 6H); 13C NMR (101 MHz, CDCl3) δ 158.0, 148.6, 
144.7, 141.5, 137.8, 130.5, 129.5, 124.6, 86.4, 17.3, 16.1;
11
B NMR (128 MHz, CDCl3) δ 0.38 (t, 
J = 31.8 Hz); HRMS (ESI-TOF) m/z 619.9381 [M-H]
-
 calcd for C19H16BF2I2N3O2 619.9435. 
Synthesis of 3,5-dibromo-BODIPY 13: 
1.0 mL (15.0 mmol) pyrrole was suspended in 33 mL (6.0 mmol) 0.18 M HCl (aq), and 
0.75g (5.0 mmol) 4-nitrobenzaldeyde was added. The mixture was stirred for 2 hours to give 
dipyrromethane 11 as a precipitate. The filtered precipitate was dried under vacuum and then 
dissolved in anhydrous THF. 1.9g (10 mmol) recrystallized NBS was dissolved in THF and 
added into the dipyrromethane solution slowly under -78
o
C. The reaction was allowed to stir for 
another 10 minutes, and 1.10 g (5 mmol) DDQ was dissolved in THF and added into the solution 
dropwisely. The solution then warmed to room temperature upon the addition of DDQ. THF was 
removed under vacuum and the residue was passed a flash column using 100% DCM as the 
eluent to remove insoluble byproducts. Dipyrromethane 11 was dissolved in DCM, followed by 
addition of 3.5 mL (25.0 mmol) Et3N and 4.3 mL (35.0 mmol) BF3 etherate. The complexation 
reaction was allowed to stir for 2 hours, and the solvent was removed vacuum. The black residue 
was dissolved in 100 mL ethyl acetate, and then washed by 100 mL 1N HCl (aq), 100 mL 
saturated NaHCO3 (aq) and 100 mL saturated NaCl (aq). Ethyl acetate was removed under 
vacuum after the solution was dried over anhydrous Na2SO4. The oily residue was purified by 
silica gel column chromatography and recrystallized in 1:1 DCM/Hexane, and BODIPY 12 was 
obtained in a 7% overall yield. BODIPY 8: Yield 88%. mp(°C)> 300; 
1
H NMR (400 MHz, 
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CD2Cl2) δ 8.41 – 8.34 (m, 2H), 7.75 – 7.68 (m, 2H), 6.76 (d, J = 4.4 Hz, 2H), 6.61 (d, J = 4.4 Hz, 
2H); 11B NMR (128 MHz, CD2Cl2) δ 0.56 (t, J = 33.1 Hz); HRMS (ESI-TOF) m/z 467.9096 [M]
-
 
calcd for C15H8BBr2F2N3O2 467.9086. 
Cross coupling conditions: 
0.100 mmol halogenated BODIPY, 5 mol% Pd catalyst (Pd(dppf)Cl2 was used for 6, 9 
and 17, Pd(PPh3)2Cl2 was used for 14 and 18) and 10 equiv. of aryl boronic acid were mixed 
under inert atmosphere. Toluene (2 mL) and THF (2 mL) were added via syringe and the 
solution was heated at 70 
o
C in an oil bath for 3 min. K2CO3 (1 M, 0.5 mL) solution was added 
via syringe and the reaction was monitored by TLC until complete consumption of starting 
halogenated BODIPY. The cooled solution was filtered through celite to remove excess 
palladium and boronic acid, and the solvent was concentrated under vacuum. The residue was 
purified by silica gel column chromatography to afford the corresponding arylated BODIPY, 
which were recrystallized using 1:1 dichloromethane/hexane. 
BODIPY 6: Yield 72%. mp(°C)> 300;
 1
H NMR (400 MHz, CDCl3) δ 8.31 – 8.23 (m, 
4H), 7.54 (d, J = 6.3 Hz, 3H), 7.39 – 7.31 (m, 6H), 2.57 (s, 6H), 1.34 (s, 6H); 11B NMR (128 
MHz, CDCl3) δ 0.79 (t, J = 32.5 Hz).; HRMS (ESI-TOF) m/z 546.1981 [M-F]
-+
 calcd for 
C31H25BFN4O4 546.1984. 
BODIPY 9: Yield 77%. mp(°C)> 300; 
1
H NMR (500 MHz, CD2Cl2) δ 8.46 – 8.39 (m, 
2H), 8.26 (dd, J = 8.7, 2.8 Hz, 4H), 7.66 (dq, J = 5.9, 2.6 Hz, 2H), 7.36 (dq, J = 5.8, 2.6 Hz, 4H), 
2.54 (s, 6H), 1.33 (s, 6H); 
13
C NMR (126 MHz, CD2Cl2) δ 155.3, 148.6, 147.1, 141.5, 140.2, 
139.6, 132.4, 131.0, 130.9, 129.7, 124.7, 123.7, 13.3, 13.0; 
11
B NMR (128 MHz, CD2Cl2) δ 0.73 
(t, J = 32.1 Hz); HRMS (ESI-TOF) m/z 591.1802 [M-F]
+
 calcd for C31H23BFN5O6 591.1835. 
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BODIPY 17: Yield 82%. mp(°C)> 300; 
1
H NMR (400 MHz, CDCl3) δ 8.45 – 8.36 (m, 
2H), 7.65 – 7.57 (m, 2H), 7.11 – 7.03 (m, 4H), 6.97 – 6.90 (m, 4H), 3.83 (s, 6H), 2.53 (s, 6H), 
1.28 (s, 6H); 13C NMR (101 MHz, CDCl3) δ 158.9, 155.6, 148.4, 142.5, 138.3, 134.1, 131.2, 
131.1, 130.9, 130.4, 129.8, 129.7, 125.3, 124.5, 124.4, 123.7, 114.0, 113.9, 55.2, 13.5, 13.1; 
11
B 
NMR (128 MHz, CDCl3) δ 0.78 (t, J = 32.7 Hz); HRMS (ESI-TOF) m/z 561.2348 [M-F]
+
 calcd 
for C33H30BFN3O4 561.2344. 
BODIPY 14: Yield 60%. mp(°C) 288; 
1
H NMR (400 MHz, CD2Cl2) δ 8.48 – 8.40 (m, 
2H), 8.33 – 8.24 (m, 4H), 8.09 – 8.00 (m, 4H), 7.87 – 7.79 (m, 2H), 6.96 (dd, J = 4.4, 1.2 Hz, 
2H), 6.81 (dd, J = 4.4, 1.3 Hz, 2H); 
11
B NMR (128 MHz, CD2Cl2) δ 1.14 (t, J = 31.8 Hz).; 
HRMS (ESI-TOF) m/z 535.1218 [M-F]
+
 calcd for C27H16BFN5O6 535.1209. 
BODIPY 18: Yield 89%. mp(°C)> 300; 
1
H NMR (400 MHz, CD2Cl2) δ 8.38 (d, J = 8.2 
Hz, 2H), 7.87 (d, J = 8.4 Hz, 4H), 7.78 (d, J = 8.2 Hz, 2H), 6.99 (d, J = 8.4 Hz, 4H), 6.80 (d, J = 
4.3 Hz, 2H), 6.69 (d, J = 4.3 Hz, 2H), 3.87 (s, 6H); 13C NMR (101 MHz, CD2Cl2) δ 161.3, 159.3, 
149.0, 140.9, 139.2, 136.0, 131.7, 131.4, 131.33, 131.29, 130.0, 124.9, 123.5, 121.33, 121.29, 
113.9, 107.7, 106.6, 55.5; 
11
B NMR (128 MHz, CDCl3) δ 1.39 (t, J = 32.2 Hz).; HRMS (ESI-
TOF) m/z 505.1706 [M-F]
+
 calcd for C29H22BFN3O4 505.1718. 
5.4.3 X-ray Determined Molecular Structures 
Crystal structures were determined using low-temperature data from a Bruker Kappa 
APEX-II DUO diffractometer with either MoKα or CuKα radiation. For all structures, H atoms 
were located from difference maps but constrained in calculated positions during refinement. 
4: C19H18BF2N3O2, M=369.17, monoclinic, a=30.2933(12), b=11.7928(6), c=19.4126(4) 
Å,  β=96.341(3)°, T=100 K, space group C2/c, Z=16, 17283 reflections measured, 4508 unique 
(Rint=0.050), θmax=27.6°, final R=0.052; 
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8: C19H16BF2I2N3O2, M=620.96, triclinic, a=8.1914(11), b=9.5397(13), c=13.7575(19) Å,  
β=88.751(7)°, T=90 K, space group P1, Z=2, 45131 reflections measured, 10220 unique 
(Rint=0.036), θmax=40.4°, final R=0.029; 
9: C31H24BF2N5O6, M=654,45, monoclinic, a=8.1590(9), b=9.8314(11), c=19.581(2) Å,  
β=92.642(7)°, T=90 K, space group P21, Z=2, 8133 reflections measured, 5675 unique 
(Rint=0.014), θmax=29.1°, final R=0.041; 
13: C15H8BBr2F2N3O2, M=470.87, monoclinic, a=8.3873(2), b=13.1438(4), c=14,5793(4) 
Å,  β=100.4009(15)°, T=90 K, space group P21/n, Z=4, 58239 reflections measured, 7792 unique 
(Rint=0.033), θmax=40.3°, final R=0.031; 
14: C27H16BF2N5O6, M=555.26, orthorhombic, a=9.6987(18), b=11.886(2), c=20.278(3) 
Å,  β=88.751(7)°, T=90 K, space group P212121, Z=4, 21780 reflections measured, 6383 unique 
(Rint=0.035), θmax=31.1°, final R=0.042; 
17: C29H22BF2N3O4, M=525.30, triclinic, a=7.0860(3), b=12.9107(7), c=13.2005(8) Å,  
β=79.572(3)°, T=90 K, space group P1, Z=2, 21733 reflections measured, 7013 unique 
(Rint=0.023), θmax=1.6°, final R=0.043; 
18: C33H30BCl2F2N3O4, M=666.33, triclinic, a=9.9705(6), b=13.6149(9), c=13.9672(9) Å,  
β=71.667(7)°, T=90 K, space group P1, Z=2, 19252 reflections measured, 4478 unique 
(Rint=0.043), θmax=69.0°, final R=0.051; 
5.4.4 Electrochemical Studies 
Cyclic voltammetry was carried out using an EG&G Princeton Applied Research (PAR) 
173 potentiostat coupled to an EG&GPAR Model 175 Universal Programmer. Current-voltage 
curves were recorded on an EG&G PAR R-0151 X-Y recorder. A homemade three-electrode cell 
was used for cyclic voltammetric measurements and consisted of a glassy carbon working 
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electrode, a platinum counter electrode and a homemade saturated calomel reference electrode 
(SCE). The SCE was separated from the bulk of the solution by a fritted bridge of low porosity, 
which contained the solvent/supporting electrolyte mixture. 
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APPENDIX 
APPENDIX A: NMR Characterization of Compounds Found in Chapter 2 
 
Figure A.1: 
1
H NMR spectrum of 3b in CDCl3 
 
Figure A.2: 
13
C NMR spectrum of 3b in CDCl3 
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Figure A.3: 
1
HNMR spectrum of 6a in CDCl3 
 
 
Figure A.4: 
13
C NMR spectrum of 6a in CDCl3 
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Figure A.5: 
11
B NMR spectrum of 6a in CDCl3 
 
 
Figure A.6: 
1
H NMR spectrum of 6b in CDCl3 
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Figure A.7: 
13
C NMR spectrum of 6b in CDCl3 
 
 
 
Figure A.8: 
11
B NMR spectrum of 6b in CDCl3 
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Figure A.9: 
1
H NMR spectrum of 8a in CDCl3 
 
Figure A.10: 
1
H spectrum of 8b in CD2Cl2 
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Figure A.11: 
1
H NMR spectrum of 9a in CD2Cl2 
 
Figure A.12: 
13
C NMR spectrum of 10a in CD2Cl2 
 
161 
 
 
Figure A.13: 
11
B NMR spectrum of 9a in CD2Cl2 
 
Figure A.14: 
1
H NMR spectrum of 10a in CD2Cl2 
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Figure A.15: 
13
C NMR spectrum of 10a in CD2Cl2 
 
Figure A.16: 
11
B NMR spectrum of 10a in CD2Cl2 
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Figure A.17: 
1
H NMR spectrum of 10b in CD2Cl2 
 
  
Figure A.18: 
13
C NMR spectrum of 10b in CD2Cl2 
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Figure A.19: 
11
B NMR spectrum of 10b in CD2Cl2 
 
 
 Figure A.20: 
1
H NMR spectrum of 10c in CD2Cl2 
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Figure A.21: 
13
C NMR spectrum of 13 in CDCl3 
 
 
Figure A.22: 
11
B NMR spectrum of 13 in CD2Cl2 
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Figure A.23: 
1
H NMR spectrum of 13 in CD2Cl2 
 
 Figure A.24: 
13
C NMR spectrum of 13 in CD2Cl2 
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Figure A.25: 
11
B NMR spectrum of 13 in CD2Cl2 
  
Figure A.26: 
1
H NMR spectrum of 14 in CD2Cl2 
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 Figure A.27: 
13
C NMR spectrum of 14 in CD2Cl2 
  
Figure A.28: 
11
B NMR spectrum of 14 in CD2Cl2 
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Figure A.29: 
1
H NMR spectrum of 17a in CDCl3 
 
 
Figure A.30: 
13
C NMR spectrum of 17a in CDCl3 
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Figure A.31: 
11
B NMR spectrum of 17a in CDCl3 
 
Figure A.32: 
1
H NMR spectrum of 17b in CD2Cl2 
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Figure A.33: 
13
C NMR spectrum of 17b in CD2Cl2 
 
Figure A.34: 
11
B NMR spectrum of 17b in CD2Cl2 
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Figure A.35: 
1
H NMR spectrum of 18 in CD2Cl2 
 
Figure A. 36: 13C NMR spectrum of 18 in CD2Cl2 
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Figure A.37: 11B NMR spectrum of 18 in CD2Cl2 
  
Figure A.38: 
1
H NMR spectrum of 19 in CD2Cl2 
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Figure A.39: 
13
C NMR spectrum of 19 in CD2Cl2 
 
Figure A.40: 11B NMR spectrum of 19 in CD2Cl2 
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Figure A.41: 
1
H NMR spectrum of 20 in CDCl3 
 
 
Figure A.42: 
13
C NMR spectrum of 20 in CDCl3 
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Figure A.43: 
11
B NMR spectrum of 20 in CDCl3 
 
 
 Figure A.44: 
1
H NMR spectrum of 21 in CDCl3 
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Figure A.45: 
13
C NMR spectrum of 21 in CDCl3 
  
Figure A.46: 11B NMR spectrum of 21 in CDCl3 
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Figure A.47: 
1
H NMR spectrum of 23 in CDCl3 
 
Figure A.48: 
13
C NMR spectrum of 23 in CDCl3 
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Figure A.49: 
11
B NMR spectrum of 23 in CDCl3 
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APPENDIX B: NMR Characterization of Compounds Found in Chapter 3 
 
Figure B.1: 
1
H NMR spectrum of 3a in CDCl3 
 
Figure B.2:
13
C NMR spectrum of 3a in CDCl3 
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Figure B.3: 
11
B NMR spectrum of 3a in CDCl3 
 
 
Figure B.4: 
1
H NMR spectrum of 3b in CD2Cl2 
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Figure B.5: 
13
C NMR spectrum of 3b in CD2Cl2 
 
Figure B.6: 
11
B NMR spectrum of 3b in CD2Cl2 
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Figure B.7: 
1
H NMR spectrum of 3c in CD2Cl2 
 
 
Figure B.8: 
13
C NMR spectrum of 3c in CD2Cl2 
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Figure B.9: 
11
B NMR spectrum of 3c in CD2Cl2 
 
Figure B.10: 
1
H NMR spectrum of 4 in CDCl3 
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Figure B.11: 
13
C NMR spectrum of 4 in CDCl3 
 
Figure B.12: 
11
B NMR spectrum of 4 in CDCl3 
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Figure B.13: 
1
H NMR spectrum of 6 in CDCl3 
 
Figure B.14: 
13
C NMR spectrum of 6 in CDCl3 
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Figure B.15: 
11
B NMR spectrum of 6 in CDCl3 
 
 
Figure B.16: 
1
H NMR spectrum of 7 in CD2Cl2 
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Figure B.17: 
13
C NMR spectrum of 7 in CD2Cl2 
 
Figure B.18: 
11
B NMR spectrum of 7 in CD2Cl2 
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Figure B.19: 
1
H NMR spectrum of 8a in CDCl3 
 
Figure B.20: 
13
C NMR spectrum of 8a in CDCl3 
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Figure B.21: 
11
B NMR spectrum of 8a in CDCl3 
 
 
Figure B.22: 
1
H NMR spectrum of 8b in CDCl3 
191 
 
 
Figure B.23: 
13
C NMR spectrum of 8b in CDCl3 
 
Figure B.24: 
11
B NMR spectrum of 8b in CDCl3 
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Figure B.25: 
1
H NMR spectrum of 10 in CDCl3 
 
 
Figure B.26: 
13
C NMR spectrum of 10 in CDCl3 
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Figure B.27: 
11
B NMR spectrum of 10 in CDCl3 
 
 
Figure B.28: 
1
H NMR spectrum of 11 in CD2Cl2 
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Figure B.29: 
13
C NMR spectrum of 11 in CD2Cl2 
 
 
Figure B.30: 
11
B NMR spectrum of 11 in CD2Cl2 
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Figure B.31: 
1
H NMR spectrum of 12 in CD2Cl2 
 
Figure B.32: 
13
C NMR spectrum of 12 in CD2Cl2 
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Figure B.33: 
11
B NMR spectrum of 12 in CD2Cl2 
 
Figure B.34: 
1
H NMR spectrum of 13 in CD2Cl2 
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Figure B.35: 
13
C NMR spectrum of 13 in CD2Cl2 
 
Figure B.36: 
11
B NMR spectrum of 13 in CD2Cl2 
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Figure B.37: 
1
H NMR spectrum of 14 in CD2Cl2 
 
Figure B.38: 
13
C NMR spectrum of 14 in CD2Cl2 
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Figure B.39: 
11
B NMR spectrum of 14 in CD2Cl2 
 
Figure B.40: 
1
H NMR spectrum of 15 in CD2Cl2 
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Figure B.41: 
13
C NMR spectrum of 15 in CD2Cl2 
 
Figure B.42: 
11
B NMR spectrum of 15 in CD2Cl2 
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Figure B.43: 
1
H NMR spectrum of 16 in CD2Cl2 
 
Figure B.44: 
13
C NMR spectrum of 16 in CD2Cl2 
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Figure B.45: 
11
B NMR spectrum of 16 in CD2Cl2 
 
Figure B.46: 
1
H NMR spectrum of 17 in CDCl3 
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Figure B.47: 
13
C NMR spectrum of 17 in CDCl3 
 
Figure B.48: 
11
B NMR spectrum of 17 in CDCl3 
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Figure B.49: 
1
H NMR spectrum of 18 in CD2Cl2 
 
Figure B.50: 
13
C NMR spectrum of 18 in CD2Cl2 
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Figure B.51: 
11
B NMR spectrum of 18 in CD2Cl2 
 
Figure B.52: 
1
H NMR spectrum of 19 in CDCl3 
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Figure B.53: 
13
C NMR spectrum of 19 in CDCl3 
 
Figure B.54: 
11
B NMR spectrum of 19 in CDCl3 
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Figure B.55: 
1
H NMR spectrum of 20 in CD2Cl2 
 
Figure B.56: 
13
C NMR spectrum of 20 in CD2Cl2 
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Figure B.57: 
11
B NMR spectrum of 20 in CD2Cl2 
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APPENDIX C: NMR Characterization of Compounds Found in Chapter 4 
 
 
Figure C.1: 
1
H NMR spectrum of BODIPY 2c in CD2Cl2 
 
 
Figure C.2: 
13
C NMR spectrum of BODIPY 2c in CD2Cl2 
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Figure C.3: 
11
B NMR spectrum of BODIPY 2c in CD2Cl2 
 
 
Figure C.4: 
19
F NMR spectrum of BODIPY 2c in CD2Cl2 
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Figure C.5: 
1
H NMR spectrum of BODIPY 2d in CDCl3 
 
 
Figure C.6: 
13
C NMR spectrum of BODIPY 2d in CDCl3 
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Figure C.7: 
11
B NMR spectrum of BODIPY 2d in CDCl3 
 
 
Figure C.8: 
19
F NMR spectrum of BODIPY 2d in CDCl3 
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Figure C.9: 
1
H NMR spectrum of BODIPY 2e in CD2Cl2 
 
Figure C.10: 
13
C NMR spectrum of BODIPY 2e in CD2Cl2 
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Figure C.11: 
11
B NMR spectrum of BODIPY 2e in CD2Cl2 
 
 
Figure C.12: 
11
B NMR spectrum of BODIPY 2e in CD2Cl2 
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Figure C.13: 
1
H NMR spectrum of BODIPY 2f in CDCl3 
 
 
Figure C.14: 
13
C NMR spectrum of BODIPY 2f in CDCl3 
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Figure C.15: 
11
B NMR spectrum of BODIPY 2f in CDCl3 
 
Figure C.16: 
1
H NMR spectrum of BODIPY 2g in CD2Cl2 
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Figure C.17: 
13
C NMR spectrum of BODIPY 2g in CD2Cl2 
 
 
Figure C.18: 
11
B NMR spectrum of BODIPY 2g in CD2Cl2 
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Figure C.19: 
1
H NMR spectrum of BODIPY 2h in CDCl3 
 
Figure C.20: 
13
C NMR spectrum of BODIPY 2h in CD2Cl2 
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Figure C.21: 
11
B NMR spectrum of BODIPY 2h in CD2Cl2 
 
Figure C.22: 
1
H NMR spectrum of BODIPY 2i in CD2Cl2 
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Figure C.23: 
13
C NMR spectrum of BODIPY 2i in CD2Cl2 
 
Figure C.24: 
11
B NMR spectrum of BODIPY 2i in CD2Cl2 
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Figure C.25: 
19
F NMR spectrum of BODIPY 2i in CD2Cl2 
 
Figure C.26: 
1
H NMR spectrum of BODIPY 4a in CDCl3 
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Figure C.27: 
13
C NMR spectrum of BODIPY 4a in CDCl3 
 
 
Figure C.28: 
11
B NMR spectrum of BODIPY 4a in CDCl3 
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Figure C.29: 
19
F NMR spectrum of BODIPY 4a in CDCl3 
 
 
Figure C.30: 
1
H NMR spectrum of BODIPY 4b in CD2Cl2 
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Figure C.31: 
13
C NMR spectrum of BODIPY 4b in CD2Cl2 
 
Figure C.32: 
11
B NMR spectrum of BODIPY 4b in CD2Cl2 
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Figure C.33: 
19
F NMR spectrum of BODIPY 4b in CD2Cl2 
 
 
Figure C.34: 
1
H NMR spectrum of BODIPY 4c in CD2Cl2 
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Figure C.35: 
13
C NMR spectrum of BODIPY 2h in CD2Cl2 
 
 
Figure C.36: 
11
B NMR spectrum of BODIPY 4c in CD2Cl2 
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Figure C.37: 
19
F NMR spectrum of BODIPY 4c in CD2Cl2 
 
 
Figure C.38: 
1
H NMR spectrum of BODIPY 4d in CD2Cl2 
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Figure C.39: 
13
C NMR spectrum of BODIPY 4d in CD2Cl2 
 
Figure C.40: 
11
B NMR spectrum of BODIPY 4d in CD2Cl2 
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Figure C.41: 
19
F NMR spectrum of BODIPY 4d in CD2Cl2 
 
Figure C.42: 
1
H NMR spectrum of BODIPY 4e in CD2Cl2 
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Figure C.43: 
13
C NMR spectrum of BODIPY 4e in CD2Cl2 
 
Figure C.44: 
11
B NMR spectrum of BODIPY 4e in CD2Cl2 
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Figure C.45: 
19
F NMR spectrum of BODIPY 4e in CD2Cl2 
 
 
Figure C.46: 
1
H NMR spectrum of BODIPY 4f in CD2Cl2 
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Figure C.47: 
13
C NMR spectrum of BODIPY 4f in CD2Cl2 
 
 
Figure C.48: 
11
B NMR spectrum of BODIPY 4f in CD2Cl2 
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Figure C.49: 
1
H NMR spectrum of BODIPY 4g in CDCl3 
 
 
Figure C.50: 
13
C NMR spectrum of BODIPY 4g in CD2Cl2 
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Figure C.51: 
11
B NMR spectrum of BODIPY 4g in CD2Cl2 
 
Figure C.52: 
1
H NMR spectrum of BODIPY 4h in CD2Cl2 
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Figure C.53: 
13
C NMR spectrum of BODIPY 4h in CD2Cl2 
 
Figure C.54: 
11
B NMR spectrum of BODIPY 4h in CD2Cl2 
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Figure C.55: 
1
H NMR spectrum of BODIPY 4i in CD2Cl2 
 
 
Figure C.56: 
13
C NMR spectrum of BODIPY 4i in CD2Cl2 
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Figure C.57: 
11
B NMR spectrum of BODIPY 4i in CD2Cl2 
 
 
Figure C.58: 
19
F NMR spectrum of BODIPY 4i in CD2Cl2 
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Figure C.59: 
1
H NMR spectrum of BODIPY 4j in CD2Cl2 
 
 
Figure C.60: 
13
C NMR spectrum of BODIPY 4j in CD2Cl2 
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Figure C.61: 
11
B NMR spectrum of BODIPY 4j in CD2Cl2 
 
 
Figure C.62: 
19
F NMR spectrum of BODIPY 4j in CD2Cl2 
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Figure C.63: 
1
H NMR spectrum of BODIPY 4k in CD2Cl2 
 
 
Figure C.64: 
13
C NMR spectrum of BODIPY 4k in CD2Cl2 
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Figure C.65: 
11
B NMR spectrum of BODIPY 4k in CD2Cl2 
 
 
Figure C.66: 
19
F NMR spectrum of BODIPY 4k in CD2Cl2 
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Figure C.67: 
1
H NMR spectrum of BODIPY 5b in CD2Cl2 
 
Figure C.68: 
13
C NMR spectrum of BODIPY 5b in CD2Cl2 
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Figure C.69: 
1
H NMR spectrum of BODIPY 6b in CD2Cl2 
 
Figure C.70: 
13
C NMR spectrum of BODIPY 6b in CD2Cl2 
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Figure C.71: 
11
B NMR spectrum of BODIPY 6b in CD2Cl2 
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APPENDIX D: NMR Characterization of Compounds Found in Chapter 5 
 
Figure D.1: 
1
H NMR spectrum of 2 in CD2Cl2 
 
Figure D.2: 
11
B NMR spectrum of 2 in CD2Cl2 
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Figure D.3: 
1
H NMR spectrum of 4 in CDCl3 
 
Figure D.4: 
1
H NMR spectrum of 5 in CD2Cl2 
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Figure D.5: 
13
C NMR spectrum of 5 in CD2Cl2 
 
Figure D.6: 
11
B NMR spectrum of 5 in CD2Cl2 
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Figure D.7: 
1
H NMR spectrum of 6 in CD2Cl2 
 
Figure D.8: 
11
B NMR spectrum of 6 in CD2Cl2 
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Figure D.9: 
1
H NMR spectrum of 7 in CD2Cl2 
 
 
Figure D.10: 
13
C NMR spectrum of 7 in CD2Cl2 
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Figure D.11: 
11
B NMR spectrum of 7 in CD2Cl2 
 
Figure D.12: 
1
H NMR spectrum of 8 in CDCl3 
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Figure D.13: 
13
C NMR spectrum of 8 in CDCl3 
 
Figure D.14: 
11
B NMR spectrum of 8 in CDCl3 
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Figure D.15: 
1
H NMR spectrum of 9 in CD2Cl2 
 
Figure D.16: 
13
C NMR spectrum of 9 in CD2Cl2 
253 
 
 
Figure D.17: 
11
B NMR spectrum of 9 in CD2Cl2 
 
Figure D.18: 
1
H NMR spectrum of 13 in CD2Cl2 
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Figure D.19: 
11
B NMR spectrum of 13 in CD2Cl2 
 
Figure D.20: 
1
H NMR spectrum of 14 in CD2Cl2 
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Figure D.21: 
11
B NMR spectrum of 14 in CD2Cl2 
 
Figure D.22: 
1
H NMR spectrum of 17 in CDCl3 
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Figure D.23: 
13
C NMR spectrum of 17 in CDCl3 
 
Figure D.24: 
11
B NMR spectrum of 17 in CDCl3 
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Figure D.25: 
1
H NMR spectrum of 18 in CD2Cl2 
 
Figure D.26: 
13
C NMR spectrum of 18 in CD2Cl2 
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Figure D.27: 
11
B NMR spectrum of 18 in CD2Cl2 
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